{
 "cells": [
  {
   "attachments": {
    "val4.png": {
     "image/png": "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"
    }
   },
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Assignment on clinical trial data\n",
    "\n",
    "## About assignment: \n",
    "\n",
    ">Objective: Help people to discover relevant clinical trials suitable to their needs from a corpus of trials specific to the medical condition. Each clinical trial is defined by a set of inclusion and exclusion criteria specified in the text. Criteria can be demographic parameters like age, gender, location etc. and medical parameters like platelets count, sugar level etc. Visitors can search for trails by selecting medical condition,\n",
    "specific demographic attributes and answering condition to specific questions that help to narrow down hundreds of trials to 10-15 trials. We need to identify set of questions(for each medical condition) that we can ask visitors \n",
    "and those should help to identify or filter relevant clinical trials.\n",
    "\n",
    "## Question: How do we identify these questions that will help us to narrow down the clinical trials from 100 to 10-15?\n",
    "\n",
    "--------------------------------------------------------------------------------------------------------------------\n",
    "### Let's summarize the objective and Question\n",
    "+ Questions need to be identified for each medical condition\n",
    "+ For each medical condition several clinical trials are availabel\n",
    "+ $\\forall$ medical conditions, Each clinical trial = {demographic parameters, medical parameters}\n",
    "+ For each medical condition, Finding questions => identifying important features/attributes that 'best separates' various clinical trials availabel. \n",
    "\n",
    "### Solution approach:\n",
    "+ We should look for those trial atributes which have maximum discriminatory power in terms of separating clinical trials,  $X_i$'s\n",
    "+ For example, features such as medical Conditions, Gender, Age, Phases reduces the search space ( $\\Omega$) significantly. Also, we can use trial location (if given) to reduce $\\Omega$\n",
    "    * We can create a boolean-mask on whole dataframe and filer out the required data based on given input\n",
    "+ We can monitor the matching trials after each given input, If at any of this matching stage the, $|\\Omega| \\leq 15$ we show the results.  \n",
    "+ Otherwise, we need to further reduce $\\Omega$,  we need to ask more specific questions based on trial parameters.\n",
    "+ For this we can consider following,\n",
    "#### Approach :\n",
    "\n",
    "     ![val4.png](attachment:val4.png)\n",
    "\n",
    "+ We can extract the information from strings of dataframe columns, by identifying patterns in string to get features (For example, We can extract unique types of Intervention methods)\n",
    "+ We are looking for categorical variables which will partition the $\\Omega$ into many subparts (see fig. for explanation)\n",
    "\n",
    "Let's see How we can implement this approach in real world clinical trials data set\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "import matplotlib.pyplot as plt\n",
    "from collections import Counter\n",
    "from tqdm import tqdm\n",
    "from difflib import SequenceMatcher\n",
    "from sklearn import metrics\n",
    "import itertools\n",
    "%matplotlib inline"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Working with publically available dataset from https://ClinicalTrials.gov/ with All atributes and Recruiment= Recruiting"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(10000, 26)\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style>\n",
       "    .dataframe thead tr:only-child th {\n",
       "        text-align: right;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: left;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Rank</th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Title</th>\n",
       "      <th>Recruitment</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Sponsor/Collaborators</th>\n",
       "      <th>Gender</th>\n",
       "      <th>Age</th>\n",
       "      <th>...</th>\n",
       "      <th>First Received</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>Last Updated</th>\n",
       "      <th>Last Verified</th>\n",
       "      <th>Results First Received</th>\n",
       "      <th>Acronym</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Outcome Measures</th>\n",
       "      <th>URL</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1</td>\n",
       "      <td>NCT03269526</td>\n",
       "      <td>BATs Treatment for Pancreatic Cancer, Phase Ib/II</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Locally Advanced Pancreatic Adenocarcinoma|Met...</td>\n",
       "      <td>Drug: EGFR BATs after standard of care chemo</td>\n",
       "      <td>University of Virginia</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>...</td>\n",
       "      <td>August 11, 2017</td>\n",
       "      <td>July 28, 2017</td>\n",
       "      <td>June 1, 2022</td>\n",
       "      <td>August 30, 2017</td>\n",
       "      <td>August 2017</td>\n",
       "      <td>No Study Results Posted</td>\n",
       "      <td>null</td>\n",
       "      <td>June 1, 2020</td>\n",
       "      <td>Incidence of adverse events|Overall survival|C...</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT03269526</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2</td>\n",
       "      <td>NCT03269422</td>\n",
       "      <td>Radiotherapy to the Prostate and Dominant Intr...</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Prostate Cancer</td>\n",
       "      <td>Radiation: MR-based image-guided, intensity-mo...</td>\n",
       "      <td>Memorial Sloan Kettering Cancer Center</td>\n",
       "      <td>Male</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>...</td>\n",
       "      <td>August 29, 2017</td>\n",
       "      <td>August 28, 2017</td>\n",
       "      <td>August 28, 2019</td>\n",
       "      <td>August 30, 2017</td>\n",
       "      <td>August 2017</td>\n",
       "      <td>No Study Results Posted</td>\n",
       "      <td>null</td>\n",
       "      <td>August 28, 2019</td>\n",
       "      <td>Treatment related toxicity of ultra-hypofracti...</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT03269422</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>3</td>\n",
       "      <td>NCT03269344</td>\n",
       "      <td>Gabapentin for the Reduction of Radiation Ther...</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Oropharynx Cancer</td>\n",
       "      <td>Drug: Gabapentin|Drug: Placebo Oral Capsule</td>\n",
       "      <td>Henry Ford Health System</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>...</td>\n",
       "      <td>June 5, 2017</td>\n",
       "      <td>June 5, 2017</td>\n",
       "      <td>March 2019</td>\n",
       "      <td>August 30, 2017</td>\n",
       "      <td>August 2017</td>\n",
       "      <td>No Study Results Posted</td>\n",
       "      <td>null</td>\n",
       "      <td>January 2019</td>\n",
       "      <td>Change in quality of life from mucositis measu...</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT03269344</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>4</td>\n",
       "      <td>NCT03269279</td>\n",
       "      <td>Mifepristone and Misoprostol for 2nd Trimester...</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Medical; Abortion, Fetus</td>\n",
       "      <td>Drug: Mifepristone|Drug: Misoprostol</td>\n",
       "      <td>Gynuity Health Projects</td>\n",
       "      <td>Female</td>\n",
       "      <td>Child, Adult, Senior</td>\n",
       "      <td>...</td>\n",
       "      <td>July 14, 2017</td>\n",
       "      <td>May 20, 2017</td>\n",
       "      <td>May 19, 2018</td>\n",
       "      <td>August 30, 2017</td>\n",
       "      <td>August 2017</td>\n",
       "      <td>No Study Results Posted</td>\n",
       "      <td>null</td>\n",
       "      <td>May 19, 2018</td>\n",
       "      <td>Rate of successful abortion</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT03269279</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>5</td>\n",
       "      <td>NCT03269227</td>\n",
       "      <td>Accelerated Hypofractionated Radiotherapy in t...</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Malignant Pleural Mesothelioma</td>\n",
       "      <td>Radiation: Accelerated hypofractionation with ...</td>\n",
       "      <td>Istituto Scientifico Romagnolo per lo Studio e...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 85 Years   (Adult, Senior)</td>\n",
       "      <td>...</td>\n",
       "      <td>August 16, 2017</td>\n",
       "      <td>August 2017</td>\n",
       "      <td>July 2020</td>\n",
       "      <td>August 29, 2017</td>\n",
       "      <td>August 2017</td>\n",
       "      <td>No Study Results Posted</td>\n",
       "      <td>MesoRT</td>\n",
       "      <td>July 2020</td>\n",
       "      <td>assessment of acute and late toxicity|Overall ...</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT03269227</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows × 26 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "   Rank   NCT Number                                              Title  \\\n",
       "0     1  NCT03269526  BATs Treatment for Pancreatic Cancer, Phase Ib/II   \n",
       "1     2  NCT03269422  Radiotherapy to the Prostate and Dominant Intr...   \n",
       "2     3  NCT03269344  Gabapentin for the Reduction of Radiation Ther...   \n",
       "3     4  NCT03269279  Mifepristone and Misoprostol for 2nd Trimester...   \n",
       "4     5  NCT03269227  Accelerated Hypofractionated Radiotherapy in t...   \n",
       "\n",
       "  Recruitment         Study Results  \\\n",
       "0  Recruiting  No Results Available   \n",
       "1  Recruiting  No Results Available   \n",
       "2  Recruiting  No Results Available   \n",
       "3  Recruiting  No Results Available   \n",
       "4  Recruiting  No Results Available   \n",
       "\n",
       "                                          Conditions  \\\n",
       "0  Locally Advanced Pancreatic Adenocarcinoma|Met...   \n",
       "1                                    Prostate Cancer   \n",
       "2                                  Oropharynx Cancer   \n",
       "3                           Medical; Abortion, Fetus   \n",
       "4                     Malignant Pleural Mesothelioma   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0       Drug: EGFR BATs after standard of care chemo   \n",
       "1  Radiation: MR-based image-guided, intensity-mo...   \n",
       "2        Drug: Gabapentin|Drug: Placebo Oral Capsule   \n",
       "3               Drug: Mifepristone|Drug: Misoprostol   \n",
       "4  Radiation: Accelerated hypofractionation with ...   \n",
       "\n",
       "                               Sponsor/Collaborators  Gender  \\\n",
       "0                             University of Virginia     All   \n",
       "1             Memorial Sloan Kettering Cancer Center    Male   \n",
       "2                           Henry Ford Health System     All   \n",
       "3                            Gynuity Health Projects  Female   \n",
       "4  Istituto Scientifico Romagnolo per lo Studio e...     All   \n",
       "\n",
       "                                      Age  \\\n",
       "0    18 Years and older   (Adult, Senior)   \n",
       "1    18 Years and older   (Adult, Senior)   \n",
       "2    18 Years and older   (Adult, Senior)   \n",
       "3                    Child, Adult, Senior   \n",
       "4  18 Years to 85 Years   (Adult, Senior)   \n",
       "\n",
       "                      ...                        First Received  \\\n",
       "0                     ...                       August 11, 2017   \n",
       "1                     ...                       August 29, 2017   \n",
       "2                     ...                          June 5, 2017   \n",
       "3                     ...                         July 14, 2017   \n",
       "4                     ...                       August 16, 2017   \n",
       "\n",
       "        Start Date  Completion Date     Last Updated Last Verified  \\\n",
       "0    July 28, 2017     June 1, 2022  August 30, 2017   August 2017   \n",
       "1  August 28, 2017  August 28, 2019  August 30, 2017   August 2017   \n",
       "2     June 5, 2017       March 2019  August 30, 2017   August 2017   \n",
       "3     May 20, 2017     May 19, 2018  August 30, 2017   August 2017   \n",
       "4      August 2017        July 2020  August 29, 2017   August 2017   \n",
       "\n",
       "    Results First Received Acronym Primary Completion Date  \\\n",
       "0  No Study Results Posted    null            June 1, 2020   \n",
       "1  No Study Results Posted    null         August 28, 2019   \n",
       "2  No Study Results Posted    null            January 2019   \n",
       "3  No Study Results Posted    null            May 19, 2018   \n",
       "4  No Study Results Posted  MesoRT               July 2020   \n",
       "\n",
       "                                    Outcome Measures  \\\n",
       "0  Incidence of adverse events|Overall survival|C...   \n",
       "1  Treatment related toxicity of ultra-hypofracti...   \n",
       "2  Change in quality of life from mucositis measu...   \n",
       "3                        Rate of successful abortion   \n",
       "4  assessment of acute and late toxicity|Overall ...   \n",
       "\n",
       "                                           URL  \n",
       "0  https://ClinicalTrials.gov/show/NCT03269526  \n",
       "1  https://ClinicalTrials.gov/show/NCT03269422  \n",
       "2  https://ClinicalTrials.gov/show/NCT03269344  \n",
       "3  https://ClinicalTrials.gov/show/NCT03269279  \n",
       "4  https://ClinicalTrials.gov/show/NCT03269227  \n",
       "\n",
       "[5 rows x 26 columns]"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df = pd.read_csv('Clinical_trials.csv')  # Read CSV\n",
    "print df.shape   # 10000 Clinical trails, with all 26 atributes\n",
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index([u'Rank', u'NCT Number', u'Title', u'Recruitment', u'Study Results',\n",
       "       u'Conditions', u'Interventions', u'Sponsor/Collaborators', u'Gender',\n",
       "       u'Age', u'Phases', u'Enrollment', u'Funded Bys', u'Study Types',\n",
       "       u'Study Designs', u'Other IDs', u'First Received', u'Start Date',\n",
       "       u'Completion Date', u'Last Updated', u'Last Verified',\n",
       "       u'Results First Received', u'Acronym', u'Primary Completion Date',\n",
       "       u'Outcome Measures', u'URL'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.keys()  # Attributes list"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Basic Exploration"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "10000\n"
     ]
    }
   ],
   "source": [
    "print len(df['NCT Number'].unique()) # All trials are different, Trails are linked to title uniquely.   "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'Recruiting'}"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "set(df['Recruitment'].values ) # Same value in all rows"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'No Results Available'}"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "set(df['Study Results'].values) # Same value in all rows"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "---\n",
    "Gives current enrollment ($E$) in each trail, We can turn this into a categorical variable with categories small_scale ($E\\leq 100$), medium_scale ( $ 100 < E \\leq 1000$), large_scale ($E > 1000$),   "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(array([ 1862.,   785.,   492.]),\n",
       " array([100, 200, 300, 400]),\n",
       " <a list of 3 Patch objects>)"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAYEAAAD8CAYAAACRkhiPAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\npI4ZApLUsX8GkyKuQ/65w5EAAAAASUVORK5CYII=\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7f56ada491d0>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# See distribution of number of enrollments to decide scale thresholds\n",
    "#plt.ylim(0, 20)\n",
    "plt.hist(sorted(df[df['Enrollment'].values != 'null'].Enrollment.values.astype(int))[::-1], bins=[100*i for i in range(1,5)])\n",
    "#pd.cut(df['Enrollment'].values.astype(int), range(1,2000, 1000) , right=False)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "6618"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(df['Conditions'].unique()) # Some clinical trials are for same/similar medical condition, Let's group data by medical conditions"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Conditions\n",
       "3 or More Chronic Conditions for 6 Months or Longer|5 or More Regular Drugs                                                                                                                                                                                                                                                                                                           2\n",
       "A Patient Discharged From an Acute-care Hospital Who Had an Acute Illness                                                                                                                                                                                                                                                                                                             1\n",
       "ACL Injury|ACL - Anterior Cruciate Ligament Rupture|ACL Sprain|ACL Tear                                                                                                                                                                                                                                                                                                               1\n",
       "ACS - Acute Coronary Syndrome                                                                                                                                                                                                                                                                                                                                                         1\n",
       "ADHD                                                                                                                                                                                                                                                                                                                                                                                  2\n",
       "ADHD|Insomnia                                                                                                                                                                                                                                                                                                                                                                         1\n",
       "ADHD|Lifestyle-Related Condition|Food Habits                                                                                                                                                                                                                                                                                                                                          1\n",
       "AL Amyloidosis                                                                                                                                                                                                                                                                                                                                                                        3\n",
       "ALK Gene Mutation|BRAF Gene Mutation|EGFR Gene Mutation|Head and Neck Squamous Cell Carcinoma|Metastatic Head and Neck Carcinoma|Recurrent Head and Neck Carcinoma|Recurrent Non-Small Cell Lung Carcinoma|ROS1 Gene Mutation|Stage III Non-Small Cell Lung Cancer|Stage IIIA Non-Small Cell Lung Cancer|Stage IIIB Non-Small Cell Lung Cancer|Stage IV Non-Small Cell Lung Cancer    1\n",
       "ALK Gene Mutation|EGFR Gene Mutation|Recurrent Non-Small Cell Lung Carcinoma|Stage IIIB Non-Small Cell Lung Cancer|Stage IV Non-Small Cell Lung Cancer                                                                                                                                                                                                                                1\n",
       "ALK-positive Non-small Cell Lung Cancer (NSCLC)|RET-positive Non-small Cell Lung Cancer (NSCLC)|RET-positive Thyroid Cancer                                                                                                                                                                                                                                                           1\n",
       "ALL, Recurrent, Adult                                                                                                                                                                                                                                                                                                                                                                 1\n",
       "ALS                                                                                                                                                                                                                                                                                                                                                                                   1\n",
       "AML                                                                                                                                                                                                                                                                                                                                                                                   4\n",
       "AML, Adult                                                                                                                                                                                                                                                                                                                                                                            1\n",
       "AML|FLT3-ITD Mutation                                                                                                                                                                                                                                                                                                                                                                 1\n",
       "ANCA-Associated Vasculitis                                                                                                                                                                                                                                                                                                                                                            1\n",
       "ARDS                                                                                                                                                                                                                                                                                                                                                                                  3\n",
       "Abdominal Aortic Aneurysm                                                                                                                                                                                                                                                                                                                                                             1\n",
       "Abdominal Aortic Aneurysm (AAA)                                                                                                                                                                                                                                                                                                                                                       1\n",
       "Abdominal Cancer                                                                                                                                                                                                                                                                                                                                                                      1\n",
       "Abdominal Obesity Metabolic Syndrome                                                                                                                                                                                                                                                                                                                                                  2\n",
       "Abdominal Obesity|Metabolic Syndrome|Disability Physical|Sarcopenic Obesity|Hypertension|Overweight and Obesity|Cardiovascular Risk Factor                                                                                                                                                                                                                                            1\n",
       "Abdominal Pain|Functional Gastrointestinal Disorders                                                                                                                                                                                                                                                                                                                                  1\n",
       "Abdominal Tumor|Abdominal Infection                                                                                                                                                                                                                                                                                                                                                   1\n",
       "Abdominal Wall Defect                                                                                                                                                                                                                                                                                                                                                                 1\n",
       "Abducens Nerve Paralysis                                                                                                                                                                                                                                                                                                                                                              1\n",
       "Abortion                                                                                                                                                                                                                                                                                                                                                                              1\n",
       "Abortion Early                                                                                                                                                                                                                                                                                                                                                                        1\n",
       "Abortion, Induced|Cervical Preparation|Pain                                                                                                                                                                                                                                                                                                                                           1\n",
       "                                                                                                                                                                                                                                                                                                                                                                                     ..\n",
       "Wound                                                                                                                                                                                                                                                                                                                                                                                 1\n",
       "Wound Complication                                                                                                                                                                                                                                                                                                                                                                    1\n",
       "Wound Heal                                                                                                                                                                                                                                                                                                                                                                            1\n",
       "Wound Infection                                                                                                                                                                                                                                                                                                                                                                       1\n",
       "Wound Vac|Suture                                                                                                                                                                                                                                                                                                                                                                      1\n",
       "Wound of Skin                                                                                                                                                                                                                                                                                                                                                                         1\n",
       "Wound, Nonpenetrating                                                                                                                                                                                                                                                                                                                                                                 1\n",
       "Wounds and Injuries                                                                                                                                                                                                                                                                                                                                                                   1\n",
       "Wounds and Injuries|Trauma                                                                                                                                                                                                                                                                                                                                                            1\n",
       "Wrinkle Severity Rating Scale(WSRS) Grade 3 (Moderate) or 4 (Severe) of Nasolabial Folds                                                                                                                                                                                                                                                                                              1\n",
       "Wrinkle|Photoaging                                                                                                                                                                                                                                                                                                                                                                    1\n",
       "Wrist Injuries|Postoperative Pain Control                                                                                                                                                                                                                                                                                                                                             1\n",
       "Writer's Cramp                                                                                                                                                                                                                                                                                                                                                                        1\n",
       "X Fragile Syndrome                                                                                                                                                                                                                                                                                                                                                                    1\n",
       "X-Linked Myotubular Myopathy                                                                                                                                                                                                                                                                                                                                                          1\n",
       "X-Linked Retinitis Pigmentosa                                                                                                                                                                                                                                                                                                                                                         2\n",
       "X-linked Hypophosphatemic Rickets/Osteomalacia                                                                                                                                                                                                                                                                                                                                        1\n",
       "Xerosis|Xerosis Cutis|Dry Skin; Eczema                                                                                                                                                                                                                                                                                                                                                1\n",
       "Xerostomia                                                                                                                                                                                                                                                                                                                                                                            1\n",
       "Yellow Fever Vaccine|Yellow Fever                                                                                                                                                                                                                                                                                                                                                     1\n",
       "Young Adult, Cancer, Physical Activity                                                                                                                                                                                                                                                                                                                                                1\n",
       "Zenker Diverticulum                                                                                                                                                                                                                                                                                                                                                                   1\n",
       "Zika                                                                                                                                                                                                                                                                                                                                                                                  1\n",
       "Zika Virus                                                                                                                                                                                                                                                                                                                                                                            3\n",
       "Zika Virus Infection                                                                                                                                                                                                                                                                                                                                                                  2\n",
       "Zika Virus|Zika Virus Infection|Virus Diseases|Flavivirus Infections|Flaviviral Diseases|Flaviviridae Infections|RNA Virus Infections                                                                                                                                                                                                                                                 1\n",
       "a. Colorectal Cancer|b. High Grade Serous Ovarian Cancer|c. Non Small-cell Lung Cancer (Squamous Cell Variant)|d. Squamous Carcinoma of the Oesophagus|e. Squamous Carcinoma of the Head and Neck (HPV Negative)|f. Urothelial Cancer|g. Breast Cancer (Triple Negative Type)|h. Pancreatic Cancer                                                                                    1\n",
       "cMET Dysegulation Advanced Solid Tumors                                                                                                                                                                                                                                                                                                                                               1\n",
       "nCPAP|BiPAP|Respiratory Distress Syndrome                                                                                                                                                                                                                                                                                                                                             1\n",
       "the Use of Antidepressants in Patients With Bipolar Depression                                                                                                                                                                                                                                                                                                                        1\n",
       "Length: 6618, dtype: int64"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#Grouping is done based on string matching, so we see ADHD, ADHD|Insomnia, ADHD|Lifestyle-Related Condition|Food Habits  etc.\n",
    "#As different medical conditions, we would like to have these clubed together\n",
    "df.groupby('Conditions').size()  "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'Industry',\n",
       " 'Industry|NIH',\n",
       " 'Industry|NIH|Other',\n",
       " 'Industry|Other',\n",
       " 'Industry|Other|NIH',\n",
       " 'Industry|Other|U.S. Fed',\n",
       " 'Industry|U.S. Fed',\n",
       " 'Industry|U.S. Fed|Other',\n",
       " 'NIH',\n",
       " 'NIH|Industry|Other',\n",
       " 'NIH|Other|Industry',\n",
       " 'Other',\n",
       " 'Other|Industry',\n",
       " 'Other|Industry|NIH',\n",
       " 'Other|Industry|U.S. Fed',\n",
       " 'Other|NIH',\n",
       " 'Other|NIH|Industry',\n",
       " 'Other|NIH|U.S. Fed',\n",
       " 'Other|NIH|U.S. Fed|Industry',\n",
       " 'Other|U.S. Fed',\n",
       " 'Other|U.S. Fed|Industry',\n",
       " 'Other|U.S. Fed|NIH',\n",
       " 'U.S. Fed',\n",
       " 'U.S. Fed|Industry',\n",
       " 'U.S. Fed|Other',\n",
       " 'U.S. Fed|Other|Industry'}"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "set(df['Funded Bys'].values) # Trials are funded by one or group of institutions"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'Interventional'}"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "set(df['Study Types'].values)     # Downloaded only 'Interventional'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{nan,\n",
       " 'N-20160071',\n",
       " '1715-133-856',\n",
       " '15010MUHC',\n",
       " 'H1704-083-846',\n",
       " '201705166',\n",
       " 'ENMSET',\n",
       " '1400-0001|2016-003224-24',\n",
       " 'IRB00007128',\n",
       " '1014802-204|2015-004796-68',\n",
       " 'MCC-15-11083|NCI-2016-01980|P30CA016059',\n",
       " 'M16-17-027',\n",
       " 'EPOC1504',\n",
       " 'AAAR4283',\n",
       " '1501015803',\n",
       " '19399',\n",
       " 'VICC THO 1684|NCI-2016-01532',\n",
       " 'Poetry-1',\n",
       " '19713',\n",
       " 'RGV-GARM3',\n",
       " 'CHS01N-1892',\n",
       " 'PHD/0194/2557',\n",
       " 'CO-338-045|2015-004394-32',\n",
       " 'CR108261|2016-003328-22|56022473MDS2002',\n",
       " '4R15/032|PI15/00114|SLT002/16/00112',\n",
       " 'CAIN457AUS05T',\n",
       " '71542613',\n",
       " '2017/05/1',\n",
       " '16-1341',\n",
       " 'Gamma-GBM',\n",
       " '16-211-3',\n",
       " 'ACP-103-035|2016-003435-38',\n",
       " 'STU00203761',\n",
       " 'KYZ2016-006',\n",
       " 'GCT1021-01',\n",
       " 'FloridaIU',\n",
       " 'QPR-17-03',\n",
       " '1609018390',\n",
       " 'ENF_APO_2017',\n",
       " '2016P000268',\n",
       " 'STH19471',\n",
       " 'GCO 15-0980',\n",
       " 'D24-DIPG',\n",
       " 'MDV3800-01|C3441001|2016-002536-33',\n",
       " '20160711',\n",
       " 'STH19479',\n",
       " '9702 Breast PET Feasibility|16/LO/0507',\n",
       " 'FW2016-F09',\n",
       " '131115',\n",
       " 'VENS',\n",
       " 'TTYMG1403',\n",
       " 'H16-02273',\n",
       " 'OSR - Prot. SMARTAPP',\n",
       " '2000020343',\n",
       " 'CIP-1010',\n",
       " '16703',\n",
       " '999917103|17-DK-N103',\n",
       " 'CEP 2016-002',\n",
       " '105005',\n",
       " 'AdvocateHC',\n",
       " '4-2016-1025',\n",
       " '2016-39|2016-003196-21',\n",
       " 'STUDY00000969',\n",
       " 'Brainport-001',\n",
       " 'IRB00087397|NCI-2016-01594|Winship3321-16',\n",
       " 'PZT1401',\n",
       " '9521',\n",
       " '150606',\n",
       " 'CMRPG2E0341',\n",
       " '150601',\n",
       " '2016-0134',\n",
       " 'DOTANOC_contacts',\n",
       " 'Citologia anal',\n",
       " 'P17-37813005',\n",
       " '5160386|16042',\n",
       " '16D.557',\n",
       " 'Degarelix-AN003',\n",
       " 'J1693',\n",
       " 'DA038095',\n",
       " 'MA-16-12-01',\n",
       " '16342|I3Y-MC-JPCJ|2016-002218-36',\n",
       " 'ESR-15-11633',\n",
       " 'CHA-IRB-1029/03/16',\n",
       " 'HLUZ_001_2016',\n",
       " 'HELMET ver1.1',\n",
       " 'TP0112',\n",
       " 'ATR-101-301',\n",
       " '058',\n",
       " 'SLU254',\n",
       " 'Charite',\n",
       " 'HMS1312',\n",
       " '2016/135-31',\n",
       " 'RIPC-VOT',\n",
       " 'GK-MR/PET T\\xc3\\xbc-004',\n",
       " 'C.2016.021',\n",
       " 'L0264.2016',\n",
       " 'SIGHTVISCO-001',\n",
       " 'ADR-001-01',\n",
       " 'CV-0003|2017-000323-27',\n",
       " 'VICC URO 16133|NCI-2016-01795',\n",
       " '1-2016-0070',\n",
       " 'MANTRA',\n",
       " 'ASAQ-LA-DHAPQP 2015 DRC',\n",
       " '100/2016/O/Sper',\n",
       " '7355|K24DA029647',\n",
       " '639/2016',\n",
       " '40',\n",
       " 'CIP-0066',\n",
       " '15-011835',\n",
       " 'QassimU',\n",
       " 'EKNZ 2015-446',\n",
       " '15-6245H',\n",
       " 'C2561001|2017-000799-26',\n",
       " 'ILBS-Cirrhosis-12',\n",
       " 'ILBS-Cirrhosis-10',\n",
       " 'OSU-16023|NCI-2017-00848',\n",
       " 'IndonesiaUAnes020',\n",
       " '2015-734',\n",
       " '16-466',\n",
       " '16-467',\n",
       " 'A2study',\n",
       " 'P002-17-1.0',\n",
       " '782-14',\n",
       " 'SLNB5010',\n",
       " '201606057RINA',\n",
       " 'TR1-1',\n",
       " 'E7080-J081-116|KEYNOTE 524',\n",
       " 'HP-00067047',\n",
       " '9760|NCI-2017-00034|P30CA015704',\n",
       " '121-2016010',\n",
       " '2017/00138',\n",
       " 'MeirMc0321-16CTIL',\n",
       " 'MDCO-PCS-16-03',\n",
       " 'MDCO-PCS-16-02',\n",
       " 'MDCO-PCS-16-01',\n",
       " '63041516.7.0000.0068',\n",
       " '00042929',\n",
       " 'H-17007893',\n",
       " 'MeRT-TBI-005',\n",
       " 'N-49-2017',\n",
       " '66939530lp',\n",
       " 'IRB00097094',\n",
       " '17-002253',\n",
       " 'NL52257.091.15',\n",
       " 'IRB-7147',\n",
       " 'ND-201',\n",
       " 'GGH2016422H',\n",
       " 'propofol after sevo',\n",
       " 'ND-205',\n",
       " 'ND-204',\n",
       " 'ND-207',\n",
       " 'SC-01',\n",
       " '2016-7228',\n",
       " 'VGHKS104-062',\n",
       " 'CASE4516',\n",
       " 'SCARM-infertility-001',\n",
       " 'SCARM-infertility-002',\n",
       " 'SCARM-infertility-003',\n",
       " '170123|17-N-0123',\n",
       " '103-7425A3',\n",
       " 'I 33616|NCI-2017-00441|P30CA016056',\n",
       " 'CHN-PLAGH-BT-023',\n",
       " '205715',\n",
       " '2017VE',\n",
       " 'TCC_LARISSA NEVES',\n",
       " 'CIN-401',\n",
       " '930307',\n",
       " 'NKEXPGD2',\n",
       " 'PRT-201-115',\n",
       " 'CHA-IRB-1002/08/14_2',\n",
       " '15285',\n",
       " '2017-512',\n",
       " 'Card1',\n",
       " 'IC 2016-01 RadioPARP|2016-001837-28',\n",
       " 'AMD - 2015',\n",
       " '340559',\n",
       " 'Rehabilitation in asthma',\n",
       " 'TEATE study',\n",
       " 'CREC Ref. No.: 2016.348',\n",
       " 'N16INM',\n",
       " '161942|5K23GM117395-03',\n",
       " '2014/00345-0',\n",
       " '2016H0021',\n",
       " 'RDCRN7706',\n",
       " 'PI2015_843_0031',\n",
       " 'PI2015_843_0032',\n",
       " 'PI2015_843_0033',\n",
       " 'AJIRB-DEV-OBS-17-70',\n",
       " '1002-047|2016-003486-26',\n",
       " 'LG-GNCL001',\n",
       " 'IRB00094982',\n",
       " 'HMME-S1612',\n",
       " '16-071J-1',\n",
       " '007-15',\n",
       " '2508|90RE5020',\n",
       " 'NU 16B08|STU00203215|P30CA060553|NCI-2017-00152',\n",
       " '2016CD004',\n",
       " 'TV48125-CNS-30056|2016-003278-42',\n",
       " 'CIV-16-04-015264',\n",
       " '2016-1074',\n",
       " 'OSU-16070|NCI-2016-01560|P30CA016058',\n",
       " 'SDUSF-2014-5 - (10)|SDUSF-2015-20 - (115)',\n",
       " '2016-0300',\n",
       " 'OBG-2559-04137',\n",
       " 'HL001',\n",
       " 'SBI-101-01',\n",
       " 'SLDJBSG_DM',\n",
       " '4083-003',\n",
       " '4083-004',\n",
       " '201701096',\n",
       " '201701098',\n",
       " 'STU 022016-057|1K23HL132054-01',\n",
       " 'PUMCH-GS05',\n",
       " 'CASE1A17',\n",
       " 'Sight Study',\n",
       " 'TJ-IRB20170201',\n",
       " '469/15',\n",
       " 'SJSJP002_01',\n",
       " 'HS#: 14-00614',\n",
       " 'POETIG',\n",
       " 'R40MC29452',\n",
       " '15-0422',\n",
       " '17-191',\n",
       " 'RF-2013-02355260',\n",
       " 'IRB 2016-08 Custodiol Study',\n",
       " 'RD-2016-04-02',\n",
       " '999917006|17-I-N006',\n",
       " 'STH19135',\n",
       " 'MYK-491-001',\n",
       " '1050164',\n",
       " '4622',\n",
       " 'ADU-CL-12',\n",
       " 'GroSNaPET',\n",
       " 'GTL-X',\n",
       " 'D5160C00041',\n",
       " 'SOC-1702',\n",
       " 'Protocol No.: 1060-001',\n",
       " 'M201-A-CT-001',\n",
       " 'ORD1083',\n",
       " 'PI15-01264',\n",
       " 'Chau',\n",
       " '16-214-05',\n",
       " '16673|2016-002167-33',\n",
       " '16-214-02',\n",
       " '1611M99381',\n",
       " '2016-002-00',\n",
       " 'NCC2014 YZ-14',\n",
       " '2016/394',\n",
       " '2017THERMA',\n",
       " 'ORE # 22071',\n",
       " 'JXQF-XYP-1606',\n",
       " 'PEMAG-2016-v2.3',\n",
       " 'Leeches for Rhizarthrosis',\n",
       " 'OSU-16301|NCI-2017-01277',\n",
       " 'CLIK066B2201|2016-002868-14',\n",
       " '0142-CSP-000',\n",
       " '20173357201827',\n",
       " 'JXQF-XYP-1608',\n",
       " 'JXQF-XYP-1609',\n",
       " '2016PUSZH001',\n",
       " 'OCTO-079|2016-002267-33',\n",
       " 'UW 16-565',\n",
       " 'CH-H&N-008',\n",
       " 'CR108219|CNTO1959PSA3002|2016-001224-63',\n",
       " '2015-007',\n",
       " 'TPF-1',\n",
       " 'S-20150133',\n",
       " 'VGFTe-DR-1548',\n",
       " 'GOIRC-02-2016',\n",
       " 'oper 603',\n",
       " 'LT4020-302',\n",
       " '4SC-201-6-2015|2016-000807-99',\n",
       " 'CART-CD19-01',\n",
       " 'Study ECOPRES',\n",
       " 'RGV-GARM',\n",
       " 'Pro00067564',\n",
       " '1509016430',\n",
       " '1R03NS096484-01',\n",
       " 'P2015034-11Y|UMIN000021129',\n",
       " 'IRB201601774|U01HG007269',\n",
       " 'TS20161229',\n",
       " 'AGC-PC',\n",
       " '2016-0783|FP00000804|NCI-2017-00831',\n",
       " '6218',\n",
       " 'AML16|NCI-2017-00928',\n",
       " 'Aero-02',\n",
       " 'MO29872|2015-004105-16',\n",
       " '2016-29-1',\n",
       " 'Pro00013111',\n",
       " 'CJ_CCA_401',\n",
       " '16-075',\n",
       " '2016-828',\n",
       " '16-076',\n",
       " '9752',\n",
       " '201612107|UL1TR000448|KL2TR000450',\n",
       " 'GN16RM134',\n",
       " '16-086D|SCR-004',\n",
       " 'UPCC 56416',\n",
       " '16-001271|NCI-2017-00435|P30CA016042',\n",
       " 'D5495C00007',\n",
       " 'H-38522',\n",
       " 'IRB201601912 - Jax',\n",
       " 'VinmecRISCGT69',\n",
       " '15-207-MUHC',\n",
       " '13.024|2014-003466-25',\n",
       " 'APRibeiro',\n",
       " 'reciproc_protapernext',\n",
       " 'WVE-HDSNP2-001',\n",
       " '4-2016-1028',\n",
       " 'ZYYY-LTNW-BE-2017-05',\n",
       " '9L-16-6|NCI-2017-00623|P30CA014089',\n",
       " 'H-1704-068-844',\n",
       " 'PSYC-188-16',\n",
       " '26817',\n",
       " '2017031602',\n",
       " '2017031601',\n",
       " 'CCD-06333AA1-01',\n",
       " 'R34MH105272',\n",
       " 'D419MC00004',\n",
       " 'CLIK066B2202|2016-004770-18',\n",
       " '16-009297',\n",
       " '2016-A01876-45',\n",
       " 'IRAS: 200591',\n",
       " 'AIT_ CP_ CFNTM_01',\n",
       " '[18F]MNI-968',\n",
       " '130822008',\n",
       " 'ISEE_2015_WRMD',\n",
       " 'OSU-16077|NCI-2016-01473|P30CA016058',\n",
       " 'H1701-038-821',\n",
       " 'P16-03',\n",
       " 'CNSexcit_SCI',\n",
       " 'MH106477',\n",
       " 'COBRE PSI',\n",
       " 'NN9535-4269|2016-000904-27|U1111-1180-1213|JapicCTI-173542',\n",
       " '0748-111',\n",
       " '696',\n",
       " '017-2017',\n",
       " 'EFC14833|2016\\xe2\\x80\\x90001799\\xe2\\x80\\x9031|U1111-1180-6169',\n",
       " '235HLT-HMO-CTIL',\n",
       " '52176-ED',\n",
       " 'APP-16-01573',\n",
       " '16045350',\n",
       " 'NPC-Oligo-M',\n",
       " 'OR15-001',\n",
       " '15-17825',\n",
       " 'IRB00028990',\n",
       " 'OR15-005',\n",
       " 'B412201524615',\n",
       " 'PRO17050001',\n",
       " 'GCO 08-0959-1001|U54DK083909',\n",
       " 'HSMarcelina',\n",
       " 'D3250C00045|2017-001040-35',\n",
       " '170686',\n",
       " 'RNN/153/16/KE',\n",
       " 'LP0162-1326|2016-004201-13',\n",
       " 'XEL-CR-03',\n",
       " 'JRTE|H-16048479',\n",
       " 'BYEC20161201',\n",
       " 'FANCOSTEM-1|2011-006197-88',\n",
       " 'OTT 16-06',\n",
       " 'RSTD_021216',\n",
       " 'AK-2015-1',\n",
       " 'GRS 1276/B/16',\n",
       " 'IOC-target',\n",
       " 'TQ-B3234-I-0001',\n",
       " 'inims08',\n",
       " 'ASTR_0789',\n",
       " '385453-18',\n",
       " 'PI2016_843_0013',\n",
       " 'PI2016_843_0011',\n",
       " '2016-003694-18',\n",
       " 'US-05-013821/11-050005',\n",
       " 'PI2016_843_0014',\n",
       " '2014/1788',\n",
       " 'BHR-700-301',\n",
       " 'HT 02-121',\n",
       " '929370',\n",
       " '20160275|2016-003554-33',\n",
       " 'RNN/47/16/KE',\n",
       " 'TL04001',\n",
       " 'SNPHO-161107',\n",
       " '2017DHLL001',\n",
       " 'DHF22621',\n",
       " 'ICU Visits',\n",
       " 'CK-101-101',\n",
       " 'PSC',\n",
       " 'Scopolamine i.m.',\n",
       " 'ZCP201703',\n",
       " '#100/16',\n",
       " 'CLEE011',\n",
       " '81600510',\n",
       " 'TV7820-IMG-10082|2016-001757-41',\n",
       " '17-384',\n",
       " '1R34MH110369-01',\n",
       " '16230',\n",
       " '1016455',\n",
       " 'EECP-3',\n",
       " 'B-1405/250-007',\n",
       " 'GBV-102-001',\n",
       " '54179060LYM2009',\n",
       " '2017-0353',\n",
       " '16-008343',\n",
       " 'CZ1702TCS',\n",
       " 'C1104-001',\n",
       " '6B-16-1|NCI-2017-00499|P30CA014089',\n",
       " '16D.606',\n",
       " 'BTC-1st MEDITREME',\n",
       " '2015-A00596-43',\n",
       " 'T1001-03',\n",
       " '2016/0404',\n",
       " 'Obese-FOB',\n",
       " 'ACSTCC',\n",
       " 'PPMC-04',\n",
       " 'GCO 16-1867',\n",
       " 'MDGN-002-CD-101',\n",
       " '2016-01475',\n",
       " '5R01NR015223|R01NR015223',\n",
       " 'SEP361-202|2016-001556-21',\n",
       " 'R2810-ONC-1606|2016-002755-16',\n",
       " 'remi074',\n",
       " '14RM008|193750',\n",
       " 'HZY2015',\n",
       " 'HZY2016',\n",
       " '001001001',\n",
       " '2016/03',\n",
       " 'ZJCH-2017-CRT',\n",
       " 'HREBA.CC-16-0986',\n",
       " 'CN001-016|2016-001654-18|WN40227',\n",
       " 'UW17-269',\n",
       " '102/100/00/16',\n",
       " 'T210/2015|2015-005392-24',\n",
       " 'HAPPIEST Trial',\n",
       " 'Pro00070686',\n",
       " '00039558',\n",
       " 'loe003516CTIL',\n",
       " 'FSG-03-01',\n",
       " 'UPuertoRico',\n",
       " 'IRB00084198',\n",
       " 'LME-167',\n",
       " '15844|I5B-MC-JGDP|2016-001099-31',\n",
       " '2017[1359]-1',\n",
       " 'HSC20160042H|R01DK107680',\n",
       " '1.616.721',\n",
       " 'clinical review (2016) (397)',\n",
       " '0182/11',\n",
       " 'NAV-0001',\n",
       " '10306/PG-2Trg/2015/1696',\n",
       " 'AGMT_NHL-15B|2016-001760-10',\n",
       " 'SYSU-OPH-001',\n",
       " 'MR311-3502',\n",
       " 'JOY 1515-03',\n",
       " 'PHAO14-CH/TEPTAU',\n",
       " '18894',\n",
       " 'EGP-437-009',\n",
       " \"Jiulongpo People's Hospital\",\n",
       " 'REPEATPREP',\n",
       " 'CHRD0814',\n",
       " 'CIR 313',\n",
       " 'HHC-2016-0221',\n",
       " 'HS-17-00406',\n",
       " 'HHC-2016-0228',\n",
       " 'BFCS',\n",
       " '2016-A02021-50',\n",
       " 'KY20162049-X-1',\n",
       " 'IRB#17-000048',\n",
       " 'HTO-MSCs',\n",
       " 'E16156',\n",
       " '1U01MD010629-01',\n",
       " 'GUP 15021',\n",
       " 'EFC14011|U1111-1161-9850',\n",
       " 'NK/3047/MD/807',\n",
       " 'GS-US-342-4062|2016-003625-42',\n",
       " '2016-00487',\n",
       " 'PECS',\n",
       " 'R44DA035014',\n",
       " 'IB2016-02',\n",
       " '826109',\n",
       " '16-440',\n",
       " '16-443',\n",
       " 'STU00090161',\n",
       " 'R16171M|2016-002321-11',\n",
       " '1608063565',\n",
       " 'CAAE: 51453915.1.0000.5149',\n",
       " 'MB-1608',\n",
       " 'IC 2016-03',\n",
       " 'GGH2016430H',\n",
       " 'MB-1606',\n",
       " 'R01HS024091',\n",
       " 'SIITM20160115',\n",
       " 'CTC0119|12614000669695',\n",
       " 'EudraCT-Nr.: 2015-003429-32',\n",
       " '16-1428',\n",
       " 'HTX-011-211',\n",
       " 'PUMCHCSTAR-006',\n",
       " '3232-CHS-ERC-14',\n",
       " '00093561',\n",
       " '2016-ECCLIPSESTEMI-01',\n",
       " 'Basec-Nr. 2016-00151',\n",
       " 'W-5222-102',\n",
       " 'UNE 052316-013',\n",
       " '2016P002123',\n",
       " '20160964|20160335',\n",
       " '15-2388',\n",
       " '15-2433',\n",
       " '16-008985',\n",
       " 'X16081002',\n",
       " 'ICM-URC 2015/71',\n",
       " 'P150956|2016-001786-93',\n",
       " 'GoldenJNH',\n",
       " '15094SW-AS',\n",
       " 'Pro20160000350|PC 51-16',\n",
       " 'NP1576',\n",
       " 'DW_DWJ1386001',\n",
       " 'INCB 62079-101',\n",
       " 'PSY-NIL-0008',\n",
       " 'PRO14050193',\n",
       " 'E-16-679',\n",
       " '2016ZB080',\n",
       " 'GS-US-342-4022|2016-003066-10',\n",
       " '2016/146',\n",
       " 'SWHB018',\n",
       " '42430|R01DK099199',\n",
       " 'CHS #2016-29',\n",
       " 'TMH-1587',\n",
       " 'SWHB016',\n",
       " 'SWHB017',\n",
       " 'SHR3824-110',\n",
       " 'PI2015_843_0016',\n",
       " 'PI2015_843_0014',\n",
       " 'IRB00082708',\n",
       " 'BS2016.1',\n",
       " 'PI2015_843_0018',\n",
       " 'PI2015_843_0019',\n",
       " '2017-0103',\n",
       " '2015P002271',\n",
       " 'IRB201700206|R03AA025430',\n",
       " '5160417',\n",
       " 'LUS64385700',\n",
       " 'INCB 18424-365 (REACH3)|CINC424D2301',\n",
       " 'DWJ1351003',\n",
       " '208111|208111102115',\n",
       " 'CHUBX 2015/04',\n",
       " 'PI14/00113',\n",
       " 'IRB ID #: 201603062|1R01HD086007-01A1',\n",
       " '1g vs 2g MgSO4',\n",
       " '170082|17-C-0082',\n",
       " 'DFCR-0003',\n",
       " 'DFCR-0002',\n",
       " 'IPF-O2-Study',\n",
       " 'CEI/1125/17|INCAN',\n",
       " 'CHU-316|2017-A00336-47',\n",
       " 'KISPI-OXIVENT 3.0',\n",
       " 'RIPC_propofol|1605-079-761',\n",
       " '1000053821',\n",
       " 'NOR-GRASPALL 2016|2016-004451-70',\n",
       " 'RICMIS/TIA',\n",
       " 'Krop & Sind|R87-A5432|7-12.0736|R113-A7015-14-S34',\n",
       " 'Neck Drain',\n",
       " 'REB16-1876',\n",
       " 'CNMCPro00007768',\n",
       " '1711525',\n",
       " '03021991',\n",
       " '1609504711',\n",
       " 'IRB-15-0442',\n",
       " 'TBI1401-02',\n",
       " '16001',\n",
       " '2016P002523',\n",
       " '254/16',\n",
       " 'Pro00057504|1P20NR016575-01',\n",
       " 'IRB-16-0182',\n",
       " 'dnr 2016/25-31',\n",
       " 'CNUHH-2015-067',\n",
       " 'CC# 17455',\n",
       " 'CCCWFU 97217|NCI-2017-00680|P30CA012197',\n",
       " 'GPNA0001-2016',\n",
       " 'EASY-1',\n",
       " 'NUHEALTH-AM01-SELENIUM',\n",
       " 'BP39054|2016-004184-39',\n",
       " 'ARN509 - 2016',\n",
       " '009/2017',\n",
       " 'CP275',\n",
       " '209397',\n",
       " '201608016',\n",
       " 'D7620C00001',\n",
       " '201611036RIN',\n",
       " 'GCO 16-2402',\n",
       " '201704134',\n",
       " 'Glasgow Caledonian NMAHP RU',\n",
       " '13.33',\n",
       " 'GCO 16-1470',\n",
       " 'WVU02HSC16',\n",
       " 'LiDMUS',\n",
       " 'Pro00051308',\n",
       " '151',\n",
       " 'WP40052',\n",
       " 'BOS-1',\n",
       " 'CHRO 2016-05',\n",
       " '159',\n",
       " '158',\n",
       " '201610156|5R01HL126892',\n",
       " 'IRB201602626',\n",
       " 'CE 14.150',\n",
       " 'MTU-EC-IM-5-195/59|TCTR20170407001',\n",
       " '0092-16-KMC',\n",
       " 'BPI-2358-105',\n",
       " 'CT-P16 1.1',\n",
       " 'CP-16-001',\n",
       " 'MP-CUSM-13-054',\n",
       " '2016004830',\n",
       " 'NeoadjMitomycin-C',\n",
       " 'FdG_HEAD_01',\n",
       " 'Hypofractionated GBM',\n",
       " '16314|I8B-MC-ITRN|2015-005357-12',\n",
       " 'KMUHIRB-20130271',\n",
       " '161802',\n",
       " 'XSGP-302',\n",
       " '1000054948',\n",
       " '6189',\n",
       " '201610743',\n",
       " '7H-16-2|NCI-2016-01583|P30CA014089',\n",
       " '2016P001769',\n",
       " '579239',\n",
       " 'UCART123_02',\n",
       " 'PHRI15-DB/RACO-MA',\n",
       " 'C-CAG in AML',\n",
       " 'mRNA-1325-P101|HHSO100201600029C',\n",
       " '951753',\n",
       " 'CEBC-CU-2017-03-19',\n",
       " '170011|17-C-0011',\n",
       " '15-0052|HHSN272201300022I',\n",
       " 'PVARF-387005',\n",
       " '2017-057',\n",
       " 'M15-925|2016-000933-37',\n",
       " '102347',\n",
       " 'UNICID15',\n",
       " '290587',\n",
       " 'NJiang2016-001',\n",
       " '9774',\n",
       " '331-201-00061',\n",
       " 'ShandongPH02',\n",
       " 'AT LARA 829MP BER-401-16',\n",
       " 'TMMU-DP-2016-4-25',\n",
       " 'D6570C00002|M-AS464-30',\n",
       " 'VitA-ROP',\n",
       " '16-276',\n",
       " '123456789',\n",
       " 'RM-27072016',\n",
       " '71675502',\n",
       " 'SF2016-1-4071',\n",
       " '1517-CL-0310',\n",
       " '2017112',\n",
       " '1517-CL-0314',\n",
       " 'VAB',\n",
       " 'TH-088',\n",
       " '002-2017',\n",
       " 'IORG0003381',\n",
       " 'VX16-770-127',\n",
       " 'PAKT CTC 151043',\n",
       " '16-013075',\n",
       " 'CTMX-M-072-001',\n",
       " '2016-00818',\n",
       " '021701|NCI-2017-00438|P30CA072720',\n",
       " '212006',\n",
       " '16-052',\n",
       " '1396-607',\n",
       " '12015C1038',\n",
       " '2016-04-156',\n",
       " 'RA315217',\n",
       " 'MH106450',\n",
       " 'RT alone',\n",
       " 'UBergen 2016/1374',\n",
       " 'VK2809-201',\n",
       " 'COL00729',\n",
       " 'Total Shoulder',\n",
       " '20170206',\n",
       " 'ISI-001-01',\n",
       " 'KASTT005_BAL_Olita',\n",
       " 'TWKY-2016-ZD-01-10',\n",
       " '2017P001409',\n",
       " 'Ahead-OV-201704',\n",
       " 'FSS-AS-30003',\n",
       " 'UHG-CFD-METEX',\n",
       " 'CL1-64315-001|2016-003768-38',\n",
       " '2016-2',\n",
       " 'Hunger and Fullness',\n",
       " 'CP-0018',\n",
       " 'FDASU-RECM041515',\n",
       " 'BP39207',\n",
       " '15-9995-BE',\n",
       " 'KMUHIRB-E(II)20150219',\n",
       " 'MCN-1',\n",
       " 'CREC Ref. No.: 2017.010-T',\n",
       " 'ASTELLAS/MAGNIFY',\n",
       " 'GS-US-427-4024|2016-002443-42',\n",
       " 'UESTC-neuSCAN-33',\n",
       " '1-10-72-316-16',\n",
       " 'State University of Maring\\xc3\\xa1',\n",
       " 'KPF16ICF10',\n",
       " '16338|I3Y-MC-JPCF|2016-004362-26',\n",
       " '20159178',\n",
       " 'MU',\n",
       " 'Etude SFED 115',\n",
       " 'P150948',\n",
       " 'BGB-3111-302',\n",
       " '2016-02-0024',\n",
       " '1320 98842',\n",
       " '2014-0966|F31AA022845-01|Kaye2',\n",
       " 'H-16042979',\n",
       " 'METC 163054',\n",
       " 'SYSUCC-007',\n",
       " 'AcupKneeOA',\n",
       " 'GCO 15-1513|R01DK109881-01|HRDC 00781',\n",
       " 'W569',\n",
       " 'HIVECT-1501',\n",
       " 'CYAD-N2T-002',\n",
       " 'PI2016_843_0035',\n",
       " 'PI2016_843_0036',\n",
       " '16-005286',\n",
       " 'HealthyioJH',\n",
       " 'Diskapi4',\n",
       " 'K.CR.I.AP.16.39',\n",
       " 'R15117',\n",
       " 'CL086',\n",
       " 'Gd T cell and Pancreatic Ca',\n",
       " '3-2016-0263',\n",
       " 'IRB201400807',\n",
       " '2000020161',\n",
       " 'eHIT_Protocol',\n",
       " 'STP 185',\n",
       " 'BR-FMS-CT-304',\n",
       " 'PCa006',\n",
       " 'IV amantadine',\n",
       " 'CMD-2016-002',\n",
       " '2016-A01049-42',\n",
       " '1395/670',\n",
       " 'CE16.351',\n",
       " 'IJB-BC-NEORHEA-2016',\n",
       " '069/2016',\n",
       " 'N-20160037',\n",
       " 'REC 16/SS0031 R&D: 2016/0118',\n",
       " 'P-Monofer-PK-IDA-01',\n",
       " 'MARAND-X',\n",
       " '17-0081',\n",
       " 'CCTG 603',\n",
       " 'CCTG 602',\n",
       " '2016-A01121-50',\n",
       " 'H16-02233',\n",
       " 'Pro00023706',\n",
       " 'EC_LL_MYC_PS',\n",
       " '10054040',\n",
       " '15-01178',\n",
       " 'FMASU MD 293/2016',\n",
       " 'CAUH-SP1',\n",
       " '16-04804-XP DOD|1R01DK104872-01A1',\n",
       " 'RTA 402-C-1603',\n",
       " 'RTA 402-C-1602',\n",
       " '5000121',\n",
       " '03/2017',\n",
       " 'ACE-LY-110',\n",
       " '20150146',\n",
       " 'TPX-0005-01',\n",
       " '22864|2016-003111-35|CA290841|A21400',\n",
       " '2006114',\n",
       " '1701-008',\n",
       " 'MP-101-01',\n",
       " 'IPCSUPER',\n",
       " 'NL51023.068.16',\n",
       " 'NN1436-4314|2016-000436-18|U1111-1178-9795',\n",
       " 'R34_PrEPMississippi',\n",
       " '3VM1216',\n",
       " 'APR-2015',\n",
       " 'B-1610/367-002',\n",
       " 'BeijingH-01-RT',\n",
       " 'OFB-IDA',\n",
       " 'S-20160083',\n",
       " 'CHU-301|2014-A01300-47',\n",
       " '00021790',\n",
       " 'IRB201602471|R01DE025832-01',\n",
       " 'R01NR015789',\n",
       " 'ENDOSCRATCH',\n",
       " 'CR108217|2016-001653-40|64041575RSV2003',\n",
       " 'Pro00056889|1R01AA025086',\n",
       " 'MU-CIRB 2016/048.0704',\n",
       " '15072016',\n",
       " 'KX-ORAX-005',\n",
       " 'HSIGansu',\n",
       " '349',\n",
       " '17-1024',\n",
       " 'KITE-718-301',\n",
       " 'TDU14981|2016-002415-18|U1111-1184-8607',\n",
       " 'Vortioxetine-4003|U1111-1185-6902',\n",
       " 'A083-02|ACE-083',\n",
       " 'SUMMA-PC',\n",
       " 'E2609-G000-301|2016-003928-23',\n",
       " 'REF-CSC-2682',\n",
       " 'G405',\n",
       " 'SPPA-2017',\n",
       " '1305-0011|2017-002003-10',\n",
       " 'G402',\n",
       " 'CHU-335|2016-001603-23',\n",
       " '1000053509',\n",
       " 'DP-TRS-T21',\n",
       " '2016/1931',\n",
       " 'InVeg (2)',\n",
       " 'IIBSP-VIV-2016-109',\n",
       " 'H17-00584',\n",
       " 'CIN001- Liver Fibrosis',\n",
       " 'INT/IEC/2017/609',\n",
       " '2017-00545',\n",
       " '2016/626',\n",
       " 'QOL-ONE Rev2MDS',\n",
       " 'K\\xc3\\x9c GOKAEK 2017/71',\n",
       " 'PD219/16',\n",
       " 'GHGI061',\n",
       " '1517-CL-0543|2015-002565-28',\n",
       " 'COLP',\n",
       " '16-2878|UG1EY025992',\n",
       " '927079|K23MH111606',\n",
       " 'R668-AD-1607',\n",
       " '405153/2012-0',\n",
       " '16-420',\n",
       " '16-425',\n",
       " 'EK 049/17',\n",
       " 'R668-AD-1526|2015-004458-16',\n",
       " 'MP-37-2017-2573',\n",
       " '1608001570',\n",
       " 'ORL-SEN-2530',\n",
       " '17100192',\n",
       " 'BX11',\n",
       " 'TLC399A2002',\n",
       " '16-1404',\n",
       " 'reexamination',\n",
       " '91153461',\n",
       " 'CfJSSouthwestH',\n",
       " 'CATS Tonometer, LLC - CP-01',\n",
       " 'CR019',\n",
       " '\"Moriggia-Pelascini\" Hospital',\n",
       " 'MOP-130576',\n",
       " 'STUDY00002937|16GRNT31010001',\n",
       " 'GS-US-418-4279|2017-000402-38',\n",
       " '48302915.1.0000.5307',\n",
       " 'CODIM-MBM-12-123B',\n",
       " 'KO-ERK-001',\n",
       " 'ASD 15-04',\n",
       " 'Pro00079617|HHSN268201700001C',\n",
       " '69HCL15_0744',\n",
       " 'CH-H&N-008-1',\n",
       " 'N201602096',\n",
       " '20160250|2016-004066-26',\n",
       " 'MP-37-2017-2793',\n",
       " 'Version 7',\n",
       " 'B7931005|2016-004048-13|ALLEGRO',\n",
       " 'Version 2',\n",
       " 'ZS-TACE-EBRT-2017|2016ZSLC20',\n",
       " '16-005490',\n",
       " 'APP20160212',\n",
       " 'HepQuant-002-2124',\n",
       " '0S-16-8|NCI-2017-00189|P30CA014089',\n",
       " 'ICBT@STEP3',\n",
       " 'HUM00123412',\n",
       " 'IRB000110677',\n",
       " '20150478',\n",
       " 'ESR 15-11561-61-DUNE|2016-002858-20',\n",
       " '9339/001',\n",
       " 'PRO29327',\n",
       " '20160589',\n",
       " 'ND-203',\n",
       " 'ND-202',\n",
       " '2016/15608',\n",
       " '2884',\n",
       " 'Protocol F1.0 - 22/05/2013',\n",
       " 'Odonto-NOAC',\n",
       " 'SC-02',\n",
       " 'A12092016- ammendment 1',\n",
       " 'B330',\n",
       " 'AP 1001',\n",
       " 'BIO-123',\n",
       " '17P.082',\n",
       " '018-16-FB',\n",
       " '161287/UCHMC1504',\n",
       " 'IRAS 184490',\n",
       " 'ZS-IR-2016',\n",
       " 'IRCCSDonato',\n",
       " '15G.393',\n",
       " '206995',\n",
       " '16-506',\n",
       " '146-9251-201',\n",
       " '15-07-410',\n",
       " 'IRB00080981',\n",
       " 'MD038',\n",
       " 'PREMOD2 - NIRS Sub-study|1R01HD088646-01A1',\n",
       " 'IRB-33797',\n",
       " 'TCGHUROL012',\n",
       " 'AMLSG26-16',\n",
       " 'UmeaU-PECS',\n",
       " 'SM04690-OA-04',\n",
       " 'TMP-1115_01',\n",
       " 'NMRR23315',\n",
       " 'ALD403-CLIN-011',\n",
       " 'PCIA102-16',\n",
       " 'RA101495-01.203',\n",
       " 'ideal depth of central line',\n",
       " 'B-1508/312-004',\n",
       " 'HYMC-0061-17',\n",
       " 'CX20161020',\n",
       " 'XACT-2|OISE-16-62105-1',\n",
       " 'H14-01702 (Phase 2)',\n",
       " '16G.052',\n",
       " 'ERC.0002738',\n",
       " 'Pro00068040|1R21DK106603-01A1',\n",
       " 'ATX-MTM-002',\n",
       " 'PT2977-101',\n",
       " 'BRIMOCAN',\n",
       " '19748',\n",
       " 'Dx01',\n",
       " 'FEMH-105117-E',\n",
       " 'SZ5601',\n",
       " 'DCC-3014-01-001',\n",
       " '16-01434',\n",
       " 'ECT2017-002',\n",
       " 'PRO16110378',\n",
       " '15-0108',\n",
       " 'HMR-1001',\n",
       " 'R01HD084547',\n",
       " '151837',\n",
       " 'IRBNet 885148',\n",
       " 'BT005',\n",
       " '1705315090',\n",
       " '1R01HL133069-01',\n",
       " '2015-22',\n",
       " '0127-16-WOMC',\n",
       " 'ASN002AD-101',\n",
       " 'SSG XXV: Stop-GIST',\n",
       " 'IRB00123834',\n",
       " 'N15DOP',\n",
       " 'MML-LEV-2013-01',\n",
       " 'OCUN-023',\n",
       " '2786-2015',\n",
       " '2016-0341',\n",
       " '5R21HD085063',\n",
       " 'EPN 2015/1820-31',\n",
       " '15 7834 08',\n",
       " '17-013694',\n",
       " 'yjcl2017',\n",
       " '4-3163/2015',\n",
       " 'OMT28-C0101',\n",
       " 'UF 9554',\n",
       " 'ABSuarez',\n",
       " 'F160224001',\n",
       " 'SARO.15.001.04',\n",
       " 'CTONG 1512',\n",
       " 'DW_DWP14012002',\n",
       " '15 7842 16',\n",
       " '1343/2017',\n",
       " 'ICD_01',\n",
       " '3-2016-0241',\n",
       " '4889',\n",
       " 'Ethanol Injection',\n",
       " 'URCC16092|NCI-2017-00790|URCC-16092|R21CA187500|UG1CA189961',\n",
       " 'A041501|NCI-2016-01981|U10CA180821',\n",
       " 'CVAY736A2201',\n",
       " 'IRAS project ID: 213205',\n",
       " '69HCL16_0411',\n",
       " '16-1659',\n",
       " 'C-II-011',\n",
       " '15-01349',\n",
       " 'Syndesmose2016',\n",
       " 'XJH-A-2016-10-10',\n",
       " 'CCT-PNK-007-MM-001',\n",
       " 'HSPH-16-0912',\n",
       " 'Yangzhou1PH',\n",
       " 'UiB112016',\n",
       " 'AYPB-MDD-\\xe2\\x85\\xa1b-1701|2017ZX09304-020',\n",
       " 'BRN0035|NCI-2016-01973|P30CA124435',\n",
       " 'IMPAACT 2018|38405',\n",
       " '1602T0832|2016-002688-32',\n",
       " '8545',\n",
       " 'VISCO KNEE UFF',\n",
       " 'RGCI&RC',\n",
       " 'RADMIS',\n",
       " 'LovisenbergOrto',\n",
       " 'E7389-G000-213|2016-003352-67',\n",
       " 'YYP-YYD701_001',\n",
       " 'ML39349|2016-003924-22',\n",
       " 'Eisai-01',\n",
       " 'Same Day CPrep',\n",
       " '33392',\n",
       " '33391',\n",
       " '2016-17',\n",
       " 'CAAE 6717515.1.0000.5259',\n",
       " '157758/02',\n",
       " '1608015|2016-A00319-42',\n",
       " 'IRB00008788',\n",
       " 'SMASH trial',\n",
       " 'SUN-Aarhus-2017- 653',\n",
       " 'InstiGem',\n",
       " 'XJMSC0001',\n",
       " 'SAR-081',\n",
       " 'DP2017',\n",
       " '16455|I6T-MC-AMAE',\n",
       " ...}"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "set(df['Other IDs'].values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'April 1, 2016',\n",
       " 'April 1, 2017',\n",
       " 'April 10, 2017',\n",
       " 'April 11, 2015',\n",
       " 'April 11, 2017',\n",
       " 'April 12, 2016',\n",
       " 'April 12, 2017',\n",
       " 'April 13, 2016',\n",
       " 'April 13, 2017',\n",
       " 'April 14, 2016',\n",
       " 'April 14, 2017',\n",
       " 'April 15, 2016',\n",
       " 'April 15, 2017',\n",
       " 'April 16, 2015',\n",
       " 'April 16, 2017',\n",
       " 'April 17, 2017',\n",
       " 'April 18, 2016',\n",
       " 'April 18, 2017',\n",
       " 'April 19, 2016',\n",
       " 'April 19, 2017',\n",
       " 'April 2, 2017',\n",
       " 'April 20, 2016',\n",
       " 'April 20, 2017',\n",
       " 'April 21, 2016',\n",
       " 'April 21, 2017',\n",
       " 'April 22, 2017',\n",
       " 'April 23, 2014',\n",
       " 'April 23, 2017',\n",
       " 'April 24, 2016',\n",
       " 'April 24, 2017',\n",
       " 'April 25, 2016',\n",
       " 'April 25, 2017',\n",
       " 'April 26, 2016',\n",
       " 'April 26, 2017',\n",
       " 'April 27, 2016',\n",
       " 'April 27, 2017',\n",
       " 'April 28, 2016',\n",
       " 'April 28, 2017',\n",
       " 'April 29, 2016',\n",
       " 'April 29, 2017',\n",
       " 'April 3, 2017',\n",
       " 'April 30, 2017',\n",
       " 'April 4, 2017',\n",
       " 'April 5, 2017',\n",
       " 'April 6, 2016',\n",
       " 'April 6, 2017',\n",
       " 'April 7, 2016',\n",
       " 'April 7, 2017',\n",
       " 'April 8, 2016',\n",
       " 'April 8, 2017',\n",
       " 'April 9, 2017',\n",
       " 'August 1, 2016',\n",
       " 'August 1, 2017',\n",
       " 'August 10, 2016',\n",
       " 'August 10, 2017',\n",
       " 'August 11, 2016',\n",
       " 'August 11, 2017',\n",
       " 'August 12, 2016',\n",
       " 'August 12, 2017',\n",
       " 'August 13, 2016',\n",
       " 'August 13, 2017',\n",
       " 'August 14, 2016',\n",
       " 'August 14, 2017',\n",
       " 'August 15, 2016',\n",
       " 'August 15, 2017',\n",
       " 'August 16, 2016',\n",
       " 'August 16, 2017',\n",
       " 'August 17, 2016',\n",
       " 'August 17, 2017',\n",
       " 'August 18, 2016',\n",
       " 'August 18, 2017',\n",
       " 'August 19, 2016',\n",
       " 'August 19, 2017',\n",
       " 'August 2, 2016',\n",
       " 'August 2, 2017',\n",
       " 'August 20, 2017',\n",
       " 'August 21, 2016',\n",
       " 'August 21, 2017',\n",
       " 'August 22, 2016',\n",
       " 'August 22, 2017',\n",
       " 'August 23, 2016',\n",
       " 'August 23, 2017',\n",
       " 'August 24, 2015',\n",
       " 'August 24, 2016',\n",
       " 'August 24, 2017',\n",
       " 'August 25, 2015',\n",
       " 'August 25, 2016',\n",
       " 'August 25, 2017',\n",
       " 'August 26, 2016',\n",
       " 'August 26, 2017',\n",
       " 'August 27, 2016',\n",
       " 'August 27, 2017',\n",
       " 'August 28, 2015',\n",
       " 'August 28, 2016',\n",
       " 'August 28, 2017',\n",
       " 'August 29, 2016',\n",
       " 'August 29, 2017',\n",
       " 'August 3, 2016',\n",
       " 'August 3, 2017',\n",
       " 'August 30, 2016',\n",
       " 'August 30, 2017',\n",
       " 'August 31, 2016',\n",
       " 'August 4, 2016',\n",
       " 'August 4, 2017',\n",
       " 'August 5, 2014',\n",
       " 'August 5, 2016',\n",
       " 'August 5, 2017',\n",
       " 'August 6, 2017',\n",
       " 'August 7, 2016',\n",
       " 'August 7, 2017',\n",
       " 'August 8, 2016',\n",
       " 'August 8, 2017',\n",
       " 'August 9, 2016',\n",
       " 'August 9, 2017',\n",
       " 'December 1, 2015',\n",
       " 'December 1, 2016',\n",
       " 'December 10, 2016',\n",
       " 'December 11, 2016',\n",
       " 'December 12, 2016',\n",
       " 'December 13, 2016',\n",
       " 'December 14, 2016',\n",
       " 'December 15, 2016',\n",
       " 'December 16, 2014',\n",
       " 'December 16, 2016',\n",
       " 'December 17, 2016',\n",
       " 'December 18, 2016',\n",
       " 'December 19, 2016',\n",
       " 'December 2, 2016',\n",
       " 'December 20, 2016',\n",
       " 'December 21, 2016',\n",
       " 'December 22, 2016',\n",
       " 'December 23, 2016',\n",
       " 'December 24, 2016',\n",
       " 'December 25, 2016',\n",
       " 'December 26, 2016',\n",
       " 'December 27, 2016',\n",
       " 'December 28, 2016',\n",
       " 'December 29, 2016',\n",
       " 'December 3, 2016',\n",
       " 'December 30, 2016',\n",
       " 'December 31, 2016',\n",
       " 'December 4, 2016',\n",
       " 'December 5, 2016',\n",
       " 'December 6, 2015',\n",
       " 'December 6, 2016',\n",
       " 'December 7, 2016',\n",
       " 'December 8, 2015',\n",
       " 'December 8, 2016',\n",
       " 'December 9, 2013',\n",
       " 'December 9, 2014',\n",
       " 'December 9, 2016',\n",
       " 'February 1, 2016',\n",
       " 'February 1, 2017',\n",
       " 'February 10, 2016',\n",
       " 'February 10, 2017',\n",
       " 'February 11, 2016',\n",
       " 'February 11, 2017',\n",
       " 'February 12, 2017',\n",
       " 'February 13, 2017',\n",
       " 'February 14, 2016',\n",
       " 'February 14, 2017',\n",
       " 'February 15, 2017',\n",
       " 'February 16, 2016',\n",
       " 'February 16, 2017',\n",
       " 'February 17, 2016',\n",
       " 'February 17, 2017',\n",
       " 'February 18, 2017',\n",
       " 'February 19, 2015',\n",
       " 'February 19, 2017',\n",
       " 'February 2, 2016',\n",
       " 'February 2, 2017',\n",
       " 'February 20, 2017',\n",
       " 'February 21, 2017',\n",
       " 'February 22, 2016',\n",
       " 'February 22, 2017',\n",
       " 'February 23, 2017',\n",
       " 'February 24, 2016',\n",
       " 'February 24, 2017',\n",
       " 'February 25, 2016',\n",
       " 'February 25, 2017',\n",
       " 'February 26, 2016',\n",
       " 'February 26, 2017',\n",
       " 'February 27, 2017',\n",
       " 'February 28, 2017',\n",
       " 'February 3, 2017',\n",
       " 'February 4, 2017',\n",
       " 'February 5, 2016',\n",
       " 'February 5, 2017',\n",
       " 'February 6, 2017',\n",
       " 'February 7, 2016',\n",
       " 'February 7, 2017',\n",
       " 'February 8, 2016',\n",
       " 'February 8, 2017',\n",
       " 'February 9, 2015',\n",
       " 'February 9, 2017',\n",
       " 'January 1, 2017',\n",
       " 'January 10, 2017',\n",
       " 'January 11, 2017',\n",
       " 'January 12, 2016',\n",
       " 'January 12, 2017',\n",
       " 'January 13, 2017',\n",
       " 'January 14, 2015',\n",
       " 'January 14, 2016',\n",
       " 'January 14, 2017',\n",
       " 'January 15, 2017',\n",
       " 'January 16, 2017',\n",
       " 'January 17, 2017',\n",
       " 'January 18, 2016',\n",
       " 'January 18, 2017',\n",
       " 'January 19, 2017',\n",
       " 'January 2, 2017',\n",
       " 'January 20, 2017',\n",
       " 'January 21, 2016',\n",
       " 'January 21, 2017',\n",
       " 'January 22, 2016',\n",
       " 'January 22, 2017',\n",
       " 'January 23, 2017',\n",
       " 'January 24, 2017',\n",
       " 'January 25, 2016',\n",
       " 'January 25, 2017',\n",
       " 'January 26, 2017',\n",
       " 'January 27, 2017',\n",
       " 'January 28, 2017',\n",
       " 'January 29, 2016',\n",
       " 'January 29, 2017',\n",
       " 'January 3, 2017',\n",
       " 'January 30, 2015',\n",
       " 'January 30, 2017',\n",
       " 'January 31, 2016',\n",
       " 'January 31, 2017',\n",
       " 'January 4, 2017',\n",
       " 'January 5, 2017',\n",
       " 'January 6, 2015',\n",
       " 'January 6, 2016',\n",
       " 'January 6, 2017',\n",
       " 'January 7, 2017',\n",
       " 'January 8, 2017',\n",
       " 'January 9, 2017',\n",
       " 'July 1, 2016',\n",
       " 'July 1, 2017',\n",
       " 'July 10, 2016',\n",
       " 'July 10, 2017',\n",
       " 'July 11, 2016',\n",
       " 'July 11, 2017',\n",
       " 'July 12, 2012',\n",
       " 'July 12, 2015',\n",
       " 'July 12, 2016',\n",
       " 'July 12, 2017',\n",
       " 'July 13, 2016',\n",
       " 'July 13, 2017',\n",
       " 'July 14, 2017',\n",
       " 'July 15, 2016',\n",
       " 'July 15, 2017',\n",
       " 'July 16, 2014',\n",
       " 'July 16, 2017',\n",
       " 'July 17, 2017',\n",
       " 'July 18, 2016',\n",
       " 'July 18, 2017',\n",
       " 'July 19, 2016',\n",
       " 'July 19, 2017',\n",
       " 'July 2, 2017',\n",
       " 'July 20, 2015',\n",
       " 'July 20, 2016',\n",
       " 'July 20, 2017',\n",
       " 'July 21, 2016',\n",
       " 'July 21, 2017',\n",
       " 'July 22, 2016',\n",
       " 'July 22, 2017',\n",
       " 'July 23, 2016',\n",
       " 'July 23, 2017',\n",
       " 'July 24, 2015',\n",
       " 'July 24, 2016',\n",
       " 'July 24, 2017',\n",
       " 'July 25, 2016',\n",
       " 'July 25, 2017',\n",
       " 'July 26, 2016',\n",
       " 'July 26, 2017',\n",
       " 'July 27, 2016',\n",
       " 'July 27, 2017',\n",
       " 'July 28, 2015',\n",
       " 'July 28, 2016',\n",
       " 'July 28, 2017',\n",
       " 'July 29, 2016',\n",
       " 'July 29, 2017',\n",
       " 'July 3, 2017',\n",
       " 'July 30, 2016',\n",
       " 'July 30, 2017',\n",
       " 'July 31, 2017',\n",
       " 'July 4, 2017',\n",
       " 'July 5, 2016',\n",
       " 'July 5, 2017',\n",
       " 'July 6, 2016',\n",
       " 'July 6, 2017',\n",
       " 'July 7, 2016',\n",
       " 'July 7, 2017',\n",
       " 'July 8, 2015',\n",
       " 'July 8, 2016',\n",
       " 'July 8, 2017',\n",
       " 'July 9, 2017',\n",
       " 'June 1, 2016',\n",
       " 'June 1, 2017',\n",
       " 'June 10, 2016',\n",
       " 'June 10, 2017',\n",
       " 'June 11, 2017',\n",
       " 'June 12, 2016',\n",
       " 'June 12, 2017',\n",
       " 'June 13, 2013',\n",
       " 'June 13, 2016',\n",
       " 'June 13, 2017',\n",
       " 'June 14, 2016',\n",
       " 'June 14, 2017',\n",
       " 'June 15, 2016',\n",
       " 'June 15, 2017',\n",
       " 'June 16, 2014',\n",
       " 'June 16, 2017',\n",
       " 'June 17, 2016',\n",
       " 'June 17, 2017',\n",
       " 'June 18, 2017',\n",
       " 'June 19, 2017',\n",
       " 'June 2, 2016',\n",
       " 'June 2, 2017',\n",
       " 'June 20, 2017',\n",
       " 'June 21, 2016',\n",
       " 'June 21, 2017',\n",
       " 'June 22, 2016',\n",
       " 'June 22, 2017',\n",
       " 'June 23, 2017',\n",
       " 'June 24, 2016',\n",
       " 'June 24, 2017',\n",
       " 'June 25, 2016',\n",
       " 'June 25, 2017',\n",
       " 'June 26, 2016',\n",
       " 'June 26, 2017',\n",
       " 'June 27, 2016',\n",
       " 'June 27, 2017',\n",
       " 'June 28, 2016',\n",
       " 'June 28, 2017',\n",
       " 'June 29, 2016',\n",
       " 'June 29, 2017',\n",
       " 'June 3, 2016',\n",
       " 'June 3, 2017',\n",
       " 'June 30, 2016',\n",
       " 'June 30, 2017',\n",
       " 'June 4, 2015',\n",
       " 'June 4, 2016',\n",
       " 'June 4, 2017',\n",
       " 'June 5, 2017',\n",
       " 'June 6, 2016',\n",
       " 'June 6, 2017',\n",
       " 'June 7, 2017',\n",
       " 'June 8, 2017',\n",
       " 'June 9, 2017',\n",
       " 'March 1, 2017',\n",
       " 'March 10, 2017',\n",
       " 'March 11, 2016',\n",
       " 'March 11, 2017',\n",
       " 'March 12, 2016',\n",
       " 'March 12, 2017',\n",
       " 'March 13, 2017',\n",
       " 'March 14, 2016',\n",
       " 'March 14, 2017',\n",
       " 'March 15, 2016',\n",
       " 'March 15, 2017',\n",
       " 'March 16, 2016',\n",
       " 'March 16, 2017',\n",
       " 'March 17, 2017',\n",
       " 'March 18, 2016',\n",
       " 'March 18, 2017',\n",
       " 'March 19, 2015',\n",
       " 'March 19, 2017',\n",
       " 'March 2, 2016',\n",
       " 'March 2, 2017',\n",
       " 'March 20, 2017',\n",
       " 'March 21, 2017',\n",
       " 'March 22, 2016',\n",
       " 'March 22, 2017',\n",
       " 'March 23, 2016',\n",
       " 'March 23, 2017',\n",
       " 'March 24, 2016',\n",
       " 'March 24, 2017',\n",
       " 'March 25, 2016',\n",
       " 'March 25, 2017',\n",
       " 'March 26, 2017',\n",
       " 'March 27, 2017',\n",
       " 'March 28, 2017',\n",
       " 'March 29, 2017',\n",
       " 'March 3, 2017',\n",
       " 'March 30, 2017',\n",
       " 'March 31, 2016',\n",
       " 'March 31, 2017',\n",
       " 'March 4, 2017',\n",
       " 'March 5, 2016',\n",
       " 'March 5, 2017',\n",
       " 'March 6, 2017',\n",
       " 'March 7, 2016',\n",
       " 'March 7, 2017',\n",
       " 'March 8, 2016',\n",
       " 'March 8, 2017',\n",
       " 'March 9, 2016',\n",
       " 'March 9, 2017',\n",
       " 'May 1, 2016',\n",
       " 'May 1, 2017',\n",
       " 'May 10, 2016',\n",
       " 'May 10, 2017',\n",
       " 'May 11, 2016',\n",
       " 'May 11, 2017',\n",
       " 'May 12, 2016',\n",
       " 'May 12, 2017',\n",
       " 'May 13, 2016',\n",
       " 'May 13, 2017',\n",
       " 'May 14, 2016',\n",
       " 'May 14, 2017',\n",
       " 'May 15, 2017',\n",
       " 'May 16, 2017',\n",
       " 'May 17, 2016',\n",
       " 'May 17, 2017',\n",
       " 'May 18, 2017',\n",
       " 'May 19, 2016',\n",
       " 'May 19, 2017',\n",
       " 'May 2, 2016',\n",
       " 'May 2, 2017',\n",
       " 'May 20, 2016',\n",
       " 'May 20, 2017',\n",
       " 'May 21, 2014',\n",
       " 'May 21, 2015',\n",
       " 'May 21, 2016',\n",
       " 'May 21, 2017',\n",
       " 'May 22, 2017',\n",
       " 'May 23, 2017',\n",
       " 'May 24, 2016',\n",
       " 'May 24, 2017',\n",
       " 'May 25, 2016',\n",
       " 'May 25, 2017',\n",
       " 'May 26, 2015',\n",
       " 'May 26, 2016',\n",
       " 'May 26, 2017',\n",
       " 'May 27, 2015',\n",
       " 'May 27, 2016',\n",
       " 'May 27, 2017',\n",
       " 'May 28, 2017',\n",
       " 'May 29, 2017',\n",
       " 'May 3, 2016',\n",
       " 'May 3, 2017',\n",
       " 'May 30, 2016',\n",
       " 'May 30, 2017',\n",
       " 'May 31, 2017',\n",
       " 'May 4, 2015',\n",
       " 'May 4, 2016',\n",
       " 'May 4, 2017',\n",
       " 'May 5, 2017',\n",
       " 'May 6, 2016',\n",
       " 'May 6, 2017',\n",
       " 'May 7, 2016',\n",
       " 'May 7, 2017',\n",
       " 'May 8, 2017',\n",
       " 'May 9, 2017',\n",
       " 'November 1, 2016',\n",
       " 'November 10, 2016',\n",
       " 'November 11, 2015',\n",
       " 'November 11, 2016',\n",
       " 'November 12, 2016',\n",
       " 'November 13, 2015',\n",
       " 'November 13, 2016',\n",
       " 'November 14, 2016',\n",
       " 'November 15, 2016',\n",
       " 'November 16, 2015',\n",
       " 'November 16, 2016',\n",
       " 'November 17, 2016',\n",
       " 'November 18, 2016',\n",
       " 'November 19, 2015',\n",
       " 'November 19, 2016',\n",
       " 'November 2, 2016',\n",
       " 'November 20, 2016',\n",
       " 'November 21, 2016',\n",
       " 'November 22, 2016',\n",
       " 'November 23, 2015',\n",
       " 'November 23, 2016',\n",
       " 'November 24, 2016',\n",
       " 'November 25, 2016',\n",
       " 'November 26, 2016',\n",
       " 'November 27, 2016',\n",
       " 'November 28, 2016',\n",
       " 'November 29, 2016',\n",
       " 'November 3, 2016',\n",
       " 'November 30, 2015',\n",
       " 'November 30, 2016',\n",
       " 'November 4, 2015',\n",
       " 'November 4, 2016',\n",
       " 'November 5, 2016',\n",
       " 'November 6, 2016',\n",
       " 'November 7, 2016',\n",
       " 'November 8, 2016',\n",
       " 'November 9, 2016',\n",
       " 'October 1, 2015',\n",
       " 'October 1, 2016',\n",
       " 'October 10, 2016',\n",
       " 'October 11, 2016',\n",
       " 'October 12, 2016',\n",
       " 'October 13, 2016',\n",
       " 'October 14, 2016',\n",
       " 'October 15, 2015',\n",
       " 'October 15, 2016',\n",
       " 'October 16, 2015',\n",
       " 'October 16, 2016',\n",
       " 'October 17, 2016',\n",
       " 'October 18, 2016',\n",
       " 'October 19, 2016',\n",
       " 'October 2, 2016',\n",
       " 'October 20, 2016',\n",
       " 'October 21, 2016',\n",
       " 'October 22, 2016',\n",
       " 'October 23, 2015',\n",
       " 'October 23, 2016',\n",
       " 'October 24, 2016',\n",
       " 'October 25, 2016',\n",
       " 'October 26, 2015',\n",
       " 'October 26, 2016',\n",
       " 'October 27, 2016',\n",
       " 'October 28, 2015',\n",
       " 'October 28, 2016',\n",
       " 'October 29, 2016',\n",
       " 'October 3, 2016',\n",
       " 'October 30, 2014',\n",
       " 'October 30, 2016',\n",
       " 'October 31, 2016',\n",
       " 'October 4, 2016',\n",
       " 'October 5, 2016',\n",
       " 'October 6, 2016',\n",
       " 'October 7, 2016',\n",
       " 'October 8, 2016',\n",
       " 'October 9, 2016',\n",
       " 'September 1, 2016',\n",
       " 'September 10, 2016',\n",
       " 'September 11, 2016',\n",
       " 'September 12, 2016',\n",
       " 'September 13, 2016',\n",
       " 'September 14, 2016',\n",
       " 'September 15, 2016',\n",
       " 'September 16, 2015',\n",
       " 'September 16, 2016',\n",
       " 'September 17, 2016',\n",
       " 'September 18, 2015',\n",
       " 'September 18, 2016',\n",
       " 'September 19, 2016',\n",
       " 'September 2, 2015',\n",
       " 'September 2, 2016',\n",
       " 'September 20, 2016',\n",
       " 'September 21, 2015',\n",
       " 'September 21, 2016',\n",
       " 'September 22, 2015',\n",
       " 'September 22, 2016',\n",
       " 'September 23, 2016',\n",
       " 'September 24, 2016',\n",
       " 'September 25, 2016',\n",
       " 'September 26, 2016',\n",
       " 'September 27, 2016',\n",
       " 'September 28, 2016',\n",
       " 'September 29, 2016',\n",
       " 'September 3, 2014',\n",
       " 'September 3, 2015',\n",
       " 'September 30, 2015',\n",
       " 'September 30, 2016',\n",
       " 'September 4, 2016',\n",
       " 'September 5, 2016',\n",
       " 'September 6, 2016',\n",
       " 'September 7, 2016',\n",
       " 'September 8, 2015',\n",
       " 'September 8, 2016',\n",
       " 'September 9, 2016'}"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "set(df['First Received'].values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'April 1, 2011',\n",
       " 'April 1, 2014',\n",
       " 'April 1, 2015',\n",
       " 'April 1, 2016',\n",
       " 'April 1, 2017',\n",
       " 'April 10, 2015',\n",
       " 'April 10, 2017',\n",
       " 'April 11, 2016',\n",
       " 'April 11, 2017',\n",
       " 'April 12, 2016',\n",
       " 'April 12, 2017',\n",
       " 'April 13, 2016',\n",
       " 'April 13, 2017',\n",
       " 'April 14, 2017',\n",
       " 'April 15, 2016',\n",
       " 'April 15, 2017',\n",
       " 'April 16, 2013',\n",
       " 'April 16, 2015',\n",
       " 'April 16, 2017',\n",
       " 'April 17, 2017',\n",
       " 'April 18, 2016',\n",
       " 'April 18, 2017',\n",
       " 'April 19, 2017',\n",
       " 'April 2, 2017',\n",
       " 'April 20, 2016',\n",
       " 'April 20, 2017',\n",
       " 'April 2010',\n",
       " 'April 2013',\n",
       " 'April 2014',\n",
       " 'April 2015',\n",
       " 'April 2016',\n",
       " 'April 2017',\n",
       " 'April 21, 2016',\n",
       " 'April 21, 2017',\n",
       " 'April 22, 2016',\n",
       " 'April 22, 2017',\n",
       " 'April 23, 2016',\n",
       " 'April 23, 2017',\n",
       " 'April 24, 2015',\n",
       " 'April 24, 2017',\n",
       " 'April 25, 2017',\n",
       " 'April 26, 2017',\n",
       " 'April 27, 2017',\n",
       " 'April 28, 2016',\n",
       " 'April 28, 2017',\n",
       " 'April 29, 2017',\n",
       " 'April 3, 2007',\n",
       " 'April 3, 2017',\n",
       " 'April 30, 2015',\n",
       " 'April 30, 2017',\n",
       " 'April 4, 2017',\n",
       " 'April 5, 2016',\n",
       " 'April 5, 2017',\n",
       " 'April 6, 2015',\n",
       " 'April 6, 2017',\n",
       " 'April 7, 2015',\n",
       " 'April 7, 2017',\n",
       " 'April 8, 2016',\n",
       " 'April 8, 2017',\n",
       " 'April 9, 2017',\n",
       " 'August 1, 2015',\n",
       " 'August 1, 2016',\n",
       " 'August 1, 2017',\n",
       " 'August 10, 2016',\n",
       " 'August 10, 2017',\n",
       " 'August 11, 2016',\n",
       " 'August 11, 2017',\n",
       " 'August 12, 2017',\n",
       " 'August 13, 2015',\n",
       " 'August 13, 2017',\n",
       " 'August 14, 2017',\n",
       " 'August 15, 2016',\n",
       " 'August 15, 2017',\n",
       " 'August 16, 2013',\n",
       " 'August 16, 2016',\n",
       " 'August 16, 2017',\n",
       " 'August 17, 2016',\n",
       " 'August 17, 2017',\n",
       " 'August 18, 2016',\n",
       " 'August 18, 2017',\n",
       " 'August 19, 2015',\n",
       " 'August 19, 2016',\n",
       " 'August 19, 2017',\n",
       " 'August 2, 2016',\n",
       " 'August 2, 2017',\n",
       " 'August 20, 2015',\n",
       " 'August 20, 2016',\n",
       " 'August 20, 2017',\n",
       " 'August 2011',\n",
       " 'August 2012',\n",
       " 'August 2013',\n",
       " 'August 2014',\n",
       " 'August 2015',\n",
       " 'August 2016',\n",
       " 'August 2017',\n",
       " 'August 21, 2017',\n",
       " 'August 22, 2015',\n",
       " 'August 22, 2017',\n",
       " 'August 23, 2016',\n",
       " 'August 23, 2017',\n",
       " 'August 24, 2016',\n",
       " 'August 24, 2017',\n",
       " 'August 25, 2015',\n",
       " 'August 25, 2016',\n",
       " 'August 25, 2017',\n",
       " 'August 26, 2013',\n",
       " 'August 26, 2016',\n",
       " 'August 27, 2017',\n",
       " 'August 28, 2017',\n",
       " 'August 29, 2016',\n",
       " 'August 29, 2017',\n",
       " 'August 3, 2015',\n",
       " 'August 3, 2016',\n",
       " 'August 3, 2017',\n",
       " 'August 30, 2016',\n",
       " 'August 30, 2017',\n",
       " 'August 31, 2015',\n",
       " 'August 31, 2016',\n",
       " 'August 31, 2017',\n",
       " 'August 4, 2016',\n",
       " 'August 4, 2017',\n",
       " 'August 5, 2013',\n",
       " 'August 5, 2016',\n",
       " 'August 6, 2015',\n",
       " 'August 6, 2017',\n",
       " 'August 7, 2017',\n",
       " 'August 8, 2016',\n",
       " 'August 8, 2017',\n",
       " 'August 9, 2016',\n",
       " 'August 9, 2017',\n",
       " 'December 1, 2007',\n",
       " 'December 1, 2015',\n",
       " 'December 1, 2016',\n",
       " 'December 1, 2017',\n",
       " 'December 11, 2014',\n",
       " 'December 11, 2016',\n",
       " 'December 12, 2016',\n",
       " 'December 13, 2016',\n",
       " 'December 14, 2015',\n",
       " 'December 14, 2016',\n",
       " 'December 15, 2016',\n",
       " 'December 16, 2016',\n",
       " 'December 19, 2012',\n",
       " 'December 19, 2016',\n",
       " 'December 2, 2015',\n",
       " 'December 2, 2016',\n",
       " 'December 20, 2015',\n",
       " 'December 20, 2016',\n",
       " 'December 20, 2017',\n",
       " 'December 2004',\n",
       " 'December 2010',\n",
       " 'December 2011',\n",
       " 'December 2012',\n",
       " 'December 2013',\n",
       " 'December 2014',\n",
       " 'December 2015',\n",
       " 'December 2016',\n",
       " 'December 2017',\n",
       " 'December 21, 2015',\n",
       " 'December 21, 2016',\n",
       " 'December 22, 1956',\n",
       " 'December 22, 2016',\n",
       " 'December 23, 2016',\n",
       " 'December 26, 2016',\n",
       " 'December 27, 2016',\n",
       " 'December 28, 2016',\n",
       " 'December 29, 2016',\n",
       " 'December 3, 2016',\n",
       " 'December 30, 2016',\n",
       " 'December 31, 2015',\n",
       " 'December 31, 2016',\n",
       " 'December 5, 2016',\n",
       " 'December 6, 2016',\n",
       " 'December 7, 2016',\n",
       " 'December 8, 2016',\n",
       " 'December 9, 2015',\n",
       " 'December 9, 2016',\n",
       " 'February 1, 2012',\n",
       " 'February 1, 2013',\n",
       " 'February 1, 2015',\n",
       " 'February 1, 2016',\n",
       " 'February 1, 2017',\n",
       " 'February 10, 2015',\n",
       " 'February 10, 2016',\n",
       " 'February 10, 2017',\n",
       " 'February 11, 2017',\n",
       " 'February 12, 2017',\n",
       " 'February 13, 2017',\n",
       " 'February 14, 2016',\n",
       " 'February 14, 2017',\n",
       " 'February 15, 2017',\n",
       " 'February 16, 2015',\n",
       " 'February 16, 2016',\n",
       " 'February 16, 2017',\n",
       " 'February 17, 2016',\n",
       " 'February 17, 2017',\n",
       " 'February 18, 2016',\n",
       " 'February 18, 2017',\n",
       " 'February 19, 2016',\n",
       " 'February 19, 2017',\n",
       " 'February 2, 2016',\n",
       " 'February 2, 2017',\n",
       " 'February 20, 2016',\n",
       " 'February 20, 2017',\n",
       " 'February 2002',\n",
       " 'February 2008',\n",
       " 'February 2009',\n",
       " 'February 2013',\n",
       " 'February 2014',\n",
       " 'February 2015',\n",
       " 'February 2016',\n",
       " 'February 2017',\n",
       " 'February 2018',\n",
       " 'February 21, 2017',\n",
       " 'February 22, 2016',\n",
       " 'February 22, 2017',\n",
       " 'February 23, 2017',\n",
       " 'February 24, 2016',\n",
       " 'February 24, 2017',\n",
       " 'February 25, 2017',\n",
       " 'February 26, 2015',\n",
       " 'February 26, 2016',\n",
       " 'February 26, 2017',\n",
       " 'February 27, 2016',\n",
       " 'February 27, 2017',\n",
       " 'February 28, 2017',\n",
       " 'February 3, 2016',\n",
       " 'February 3, 2017',\n",
       " 'February 4, 2017',\n",
       " 'February 5, 2017',\n",
       " 'February 6, 2017',\n",
       " 'February 7, 2017',\n",
       " 'February 8, 2016',\n",
       " 'February 8, 2017',\n",
       " 'February 9, 2016',\n",
       " 'February 9, 2017',\n",
       " 'January 1, 2005',\n",
       " 'January 1, 2010',\n",
       " 'January 1, 2013',\n",
       " 'January 1, 2014',\n",
       " 'January 1, 2015',\n",
       " 'January 1, 2016',\n",
       " 'January 1, 2017',\n",
       " 'January 1, 2018',\n",
       " 'January 10, 2015',\n",
       " 'January 10, 2017',\n",
       " 'January 11, 2016',\n",
       " 'January 11, 2017',\n",
       " 'January 12, 2016',\n",
       " 'January 12, 2017',\n",
       " 'January 13, 2013',\n",
       " 'January 13, 2016',\n",
       " 'January 13, 2017',\n",
       " 'January 14, 2015',\n",
       " 'January 14, 2016',\n",
       " 'January 14, 2017',\n",
       " 'January 15, 2015',\n",
       " 'January 15, 2016',\n",
       " 'January 15, 2017',\n",
       " 'January 16, 2017',\n",
       " 'January 17, 2017',\n",
       " 'January 18, 2016',\n",
       " 'January 18, 2017',\n",
       " 'January 19, 2017',\n",
       " 'January 2, 2014',\n",
       " 'January 2, 2015',\n",
       " 'January 2, 2017',\n",
       " 'January 20, 2016',\n",
       " 'January 20, 2017',\n",
       " 'January 2001',\n",
       " 'January 2006',\n",
       " 'January 2009',\n",
       " 'January 2010',\n",
       " 'January 2011',\n",
       " 'January 2012',\n",
       " 'January 2013',\n",
       " 'January 2014',\n",
       " 'January 2015',\n",
       " 'January 2016',\n",
       " 'January 2017',\n",
       " 'January 21, 2015',\n",
       " 'January 21, 2016',\n",
       " 'January 21, 2017',\n",
       " 'January 22, 2015',\n",
       " 'January 22, 2017',\n",
       " 'January 23, 2017',\n",
       " 'January 24, 2017',\n",
       " 'January 25, 2017',\n",
       " 'January 26, 2015',\n",
       " 'January 26, 2017',\n",
       " 'January 27, 2016',\n",
       " 'January 27, 2017',\n",
       " 'January 28, 2016',\n",
       " 'January 29, 2016',\n",
       " 'January 29, 2017',\n",
       " 'January 3, 2017',\n",
       " 'January 30, 2017',\n",
       " 'January 31, 2017',\n",
       " 'January 4, 2016',\n",
       " 'January 4, 2017',\n",
       " 'January 5, 2017',\n",
       " 'January 6, 2015',\n",
       " 'January 6, 2016',\n",
       " 'January 6, 2017',\n",
       " 'January 7, 2016',\n",
       " 'January 7, 2017',\n",
       " 'January 8, 2018',\n",
       " 'January 9, 2017',\n",
       " 'July 1, 2005',\n",
       " 'July 1, 2008',\n",
       " 'July 1, 2015',\n",
       " 'July 1, 2016',\n",
       " 'July 1, 2017',\n",
       " 'July 10, 2017',\n",
       " 'July 11, 2011',\n",
       " 'July 11, 2016',\n",
       " 'July 11, 2017',\n",
       " 'July 12, 2016',\n",
       " 'July 12, 2017',\n",
       " 'July 13, 2015',\n",
       " 'July 13, 2017',\n",
       " 'July 14, 2016',\n",
       " 'July 14, 2017',\n",
       " 'July 15, 2016',\n",
       " 'July 15, 2017',\n",
       " 'July 16, 2017',\n",
       " 'July 17, 2017',\n",
       " 'July 18, 2016',\n",
       " 'July 18, 2017',\n",
       " 'July 19, 2017',\n",
       " 'July 2, 2014',\n",
       " 'July 2, 2017',\n",
       " 'July 20, 2015',\n",
       " 'July 20, 2016',\n",
       " 'July 20, 2017',\n",
       " 'July 2012',\n",
       " 'July 2013',\n",
       " 'July 2014',\n",
       " 'July 2015',\n",
       " 'July 2016',\n",
       " 'July 2017',\n",
       " 'July 21, 2017',\n",
       " 'July 22, 2016',\n",
       " 'July 23, 2015',\n",
       " 'July 24, 2017',\n",
       " 'July 25, 2013',\n",
       " 'July 25, 2016',\n",
       " 'July 25, 2017',\n",
       " 'July 26, 2014',\n",
       " 'July 26, 2016',\n",
       " 'July 26, 2017',\n",
       " 'July 27, 2016',\n",
       " 'July 27, 2017',\n",
       " 'July 28, 2015',\n",
       " 'July 28, 2016',\n",
       " 'July 28, 2017',\n",
       " 'July 29, 2015',\n",
       " 'July 29, 2017',\n",
       " 'July 3, 2017',\n",
       " 'July 30, 2017',\n",
       " 'July 31, 2017',\n",
       " 'July 4, 2016',\n",
       " 'July 4, 2017',\n",
       " 'July 5, 2016',\n",
       " 'July 5, 2017',\n",
       " 'July 6, 2017',\n",
       " 'July 7, 2016',\n",
       " 'July 7, 2017',\n",
       " 'July 8, 2016',\n",
       " 'July 8, 2017',\n",
       " 'July 9, 2017',\n",
       " 'June 1, 2009',\n",
       " 'June 1, 2014',\n",
       " 'June 1, 2015',\n",
       " 'June 1, 2016',\n",
       " 'June 1, 2017',\n",
       " 'June 10, 2015',\n",
       " 'June 10, 2016',\n",
       " 'June 10, 2017',\n",
       " 'June 11, 2017',\n",
       " 'June 12, 2013',\n",
       " 'June 12, 2014',\n",
       " 'June 12, 2015',\n",
       " 'June 12, 2017',\n",
       " 'June 13, 2016',\n",
       " 'June 13, 2017',\n",
       " 'June 14, 2016',\n",
       " 'June 14, 2017',\n",
       " 'June 15, 2016',\n",
       " 'June 15, 2017',\n",
       " 'June 16, 2017',\n",
       " 'June 17, 2017',\n",
       " 'June 18, 2017',\n",
       " 'June 19, 2017',\n",
       " 'June 2, 2016',\n",
       " 'June 2, 2017',\n",
       " 'June 20, 2017',\n",
       " 'June 2006',\n",
       " 'June 2011',\n",
       " 'June 2013',\n",
       " 'June 2014',\n",
       " 'June 2015',\n",
       " 'June 2016',\n",
       " 'June 2017',\n",
       " 'June 21, 2017',\n",
       " 'June 22, 2012',\n",
       " 'June 22, 2015',\n",
       " 'June 22, 2016',\n",
       " 'June 22, 2017',\n",
       " 'June 23, 2016',\n",
       " 'June 23, 2017',\n",
       " 'June 24, 2016',\n",
       " 'June 24, 2017',\n",
       " 'June 25, 2015',\n",
       " 'June 25, 2017',\n",
       " 'June 26, 2017',\n",
       " 'June 27, 2016',\n",
       " 'June 27, 2017',\n",
       " 'June 28, 2017',\n",
       " 'June 29, 2014',\n",
       " 'June 29, 2016',\n",
       " 'June 29, 2017',\n",
       " 'June 3, 2017',\n",
       " 'June 30, 2015',\n",
       " 'June 30, 2016',\n",
       " 'June 30, 2017',\n",
       " 'June 4, 2017',\n",
       " 'June 5, 2015',\n",
       " 'June 5, 2017',\n",
       " 'June 6, 2011',\n",
       " 'June 6, 2016',\n",
       " 'June 6, 2017',\n",
       " 'June 7, 2012',\n",
       " 'June 7, 2016',\n",
       " 'June 7, 2017',\n",
       " 'June 8, 2016',\n",
       " 'June 8, 2017',\n",
       " 'June 9, 2017',\n",
       " 'March 1, 2016',\n",
       " 'March 1, 2017',\n",
       " 'March 10, 2016',\n",
       " 'March 10, 2017',\n",
       " 'March 11, 2015',\n",
       " 'March 11, 2016',\n",
       " 'March 11, 2017',\n",
       " 'March 12, 2017',\n",
       " 'March 13, 2016',\n",
       " 'March 13, 2017',\n",
       " 'March 14, 2017',\n",
       " 'March 15, 2015',\n",
       " 'March 15, 2016',\n",
       " 'March 15, 2017',\n",
       " 'March 16, 2016',\n",
       " 'March 16, 2017',\n",
       " 'March 17, 2017',\n",
       " 'March 18, 2017',\n",
       " 'March 19, 2016',\n",
       " 'March 19, 2017',\n",
       " 'March 2, 2016',\n",
       " 'March 2, 2017',\n",
       " 'March 20, 2017',\n",
       " 'March 2010',\n",
       " 'March 2012',\n",
       " 'March 2013',\n",
       " 'March 2014',\n",
       " 'March 2015',\n",
       " 'March 2016',\n",
       " 'March 2017',\n",
       " 'March 21, 2016',\n",
       " 'March 21, 2017',\n",
       " 'March 22, 2016',\n",
       " 'March 22, 2017',\n",
       " 'March 23, 2013',\n",
       " 'March 23, 2017',\n",
       " 'March 24, 2015',\n",
       " 'March 24, 2017',\n",
       " 'March 25, 2015',\n",
       " 'March 25, 2017',\n",
       " 'March 26, 2017',\n",
       " 'March 27, 2017',\n",
       " 'March 28, 2016',\n",
       " 'March 28, 2017',\n",
       " 'March 29, 2017',\n",
       " 'March 3, 2017',\n",
       " 'March 30, 2016',\n",
       " 'March 30, 2017',\n",
       " 'March 31, 2017',\n",
       " 'March 4, 2017',\n",
       " 'March 5, 2017',\n",
       " 'March 6, 2017',\n",
       " 'March 7, 2012',\n",
       " 'March 7, 2017',\n",
       " 'March 8, 2016',\n",
       " 'March 8, 2017',\n",
       " 'March 9, 2016',\n",
       " 'March 9, 2017',\n",
       " 'May 1, 2012',\n",
       " 'May 1, 2014',\n",
       " 'May 1, 2015',\n",
       " 'May 1, 2016',\n",
       " 'May 1, 2017',\n",
       " 'May 10, 2016',\n",
       " 'May 10, 2017',\n",
       " 'May 11, 2016',\n",
       " 'May 11, 2017',\n",
       " 'May 12, 2015',\n",
       " 'May 12, 2016',\n",
       " 'May 12, 2017',\n",
       " 'May 13, 2017',\n",
       " 'May 14, 2015',\n",
       " 'May 14, 2016',\n",
       " 'May 14, 2017',\n",
       " 'May 15, 2015',\n",
       " 'May 15, 2016',\n",
       " 'May 15, 2017',\n",
       " 'May 16, 2016',\n",
       " 'May 16, 2017',\n",
       " 'May 17, 2017',\n",
       " 'May 18, 2016',\n",
       " 'May 18, 2017',\n",
       " 'May 19, 2016',\n",
       " 'May 19, 2017',\n",
       " 'May 2, 2015',\n",
       " 'May 2, 2017',\n",
       " 'May 20, 2016',\n",
       " 'May 20, 2017',\n",
       " 'May 2009',\n",
       " 'May 2011',\n",
       " 'May 2012',\n",
       " 'May 2013',\n",
       " 'May 2014',\n",
       " 'May 2015',\n",
       " 'May 2016',\n",
       " 'May 2017',\n",
       " 'May 21, 2017',\n",
       " 'May 22, 2014',\n",
       " 'May 22, 2017',\n",
       " 'May 23, 2017',\n",
       " 'May 24, 2016',\n",
       " 'May 24, 2017',\n",
       " 'May 25, 2016',\n",
       " 'May 25, 2017',\n",
       " 'May 26, 2016',\n",
       " 'May 26, 2017',\n",
       " 'May 27, 2015',\n",
       " 'May 27, 2017',\n",
       " 'May 28, 2016',\n",
       " 'May 28, 2017',\n",
       " 'May 29, 2015',\n",
       " 'May 29, 2016',\n",
       " 'May 29, 2017',\n",
       " 'May 3, 2017',\n",
       " 'May 30, 2013',\n",
       " 'May 30, 2016',\n",
       " 'May 30, 2017',\n",
       " 'May 31, 2015',\n",
       " 'May 31, 2017',\n",
       " 'May 4, 2016',\n",
       " 'May 4, 2017',\n",
       " 'May 5, 2017',\n",
       " 'May 6, 2016',\n",
       " 'May 6, 2017',\n",
       " 'May 7, 2017',\n",
       " 'May 8, 2015',\n",
       " 'May 8, 2017',\n",
       " 'May 9, 2017',\n",
       " 'November 1, 2014',\n",
       " 'November 1, 2015',\n",
       " 'November 1, 2016',\n",
       " 'November 1, 2017',\n",
       " 'November 10, 2016',\n",
       " 'November 11, 2016',\n",
       " 'November 12, 2013',\n",
       " 'November 12, 2016',\n",
       " 'November 13, 2015',\n",
       " 'November 13, 2016',\n",
       " 'November 14, 2016',\n",
       " 'November 15, 2015',\n",
       " 'November 15, 2016',\n",
       " 'November 16, 2015',\n",
       " 'November 16, 2016',\n",
       " 'November 17, 2014',\n",
       " 'November 17, 2016',\n",
       " 'November 18, 2016',\n",
       " 'November 19, 2016',\n",
       " 'November 2, 2011',\n",
       " 'November 2, 2015',\n",
       " 'November 2, 2016',\n",
       " 'November 20, 2013',\n",
       " 'November 20, 2016',\n",
       " 'November 2008',\n",
       " 'November 2010',\n",
       " 'November 2012',\n",
       " 'November 2013',\n",
       " 'November 2014',\n",
       " 'November 2015',\n",
       " 'November 2016',\n",
       " 'November 2017',\n",
       " 'November 21, 2016',\n",
       " 'November 22, 2013',\n",
       " 'November 22, 2016',\n",
       " 'November 23, 2015',\n",
       " 'November 23, 2016',\n",
       " 'November 24, 2014',\n",
       " 'November 24, 2016',\n",
       " 'November 25, 2016',\n",
       " 'November 26, 2013',\n",
       " 'November 26, 2015',\n",
       " 'November 26, 2016',\n",
       " 'November 28, 2016',\n",
       " 'November 29, 2012',\n",
       " 'November 29, 2016',\n",
       " 'November 3, 2014',\n",
       " 'November 3, 2016',\n",
       " 'November 30, 2016',\n",
       " 'November 4, 2014',\n",
       " 'November 4, 2016',\n",
       " 'November 5, 2016',\n",
       " 'November 6, 2016',\n",
       " 'November 7, 2016',\n",
       " 'November 8, 2016',\n",
       " 'November 9, 2015',\n",
       " 'November 9, 2016',\n",
       " 'October 1, 2013',\n",
       " 'October 1, 2015',\n",
       " 'October 1, 2016',\n",
       " 'October 1, 2017',\n",
       " 'October 10, 2016',\n",
       " 'October 11, 2015',\n",
       " 'October 11, 2016',\n",
       " 'October 12, 2016',\n",
       " 'October 13, 2014',\n",
       " 'October 13, 2016',\n",
       " 'October 14, 2016',\n",
       " 'October 15, 2016',\n",
       " 'October 15, 2017',\n",
       " 'October 16, 2013',\n",
       " 'October 16, 2017',\n",
       " 'October 17, 2013',\n",
       " 'October 17, 2014',\n",
       " 'October 17, 2016',\n",
       " 'October 18, 2016',\n",
       " 'October 19, 2015',\n",
       " 'October 19, 2016',\n",
       " 'October 2, 2015',\n",
       " 'October 2, 2016',\n",
       " 'October 20, 2016',\n",
       " 'October 2010',\n",
       " 'October 2011',\n",
       " 'October 2012',\n",
       " 'October 2013',\n",
       " 'October 2014',\n",
       " 'October 2015',\n",
       " 'October 2016',\n",
       " 'October 2017',\n",
       " 'October 21, 2016',\n",
       " 'October 22, 2016',\n",
       " 'October 23, 2015',\n",
       " 'October 24, 2014',\n",
       " 'October 24, 2016',\n",
       " 'October 25, 2016',\n",
       " 'October 26, 2016',\n",
       " 'October 27, 2014',\n",
       " 'October 27, 2016',\n",
       " 'October 28, 2013',\n",
       " 'October 28, 2014',\n",
       " 'October 28, 2015',\n",
       " 'October 28, 2016',\n",
       " 'October 28, 2017',\n",
       " 'October 3, 2014',\n",
       " 'October 3, 2016',\n",
       " 'October 30, 2017',\n",
       " 'October 31, 2016',\n",
       " 'October 4, 2016',\n",
       " 'October 5, 2016',\n",
       " 'October 6, 2016',\n",
       " 'October 7, 2014',\n",
       " 'October 7, 2016',\n",
       " 'October 8, 2015',\n",
       " 'September 1, 2014',\n",
       " 'September 1, 2015',\n",
       " 'September 1, 2016',\n",
       " 'September 1, 2017',\n",
       " 'September 10, 2017',\n",
       " 'September 11, 2016',\n",
       " 'September 11, 2017',\n",
       " 'September 12, 2016',\n",
       " 'September 13, 2013',\n",
       " 'September 13, 2016',\n",
       " 'September 13, 2017',\n",
       " 'September 14, 2014',\n",
       " 'September 14, 2016',\n",
       " 'September 14, 2017',\n",
       " 'September 15, 2011',\n",
       " 'September 15, 2015',\n",
       " 'September 15, 2016',\n",
       " 'September 15, 2017',\n",
       " 'September 16, 2015',\n",
       " 'September 16, 2016',\n",
       " 'September 19, 2016',\n",
       " 'September 2, 2015',\n",
       " 'September 2, 2016',\n",
       " 'September 2, 2017',\n",
       " 'September 20, 2016',\n",
       " 'September 2008',\n",
       " 'September 2013',\n",
       " 'September 2014',\n",
       " 'September 2015',\n",
       " 'September 2016',\n",
       " 'September 2017',\n",
       " 'September 21, 2016',\n",
       " 'September 22, 2016',\n",
       " 'September 23, 2015',\n",
       " 'September 23, 2016',\n",
       " 'September 24, 2015',\n",
       " 'September 25, 2015',\n",
       " 'September 26, 2016',\n",
       " 'September 27, 2012',\n",
       " 'September 27, 2016',\n",
       " 'September 28, 2016',\n",
       " 'September 28, 2017',\n",
       " 'September 29, 2014',\n",
       " 'September 29, 2016',\n",
       " 'September 29, 2017',\n",
       " 'September 3, 2013',\n",
       " 'September 30, 2015',\n",
       " 'September 30, 2016',\n",
       " 'September 30, 2017',\n",
       " 'September 4, 2017',\n",
       " 'September 5, 2016',\n",
       " 'September 5, 2017',\n",
       " 'September 6, 2011',\n",
       " 'September 6, 2017',\n",
       " 'September 7, 2016',\n",
       " 'September 8, 2016',\n",
       " 'September 9, 2017',\n",
       " 'null'}"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "set(df['Start Date'].values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'Jinan Military General Hospital',\n",
       " 'Cancer Institute and Hospital, Chinese Academy of Medical Sciences|Sun Yat-sen University|Fudan University|Chinese PLA General Hospital|Beijing Chest Hospital',\n",
       " 'Institute of Tropical Medicine, Belgium|Ecole Nationale de Sant\\xc3\\xa9 Publique, Rabat, Morocco',\n",
       " 'Hospital of Prato',\n",
       " 'Actelion',\n",
       " 'Kaohsiung Veterans General Hospital.|Kaohsiung Medical University Chung-Ho Memorial Hospital',\n",
       " 'Zai Lab Pty. Ltd.',\n",
       " 'Elisabeth-TweeSteden Ziekenhuis|University of Tilburg|ZonMw: The Netherlands Organisation for Health Research and Development',\n",
       " 'Uppsala University|Fundation of Ester \\xc3\\x85sberg Lindbergs memmories, Falun; Sweden|Center for clnical research Dalarna, Sweden',\n",
       " 'Levanger Hospital|Norwegian University of Science and Technology|St. Olavs Hospital',\n",
       " 'BioClin Therapeutics, Inc.',\n",
       " \"St George's, University of London\",\n",
       " 'Federal University of Health Science of Porto Alegre',\n",
       " 'Cambridge Cardiac Care Centre',\n",
       " 'Linkoeping University',\n",
       " 'Shandong University',\n",
       " 'University of Bath',\n",
       " 'Asian Institute of Gastroenterology, India',\n",
       " \"Yale University|St. Louis Children's Hospital|Dell Children\\xe2\\x80\\x99s Medical Center of Central Texas|Children's Hospital and Health System Foundation, Wisconsin\",\n",
       " 'University of Central Florida|Department of Health and Human Services',\n",
       " 'University of California, San Diego|San Diego State University',\n",
       " 'University of Colorado, Denver|United States Department of Defense',\n",
       " 'University of Campinas, Brazil|Funda\\xc3\\xa7\\xc3\\xa3o de Amparo \\xc3\\xa0 Pesquisa do Estado de S\\xc3\\xa3o Paulo',\n",
       " 'Institut de Canc\\xc3\\xa9rologie de Lorraine',\n",
       " 'Jonathan Pearlman|University of Pittsburgh',\n",
       " 'Dong-A ST Co., Ltd.',\n",
       " 'Raija Silvennoinen|Amgen|Bristol-Myers Squibb|Hospital District of Helsinki and Uusimaa|Helsinki University Central Hospital',\n",
       " 'Tata Main Hospital',\n",
       " 'Mekelle University',\n",
       " 'Hospital Universitari de Bellvitge|University of Barcelona',\n",
       " 'U.S. Army Medical Research and Materiel Command',\n",
       " 'Tulane University',\n",
       " 'Philips Light and Health|University Hospital Goettingen|Philipps University Marburg Medical Center|University Hospital, Geneva',\n",
       " 'Akebia Therapeutics',\n",
       " 'Spectranetics Corporation',\n",
       " 'Oragenics, Inc.',\n",
       " 'Daiichi Sankyo, Inc.',\n",
       " 'Massachusetts General Hospital|National Institutes of Health (NIH)|National Heart, Lung, and Blood Institute (NHLBI)',\n",
       " 'Fundacion para la Investigacion y Formacion en Ciencias de la Salud|Instituto de Salud Carlos III',\n",
       " \"Institut d'Investigaci\\xc3\\xb3 Biom\\xc3\\xa8dica de Girona Dr. Josep Trueta|Imperial College London|Oxford Brookes University|University of Girona|Cellnovo Limited|Romsoft SRL\",\n",
       " 'Synergy Pharmaceuticals Inc.',\n",
       " 'Puerta de Hierro University Hospital|Fundaci\\xc3\\xb3n Mutua Madrile\\xc3\\xb1a|Instituto de Salud Carlos III',\n",
       " 'University of California, San Francisco|The V Foundation for Cancer Research|Pacific Pediatric Neuro-Oncology Consortium',\n",
       " 'Xencor, Inc.|Chiltern International Inc.',\n",
       " 'C. Storm|Charite University, Berlin, Germany',\n",
       " 'University of Southern California|National Cancer Institute (NCI)',\n",
       " 'Guangzhou Institute of Respiratory Disease|Xiangxue Life Science Research Center|Guangdong Xiangxue Precision Medical Technology Co., Ltd|Guangzhou Xiangxue Pharmaceutical Co., Ltd',\n",
       " 'Oslo University Hospital',\n",
       " 'Rhythm Pharmaceuticals, Inc.',\n",
       " 'Southwest Oncology Group|National Cancer Institute (NCI)',\n",
       " 'University of Saskatchewan',\n",
       " \"Children's Hospital of Philadelphia|AbbVie\",\n",
       " 'Instituto Mexicano del Seguro Social',\n",
       " \"Washington University School of Medicine|The Task Force for Global Health|Murdoch Children's Research Institute\",\n",
       " 'University of Illinois at Chicago|National Institutes of Health (NIH)|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)',\n",
       " 'Postgraduate Institute of Dental Sciences Rohtak',\n",
       " 'Laboratorios del Dr. Esteve, S.A.|Premier Research Group plc',\n",
       " 'Earle Burgess|Astellas Pharma Inc|Medivation, Inc.|Carolinas Healthcare System',\n",
       " 'Institut Paoli-Calmettes|Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France|Beckman Coulter, Inc.',\n",
       " 'Ray Hershberger|National Heart, Lung, and Blood Institute (NHLBI)|National Human Genome Research Institute (NHGRI)|Ohio State University',\n",
       " 'Cork University Hospital|FOTONA, D.O.O',\n",
       " 'Charite University, Berlin, Germany|Central Institute of Mental Health, Mannheim',\n",
       " 'Case Western Reserve University|National Institutes of Health (NIH)|National Institute of Nursing Research (NINR)',\n",
       " 'Hospital Israelita Albert Einstein|Funda\\xc3\\xa7\\xc3\\xa3o de Amparo \\xc3\\xa0 Pesquisa do Estado de S\\xc3\\xa3o Paulo|Instituto do Coracao',\n",
       " 'Western Sydney Local Health District',\n",
       " \"Centre hospitalier de l'Universit\\xc3\\xa9 de Montr\\xc3\\xa9al (CHUM)|Canadian Institutes of Health Research (CIHR)\",\n",
       " \"Kim's Eye Hospital|Bayer\",\n",
       " 'Oslo University Hospital|University Hospital, Akershus',\n",
       " 'Seattle Genetics, Inc.',\n",
       " 'University of Colorado, Boulder|National Institute on Alcohol Abuse and Alcoholism (NIAAA)',\n",
       " \"The Hospital for Sick Children|Canadian Hemophilia Society|St. Michael's Hospital, Toronto\",\n",
       " 'University of Cincinnati',\n",
       " 'Universit\\xc3\\xa4tsmedizin Mannheim',\n",
       " 'USDA, Western Human Nutrition Research Center|University of California, Davis',\n",
       " 'University of British Columbia|Canadian Institutes of Health Research (CIHR)',\n",
       " 'Universidad San Jorge|Roche Diagnostics',\n",
       " 'Cl\\xc3\\xadnica de Artritis Temprana|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran',\n",
       " \"Children's Hospital of Philadelphia|Pfizer\",\n",
       " 'Nhat Nhat Pharmaceutical Company',\n",
       " 'London North West Healthcare NHS Trust',\n",
       " 'Inotrem',\n",
       " 'Mahidol University',\n",
       " 'Christian Juhl Terkelsen|Aarhus University Hospital Skejby',\n",
       " 'Dong-A University',\n",
       " \"Children's Hospital of The King's Daughters|Children's Research Institute\",\n",
       " 'Colin Grissom|Intermountain Health Care, Inc.',\n",
       " 'Palmetto Health',\n",
       " 'Chad Scarboro|Carolinas Healthcare System',\n",
       " 'Samjin Pharmaceutical Co., Ltd.',\n",
       " 'Yale-NUS College|Raffles Institution',\n",
       " 'French Cardiology Society|French Federation of Cardiology|I.V.S. Institut des Vaisseaux et du Sang|Biosensors Europe SA|AstraZeneca|Boston Scientific Corporation|Abbott Vascular|Terumo Corporation|Daiichi Sankyo, Inc.|Hexacath, France|Biotronik SE & Co. KG',\n",
       " \"Texas Woman's University\",\n",
       " 'National Jewish Health|AstraZeneca',\n",
       " 'M.D. Anderson Cancer Center|Helsinn Healthcare SA',\n",
       " 'Azienda Ospedaliera Universitaria Integrata Verona',\n",
       " 'Population Health Research Institute|Canadian Institutes of Health Research (CIHR)',\n",
       " 'Universiteit Antwerpen|University Hospital, Antwerp',\n",
       " 'Hospital Universitario de Canarias|Orion Corporation, Orion Pharma',\n",
       " 'Brown University',\n",
       " 'University of Oxford|Blue Earth Diagnostics',\n",
       " 'The Cleveland Clinic|Novartis Pharmaceuticals',\n",
       " 'National Institute on Alcohol Abuse and Alcoholism (NIAAA)|National Institutes of Health Clinical Center (CC)',\n",
       " 'Aalborg Universitetshospital|Aalborg University',\n",
       " 'Assuta Medical Center|Rabin Medical Center',\n",
       " 'Karolinska Institutet|Stockholm County Council, Sweden',\n",
       " 'Nina Bhardwaj|Icahn School of Medicine at Mount Sinai',\n",
       " \"Guy's and St Thomas' NHS Foundation Trust|King's College London\",\n",
       " 'The University of Texas Health Science Center, Houston|National Institute on Drug Abuse (NIDA)',\n",
       " \"Kowa Research Institute, Inc.|Brigham and Women's Hospital\",\n",
       " 'Universidad Peruana Cayetano Heredia',\n",
       " 'Fondazione Don Carlo Gnocchi Onlus',\n",
       " 'University College, London|Medical Research Council',\n",
       " 'University of Iowa|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)',\n",
       " 'Virginia Commonwealth University',\n",
       " 'Temple University',\n",
       " 'Stayble Therapeutics',\n",
       " 'Coopervision, Inc.',\n",
       " 'University of California, Irvine|Los Angeles Biomedical Research Institute|University of Massachusetts, Amherst|Agency for Healthcare Research and Quality (AHRQ)',\n",
       " 'Hoffmann-La Roche|Prothena Biosciences Limited',\n",
       " 'Innovative Cardiovascular Solutions|Meditrial Europe Ltd.',\n",
       " 'TC Erciyes University',\n",
       " 'ProMetic Pharma SMT Limited|ProMetic BioSciences Inc.',\n",
       " 'Memorial Sloan Kettering Cancer Center|Cornell University|Dana-Farber Cancer Institute',\n",
       " 'feng xiaobin|Southwest Hospital, China',\n",
       " 'University of Aberdeen|NHS Grampian',\n",
       " 'Heron Therapeutics',\n",
       " 'New York University School of Medicine|EMD Serono',\n",
       " 'Stratatech, a Mallinckrodt Company',\n",
       " 'M.D. Anderson Cancer Center|National Heart, Lung, and Blood Institute (NHLBI)',\n",
       " 'Alexandria University',\n",
       " 'Radboud University|Rijnstate Hospital',\n",
       " 'Washington D.C. Veterans Affairs Medical Center',\n",
       " 'University of Alberta|Heart and Stroke Foundation of Canada|Canadian Stroke Prevention Intervention Network',\n",
       " 'Darlene A. Lobel, MD|The Cleveland Clinic',\n",
       " 'University of British Columbia|Heart and Stroke Foundation of Canada',\n",
       " 'Sara Farag|The Cleveland Clinic',\n",
       " 'Rigshospitalet, Denmark|Octapharma|University of Iceland',\n",
       " 'Cancer Research UK',\n",
       " 'Tasly Pharmaceuticals, Inc.',\n",
       " 'Oramed, Ltd.|Integrium',\n",
       " 'National Jewish Health|Stanford University',\n",
       " 'University of Alabama at Birmingham|National Heart, Lung, and Blood Institute (NHLBI)|Vertex Pharmaceuticals Incorporated',\n",
       " 'University Hospital of Ferrara',\n",
       " 'Rubino Ob-Gyn Group',\n",
       " 'University Hospital Regensburg|Anticancer Fund, Belgium|Celgene',\n",
       " 'Bart\\xc5\\x82omiej W\\xc3\\xb3darski|Centre of Postgraduate Medical Education',\n",
       " 'Karolinska University Hospital',\n",
       " \"Columbia University|American Cancer Society, Inc.|Gabrielle's Angel Foundation\",\n",
       " 'Shenyang Sunshine Pharmaceutical Co., LTD.|Ecron Acunova GmbH',\n",
       " 'Centre for Addiction and Mental Health|CAMH Foundation',\n",
       " 'Grant S Lipman|Stanford University',\n",
       " 'Common Sense',\n",
       " 'Nagoya City University',\n",
       " 'DFB Soria, LLC|US Biotest, Inc.',\n",
       " 'Universidade Federal de Pernambuco',\n",
       " 'Cooperative University of Colombia|Colgate Palmolive',\n",
       " 'University of Turku',\n",
       " 'Columbia University|National Heart, Lung, and Blood Institute (NHLBI)',\n",
       " 'Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France',\n",
       " 'Johns Hopkins Bloomberg School of Public Health|United States Agency for International Development (USAID)',\n",
       " 'Real Imaging Ltd.',\n",
       " 'GeNeuro Australia PTY Ltd|Southern Star Research Pty Ltd.',\n",
       " 'Fundacion para la Investigacion y Formacion en Ciencias de la Salud|Castilla-Le\\xc3\\xb3n Health Service',\n",
       " 'University of Pennsylvania|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|National Center for Advancing Translational Science (NCATS)|Office of Rare Diseases (ORD)',\n",
       " 'Appalachian State University|Reoxcyn Discoveries Group',\n",
       " 'Seoul National University Hospital',\n",
       " 'PharmatrophiX Inc.|National Institute on Aging (NIA)',\n",
       " 'University of Aarhus|Aalborg Universitetshospital',\n",
       " 'National Research Council, Spain|Basque Country University, Spain',\n",
       " 'PATH|International Centre for Diarrhoeal Disease Research, Bangladesh',\n",
       " 'Northwell Health|Ipsen',\n",
       " 'Second Affiliated Hospital of Wenzhou Medical University|Beijing Jishuitan Hospital',\n",
       " 'Faculdade de Medicina de Petr\\xc3\\xb3polis Faculdade Arthur S\\xc3\\xa1 Earp Neto',\n",
       " 'Hutchison Medipharma Limited',\n",
       " 'Institute of Vaccines and Medical Biologicals, Vietnam|Pasteur Institute, Ho Chi Minh City|PATH|Quintiles, Inc.|World Health Organization',\n",
       " 'Versailles Hospital|Jean Michel BAUD (angiologist)|Aur\\xc3\\xa9lien MAURIZOT (angiologist)',\n",
       " 'Theralase Inc.|University Health Network, Toronto|Medelis Inc.|WCCT Global',\n",
       " 'University of Salford',\n",
       " 'University Hospital Center of Martinique|University Hospital of Guadeloupe',\n",
       " 'Lille Catholic University|Horizon Pharma Rheumatology LLC',\n",
       " 'St. Olavs Hospital|Norwegian University of Science and Technology',\n",
       " 'University of Pittsburgh|Mount Sinai Hospital, New York',\n",
       " 'Medical University of South Carolina|Bayer',\n",
       " 'London School of Hygiene and Tropical Medicine',\n",
       " 'ContraFect',\n",
       " 'Hospital Clinic of Barcelona',\n",
       " 'University of Southampton',\n",
       " 'Danish Pain Research Center|Aarhus University Hospital',\n",
       " 'Ministry of Health, Malaysia',\n",
       " 'University of Milan|Regen Lab SA',\n",
       " 'Newcastle-upon-Tyne Hospitals NHS Trust|British Heart Foundation|Newcastle University',\n",
       " 'Soroka University Medical Center',\n",
       " 'Universidade Estadual de Londrina|National Council for Scientific and Technological Development (CNPq) - Brazil',\n",
       " 'University of Barcelona|Ministerio de Econom\\xc3\\xada y Competitividad, Spain|Jordi Gol i Gurina Foundation|Universitat Polit\\xc3\\xa8cnica de Catalunya|Institut Guttmann|Germans Trias i Pujol Hospital|University of Pittsburgh',\n",
       " 'Martin-Luther-Universit\\xc3\\xa4t Halle-Wittenberg',\n",
       " 'Tufts Medical Center',\n",
       " 'Khaled Ziada, MD|University of Kentucky',\n",
       " 'M.D. Anderson Cancer Center|Janssen, LP',\n",
       " 'IVFarma LLC|BridgePharm LLC',\n",
       " 'Southwest Hospital, China|Second Affiliated Hospital, School of Medicine, Zhejiang University|Chinese PLA General Hospital',\n",
       " 'Aimmune Therapeutics, Inc.',\n",
       " 'University Hospital of North Norway|UiT The Arctic University of Norway|The Royal Norwegian Ministry of Health|Norwegian Health Association',\n",
       " 'University of Michigan Cancer Center|Department of Health and Human Services',\n",
       " 'University of Illinois at Urbana-Champaign|National Institute on Aging (NIA)',\n",
       " 'The First Affiliated Hospital with Nanjing Medical University',\n",
       " 'Anne Chang|Stanford University',\n",
       " 'Chi Lin, MD|National Cancer Institute (NCI)|University of Nebraska',\n",
       " 'Astellas Pharma Europe B.V.|FibroGen|Astellas Pharma Inc',\n",
       " 'University of Miami|National Institute of Nursing Research (NINR)',\n",
       " 'University of Erlangen-N\\xc3\\xbcrnberg|Bad Reichenhall Clinic, Center for Rehabilitation, Pulmonology and Orthopedics|German Pension Insurance, Section Bavaria South',\n",
       " \"Peking University People's Hospital|Peking University Shougang Hospital|Peking University International Hospital\",\n",
       " 'Medical Coherence LLC',\n",
       " 'Atea Pharmaceuticals, Inc.',\n",
       " 'Kosin University Gospel Hospital',\n",
       " 'Assembly Biosciences',\n",
       " 'Ewha Womans University Mokdong Hospital',\n",
       " 'Physiol',\n",
       " 'Wave Life Sciences Ltd.',\n",
       " 'Eric W. Sargent, MD|Med-El Corporation|Ascension St John Providence',\n",
       " 'Region G\\xc3\\xa4vleborg',\n",
       " 'University of Luebeck',\n",
       " \"Nottingham University Hospitals NHS Trust|AventaMed DAC|Derby Hospitals NHS Foundation Trust|Sheffield Children's NHS Foundation Trust\",\n",
       " 'Instituto Nacional de Enfermedades Respiratorias',\n",
       " 'Michele Sayag|NAOS',\n",
       " 'University of Minnesota - Clinical and Translational Science Institute|Cystic Fibrosis Foundation Therapeutics',\n",
       " \"Children's Hospitals and Clinics of Minnesota|Pops! Diabetes Care\",\n",
       " 'York University',\n",
       " 'Medical College of Wisconsin',\n",
       " 'CMC Ambroise Par\\xc3\\xa9',\n",
       " 'Cancer Institute and Hospital, Chinese Academy of Medical Sciences',\n",
       " 'Oticon Medical',\n",
       " 'Deutsches Herzzentrum Muenchen|Bayerisches Staatsministerium f\\xc3\\xbcr Wirtschaft und Medien, Energie und Tehchnologie|R & S GmbH und Co KG',\n",
       " 'Midwest Center for Metabolic and Cardiovascular Research|Almond Board of California',\n",
       " 'University of Copenhagen|Hvidovre University Hospital',\n",
       " \"Ruth O'Regan, M.D.|Novartis|Big Ten Cancer Research Consortium\",\n",
       " 'Rheacell GmbH & Co. KG|FGK Clinical Research GmbH|TICEBA GmbH|Granzer Regulatory Consulting & Services',\n",
       " 'Centre for Addiction and Mental Health|American Foundation for Suicide Prevention',\n",
       " 'California State Polytechnic University, Pomona',\n",
       " 'University of North Carolina, Chapel Hill|Med-El Corporation',\n",
       " 'Sangamo Therapeutics',\n",
       " 'Adaptimmune',\n",
       " 'Cochlear Bone Anchored Solutions',\n",
       " 'The University of Hong Kong|Hospital Authority, Hong Kong',\n",
       " 'BriaCell Therapeutics Corporation|Cancer Insight, LLC',\n",
       " 'Taipei Medical University',\n",
       " 'University Hospital Inselspital, Berne|Kerckhoff Heart Center',\n",
       " 'Rutgers, The State University of New Jersey|University of Pittsburgh|National Heart, Lung, and Blood Institute (NHLBI)',\n",
       " 'Ruihua Shi|Zhongda Hospital',\n",
       " 'Heinrich-Heine University, Duesseldorf|Philips Medical Systems',\n",
       " 'National Institute of Environmental Health Sciences (NIEHS)|National Institutes of Health Clinical Center (CC)',\n",
       " 'Helse Stavanger HF|Haydom Lutheran Hospital',\n",
       " 'Royal College of Surgeons, Ireland',\n",
       " 'GlaxoSmithKline|York Bioanalytical Solution|BI Medical.Inc|SRL Mediserch.Inc|Parexel International Japan|Q2 Solutions, LLC',\n",
       " 'Regeneron Pharmaceuticals',\n",
       " 'Genfit',\n",
       " 'Istituti Ospitalieri di Cremona|Azienda Ospedaliero-Universitaria di Parma|Centro di Riferimento Oncologico - Aviano|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano|Istituto Di Ricerche Farmacologiche Mario Negri|Ospedale Sacro Cuore - Don Calabria|Arcispedale Santa Maria Nuova-IRCCS',\n",
       " 'Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran|Mexican National Institute of Public Health',\n",
       " 'Cambridge Health Alliance|The Arthur Vining Davis Foundations|The Arnold P. Gold Foundation|National Institutes of Health (NIH)|Brown University',\n",
       " 'Biocad',\n",
       " 'University of Arizona|University of California, Davis',\n",
       " 'University of California, San Diego|Patient-Centered Outcomes Research Institute',\n",
       " 'Lukasz Adamczyk|Wroclaw Medical University',\n",
       " 'Drug Induced Liver Disease Study Group|Beijing Union Pharmaceutical Factory',\n",
       " 'Zydus Discovery DMCC',\n",
       " 'ATGen Canada Inc',\n",
       " 'University Medical Center Groningen|ZonMw: The Netherlands Organisation for Health Research and Development',\n",
       " 'Toray Industries, Inc',\n",
       " \"Rachel Fenning|Massachusetts General Hospital|Nationwide Children's Hospital|California State University, Fullerton|Healthy Smiles for Kids of Orange County|University of California, Irvine\",\n",
       " 'Isparta Military Hospital',\n",
       " 'The Christ Hospital|The University of Kansas Medical Center',\n",
       " 'Universit\\xc3\\xa9 de Sherbrooke|University of British Columbia|University of Toronto|Dalhousie University',\n",
       " 'New York State Psychiatric Institute',\n",
       " 'Harvard School of Public Health|International Livestock Research Institute|Addis Continental Institute of Public Health|Food, Agriculture and Natural Resources Policy Analysis Network',\n",
       " \"Centre hospitalier de l'Universit\\xc3\\xa9 de Montr\\xc3\\xa9al (CHUM)|Bristol-Myers Squibb\",\n",
       " 'Loughborough University',\n",
       " 'SpectraCure AB',\n",
       " 'Oslo and Akershus University College of Applied Sciences|The Norwegian Directorate for Education and Training',\n",
       " 'Ipsen',\n",
       " 'IRCCS Policlinico S. Matteo|University of Pavia',\n",
       " 'Mayo Clinic|Takeda',\n",
       " 'University Hospital, Montpellier',\n",
       " 'Institute of Hematology & Blood Diseases Hospital',\n",
       " 'Pediatric Clinical Research Platform|University of Geneva, Switzerland|University of Lausanne Hospitals|University Hospital Inselspital, Berne|Neuch\\xc3\\xa2tel Hospital, Neuch\\xc3\\xa2tel, Switzerland|Fribourg Hospital, Fribourg, Switzerland|Sion Hospital, Sion, Switzerland',\n",
       " 'WellSpan Health|Lancaster General Hospital',\n",
       " 'SerenaGroup, Inc.|NuTech Medical, Inc',\n",
       " 'Premia Spine',\n",
       " 'Acceleron Pharma, Inc.',\n",
       " 'Hopital Foch',\n",
       " 'PIQUR Therapeutics AG|University Hospital, Basel, Switzerland|University Hospital Munich|University Hospital Freiburg|Charite University, Berlin, Germany|University of Stuttgart',\n",
       " 'University of Utah|National Center for Complementary and Integrative Health (NCCIH)',\n",
       " \"St. Joseph's Hospital and Medical Center, Phoenix|National Cancer Institute (NCI)\",\n",
       " 'Allodynic Therapeutics, LLC',\n",
       " 'Fundaci\\xc3\\xb3n Neumologica Colombiana|Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnolog\\xc3\\xada (COLCIENCIAS)',\n",
       " 'Vanderbilt University Medical Center|The Cleveland Clinic',\n",
       " 'MedSIR|Bayer',\n",
       " 'Yu Fenglei|Hunan Zhaotai Yongren Biotech Co. Ltd.|Hunan Yongren Medical Innovation Co. Ltd.|Second Xiangya Hospital of Central South University',\n",
       " 'Swinburne University of Technology',\n",
       " 'University of Ottawa|Allergan',\n",
       " 'Sidney Kimmel Comprehensive Cancer Center',\n",
       " 'Bayer',\n",
       " 'Third Military Medical University',\n",
       " 'Technische Universit\\xc3\\xa4t M\\xc3\\xbcnchen',\n",
       " 'C2 Therapeutics, Inc.',\n",
       " 'CuraVac|Aepodia|Leiden University Medical Center|University Hospital, Antwerp',\n",
       " 'Baylor University',\n",
       " 'Marcus Van Aarsen|Lawson Health Research Institute|Western University, Canada',\n",
       " 'China Medical University Hospital|National Science Council, Taiwan',\n",
       " 'Carolinas Healthcare System',\n",
       " 'Mahmoud M Saadoon|Cairo University',\n",
       " 'Universidade Federal do Rio de Janeiro|Maternidade Escola da UFRJ',\n",
       " 'Vanderbilt University|Southern Methodist University|Florida State University',\n",
       " 'LifeBridge Health|American Heart Association (AHA)',\n",
       " 'Queen Mary University of London',\n",
       " 'Louisiana State University Health Sciences Center in New Orleans|3M Health Care',\n",
       " 'Public Health Foundation Enterprises, Inc.|National Institute of Allergy and Infectious Diseases (NIAID)|San Francisco Department of Public Health|University of California, San Francisco',\n",
       " \"Institut du Cancer de Montpellier - Val d'Aurelle\",\n",
       " 'Chung Shan Medical University',\n",
       " 'University of Padova',\n",
       " 'Catholic University of the Sacred Heart',\n",
       " 'Aevi Genomic Medicine',\n",
       " 'Emory University|Merck Sharp & Dohme Corp.',\n",
       " 'Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust|Queen Margaret University',\n",
       " 'University Hospital, Geneva',\n",
       " 'Wellth Inc.|University of Pennsylvania',\n",
       " 'Beijing Tongren Hospital|Zhuhai Essex Bio-Pharmaceutical Company Limited|Panacea Technology Co.\\xef\\xbc\\x8cLtd',\n",
       " 'Intensity Therapeutics, Inc.|University of Southern California|University Health Network, Toronto',\n",
       " 'Chrono Therapeutics, Inc.',\n",
       " 'Beijing Cancer Hospital|Beijing Municipal Administration of Hospitals|West China Hospital|Zhejiang Cancer Hospital|The First Affiliated Hospital of Kunming Medical College',\n",
       " 'Institut Jerome Lejeune|H\\xc3\\xb4pital Necker-Enfants Malades',\n",
       " 'Guangdong Association of Clinical Trials',\n",
       " 'A.T. Still University of Health Sciences',\n",
       " 'University Hospital, Akershus',\n",
       " 'St Joseph University, Beirut, Lebanon',\n",
       " 'University of Michigan|AstraZeneca',\n",
       " 'Dansk Fertilitetsklinik',\n",
       " 'Brazilian National Cancer Institute',\n",
       " 'Chinese University of Hong Kong',\n",
       " 'National Cancer Centre, Singapore',\n",
       " 'Yakult Honsha European Research Center, ESV|NIZO Food Research',\n",
       " 'Orion Corporation, Orion Pharma',\n",
       " 'Krankenhaus Nordwest',\n",
       " 'German CLL Study Group|Stichting Hemato-Oncologie voor Volwassenen Nederland|Nordic CLL Study Group (NCLLSG)|Swiss Group for Clinical Cancer Research',\n",
       " 'University of Miami|National Institute on Deafness and Other Communication Disorders (NIDCD)',\n",
       " 'French Cardiology Society|Centre d\\xe2\\x80\\x99investigation clinique Paris-Est, Groupe Hospitalier Piti\\xc3\\xa9-Salpetri\\xc3\\xa8re|INSERM 1166 ICAN UPMC',\n",
       " 'Grifols Therapeutics Inc.',\n",
       " 'University of Washington|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)',\n",
       " 'Bioverativ Therapeutics Inc.|Swedish Orphan Biovitrum',\n",
       " 'Oregon Health and Science University|National Heart, Lung, and Blood Institute (NHLBI)|National Jewish Health|The University of Texas Health Science Center at Tyler|National Institute of Allergy and Infectious Diseases (NIAID)',\n",
       " 'University of Westminster|Universidade Federal do Rio de Janeiro|Copenhagen University Hospital, Denmark|Rio de Janeiro State University|Instituto Fernandes Figueira|University of Oxford|Boston University',\n",
       " 'Dana-Farber Cancer Institute|Eli Lilly and Company|Celgene|Puma Biotechnology, Inc.|Accelerate Brain Cancer Cure',\n",
       " 'Harokopio University',\n",
       " 'Nutricia UK Ltd',\n",
       " 'JW Pharmaceutical',\n",
       " 'Reata Pharmaceuticals, Inc.',\n",
       " 'Polish Adult Leukemia Group',\n",
       " 'Northumbria University|Pronova BioPharma',\n",
       " 'Shirley Ryan AbilityLab|U.S. Department of Education',\n",
       " 'Stockholm University',\n",
       " \"Queen Fabiola Children's University Hospital\",\n",
       " 'Dana-Farber Cancer Institute|Janssen Pharmaceutica',\n",
       " 'MTrap, Inc.|MedPass International',\n",
       " 'University of Prince Edward Island',\n",
       " 'University of Sao Paulo General Hospital',\n",
       " 'Hospital Universitario de Canarias',\n",
       " 'University Hospital, Lille|Imagine Institute|Octapharma|CSL Behring|Laboratoire fran\\xc3\\xa7ais de Fractionnement et de Biotechnologies|Air Liquide SA|The Binding Site Ltd',\n",
       " 'Hospital Moinhos de Vento|Ministry of Health, Brazil',\n",
       " 'Marshall University',\n",
       " 'Cynata Therapeutics Limited',\n",
       " 'Guilin Medical University, China|Wuzhou Red Cross Hospital|Guangxi Naxishan Hospital|National Hospital of Guangxi Zhuang Autonomous Region',\n",
       " 'SI-BONE, Inc.',\n",
       " 'University Medical Centre Ljubljana|University of Ljubljana, Faculty of Sport',\n",
       " 'University of Missouri-Columbia',\n",
       " 'Medical University of Warsaw|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)',\n",
       " 'Rennes University Hospital',\n",
       " 'University of Calgary|General Mills Inc.',\n",
       " 'Universidade do Vale do Sapucai',\n",
       " 'The University Clinic of Pulmonary and Allergic Diseases Golnik',\n",
       " 'Stanford University|National Institutes of Health (NIH)|Redlich Pain Endowment|Rocky Mountain Foundation|The Feldman Family Foundation Pain Research Fund',\n",
       " 'Tiziana Life Sciences, PLC',\n",
       " 'Michael Iv|National Cancer Institute (NCI)|Stanford University',\n",
       " 'Hvidovre University Hospital',\n",
       " 'University of Washington|Bill and Melinda Gates Foundation',\n",
       " 'The University of Western Australia|Osteology Foundation',\n",
       " 'University of Michigan|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)',\n",
       " 'Massachusetts General Hospital|Merck Sharp & Dohme Corp.',\n",
       " 'University of Florida|National Institute on Aging (NIA)',\n",
       " 'Kenneth Bilchick, MD|University of Virginia',\n",
       " 'University of Delaware|Simbex, LLC|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)',\n",
       " 'North Dakota State University|Shire|Neuropsychiatric Research Institute, Fargo, North Dakota',\n",
       " 'University of Ja\\xc3\\xa9n',\n",
       " 'Ain Shams University',\n",
       " 'Wilfrid Laurier University',\n",
       " 'George Mason University|MedStar National Rehabilitation Network',\n",
       " 'University College Hospital Galway',\n",
       " 'Jatupon Kongtharvonskul|Police General Hospital|Ramathibodi Hospital',\n",
       " 'Hopital Lariboisi\\xc3\\xa8re',\n",
       " 'David Grant|University Health Network, Toronto',\n",
       " \"Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts|Robert Debr\\xc3\\xa9 Hospital|Institut National de la Transfusion Sanguine (INTS)|Keyrus Biopharma|For Drug Consulting|ADDMEDICA SASA\",\n",
       " 'Faculdade de Medicina do ABC',\n",
       " 'CTI BioPharma|Covance',\n",
       " 'MiracleFeet|Bai Jerbai Wadia Hospital for Children, Mumbai, India|Metwiz Materials|CURE|Biomedical Engineering and Technology (Incubation) Center, Bombay',\n",
       " 'University Medical Centre Ljubljana|Institute of Oncology Ljubljana',\n",
       " 'Gilead Sciences',\n",
       " 'Centre Hospitalier du Rouvray',\n",
       " 'Paola Anna Erba|Jagiellonian University Medical College|University Hospital Freiburg|Medical University Innsbruck|University Medical Centre Ljubljana|NATIONAL CENTRE FOR NUCLEAR RESEARCH, Poland|Erasmus Medical Center|INRASTES, NCSR Demokritos, Athens, Greece|Azienda Ospedaliero, Universitaria Pisana',\n",
       " \"Brigham and Women's Hospital|University of Cape Town\",\n",
       " 'Cvie Therapeutics Ltd.',\n",
       " 'Medical Research Council, South Africa|University of Ghana',\n",
       " 'University of Eastern Finland',\n",
       " 'University Hospital, Lille|European Commission|Institut National de la Sant\\xc3\\xa9 Et de la Recherche M\\xc3\\xa9dicale, France',\n",
       " 'The Second Hospital of Hebei Medical University',\n",
       " 'Clinique Beau Soleil|Universit\\xc3\\xa9 Montpellier',\n",
       " 'University of California, Davis|Shriners Hospitals for Children',\n",
       " 'Instituto Brasileiro de Osteopatia',\n",
       " 'Aerin Medical|Ohio State University',\n",
       " 'University of California, Los Angeles|Orchard Therapeutics Limited|University College, London|California Institute for Regenerative Medicine',\n",
       " 'Azienda Ospedaliero-Universitaria Careggi|MDM S.p.A.',\n",
       " 'Cinclus Pharma AG',\n",
       " 'Swiss Federal Institute of Technology',\n",
       " 'Universidad Los Andes, Chile|Cells for Cells, Chile',\n",
       " 'patientMpower Ltd.|Health Service Executive, Ireland',\n",
       " 'Mater Misericordiae University Hospital',\n",
       " 'Universidad de Guanajuato',\n",
       " 'Per Ashorn|International Centre for Diarrhoeal Disease Research, Bangladesh|Center for Public Health Kinetics|Kenya Medical Research Institute|University of Washington|Malawi-Liverpool-Wellcome Trust Clinical Research Programme|University of Liverpool|Centre pour le developpement des vaccines, Mali|University of Maryland|Aga Khan University|Muhimbili University of Health and Allied Sciences|Boston Children\\xe2\\x80\\x99s Hospital|World Health Organization',\n",
       " 'Faculdade de Motricidade Humana',\n",
       " 'Belfast Health and Social Care Trust',\n",
       " 'Gallaudet University|Columbia University|The Cleveland Clinic',\n",
       " 'Teleflex|Arrow International',\n",
       " 'Assistance Publique - H\\xc3\\xb4pitaux de Paris|CarThera|BPIfrance',\n",
       " 'Bristol-Myers Squibb',\n",
       " 'Theramab LLC',\n",
       " 'Atlantia Food Clinical Trials',\n",
       " 'Klara Posfay-Barbe|Gertrude Von Meissner Foundation|Recherche et D\\xc3\\xa9veloppement des HUG|Soci\\xc3\\xa9t\\xc3\\xa9 acad\\xc3\\xa9mique de Gen\\xc3\\xa8ve|University Hospital, Geneva',\n",
       " \"University of California, Davis|National Institute on Aging (NIA)|Alzheimer's Association\",\n",
       " 'PT Bio Farma',\n",
       " 'Joshua Woolley|Heffter Research Institute|River Styx Foundation|Usona Institute|Stupski Foundation|University of California, San Francisco',\n",
       " 'University of Oregon|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)',\n",
       " 'BG Trauma Center Tuebingen',\n",
       " 'PharmaMar',\n",
       " \"University of Kentucky|Children's Hospital of Philadelphia\",\n",
       " 'University of Saskatchewan|Dairy Farmers of Canada',\n",
       " 'BBraun Medical SAS',\n",
       " 'University of Waterloo',\n",
       " 'University of California, San Francisco|National Institute of Nursing Research (NINR)|Harvard School of Public Health|Northwestern University|University of Missouri, St. Louis|Washington University School of Medicine',\n",
       " 'Pedro Rodrigues Genta|University of Sao Paulo General Hospital',\n",
       " 'Hemera Biosciences',\n",
       " 'University Hospital, Lille|Biotronik France',\n",
       " 'Hospital de Clinicas de Porto Alegre|Associa\\xc3\\xa7\\xc3\\xa3o Fundo de Incentivo \\xc3\\xa0 Pesquisa',\n",
       " 'University of Belgrade',\n",
       " 'Louis Stokes VA Medical Center',\n",
       " 'University of Oxford|Clasado Biosciences Ltd',\n",
       " 'University of Colorado, Denver|Surefire Medical, Inc.',\n",
       " 'Aduro Biotech, Inc.|Hanlee P. Ji, MD',\n",
       " 'CAMC Health System',\n",
       " 'Weill Medical College of Cornell University|Stanford University|Stony Brook University',\n",
       " 'IRCCS Fondazione Stella Maris',\n",
       " 'ASST Gaetano Pini-CTO',\n",
       " 'Adria Quigley|Canadian Institutes of Health Research (CIHR)|Nova Scotia Health Authority',\n",
       " 'Joslin Diabetes Center|National Institutes of Health (NIH)',\n",
       " 'Urotronic Inc.',\n",
       " 'Lund University Hospital|South Sweden Breast Cancer Group',\n",
       " 'National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|National Institutes of Health Clinical Center (CC)',\n",
       " 'Yale University|Bristol-Myers Squibb',\n",
       " 'Nicholas LaRusso|EuroPharma, Inc.|Mayo Clinic',\n",
       " \"State Administration of Traditional Chinese Medicine of the People's Republic of China|The Second Affiliated Hospital of JiangXi University TCM|The Affiliated Hospital of JiangXi University of TCM|The Qionghai Hospital of TCM|The GanZhou Maternal and Child Health Hospital\",\n",
       " 'Papworth Hospital NHS Foundation Trust',\n",
       " 'University of North Carolina, Chapel Hill|National Institutes of Health (NIH)|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)',\n",
       " 'Medical University of Silesia|Military Institute of Medicine, Warsaw, Poland|Clinical Hospital No. 2 Pomeranian Medical University, Szczecin, Poland|Hospital name Pope John Paul, Zamosc, Poland',\n",
       " 'University of Aberdeen',\n",
       " 'University Hospital, Rouen',\n",
       " 'The Cleveland Clinic',\n",
       " 'Vanderbilt University Medical Center|Johns Hopkins University',\n",
       " 'University of Pittsburgh|Magee-Womens Research Institute',\n",
       " 'Mediti Pharma Inc.',\n",
       " 'Sadick Research Group',\n",
       " 'North Florida/South Georgia Veterans Health System',\n",
       " 'Spirox, Inc.',\n",
       " 'Adello Biologics, LLC|inVentiv Health Clinical',\n",
       " 'Polaris Group',\n",
       " 'Bruce J Gantz|University of Iowa',\n",
       " 'University of Toledo Health Science Campus',\n",
       " 'Leiden University Medical Center|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|Radboud University',\n",
       " 'University of Michigan|National Institute on Aging (NIA)|Detroit Medical Center|Detroit Area Agency on Aging',\n",
       " 'Rockefeller University',\n",
       " 'Insulet Corporation',\n",
       " 'M.D. Anderson Cancer Center|National Institutes of Health (NIH)',\n",
       " 'Shanghai Chest Hospital',\n",
       " 'Klein Buendel, Inc.|National Cancer Institute (NCI)|University of Colorado, Denver',\n",
       " \"Ala'a Sharara|Gilead Sciences|American University of Beirut Medical Center\",\n",
       " \"Shanghai 9th People's Hospital\",\n",
       " 'Abide Therapeutics',\n",
       " 'GI Windows, Inc.',\n",
       " 'Piramal Healthcare Canada Ltd|Smith & Nephew, Inc.|Global Research Solutions',\n",
       " 'Korea University Anam Hospital',\n",
       " 'Nanfang Hospital of Southern Medical University|Zhujiang Hospital',\n",
       " 'SymBio Pharmaceuticals|Yutoku Pharmaceutical',\n",
       " 'Sequent Medical, Inc',\n",
       " 'Singapore General Hospital|Singapore College of Traditional Chinese Medicine|Duke-NUS Graduate Medical School',\n",
       " 'Orthopedisch Centrum Oost Nederland|Martini Hospital Groningen',\n",
       " 'Jules Desmeules|University Hospital, Geneva',\n",
       " 'University of Texas Southwestern Medical Center',\n",
       " 'Beijing Immunochina Medical Science & Technology Co., Ltd.',\n",
       " 'VA Connecticut Healthcare System',\n",
       " 'C3 Jian, LLC',\n",
       " 'Banc de Sang i Teixits',\n",
       " 'Second Affiliated Hospital, School of Medicine, Zhejiang University',\n",
       " 'University of Iowa',\n",
       " \"Novartis Pharmaceuticals|Amgen|Banner Alzheimer's Institute|Novartis\",\n",
       " 'Astellas Pharma Korea, Inc.|Astellas Pharma Inc',\n",
       " 'Lithuanian University of Health Sciences|International Kinesio Taping association',\n",
       " 'Gumy-Pause Fabienne|University Hospital, Geneva',\n",
       " 'Huaxia Eye Hospital Group',\n",
       " 'Radboud University|Interreg',\n",
       " 'Papworth Hospital NHS Foundation Trust|Hinchingbrooke Hospital NHS Trust',\n",
       " 'Kathryn Stephenson|Walter Reed Army Institute of Research (WRAIR)|National Institute of Allergy and Infectious Diseases (NIAID)|Beth Israel Deaconess Medical Center',\n",
       " 'University of British Columbia|Merck Canada Inc',\n",
       " 'Tampere University Hospital|Helsinki University Central Hospital|Central Finland Hospital District|North Estonia Medical Centre|Hatanp\\xc3\\xa4\\xc3\\xa4 City Hospital',\n",
       " 'McGill University Health Center|Merck Sharp & Dohme Corp.',\n",
       " 'Sanofi|Regeneron Pharmaceuticals',\n",
       " 'National Health Research Institutes, Taiwan',\n",
       " 'JDP Therapeutics, Inc.',\n",
       " 'Key-Whitman Eye Center',\n",
       " 'Swiss Tropical & Public Health Institute|Prof. Manuel Battegay, Study Chair, University Hospital Basel|Bienvenu Nsakala, MD, Co-Investigator & Study Physician SolidarMed|Josephine Muhairwe, MD, MPH, Co-Investigator & Country Coordinator SolidarMed|Tracy Glass, PhD, Co-Investigator & Statistician SwissTPH|Fiona Vanobberghen, PhD, Co-Investigator & Statistician SwissTPH|Prof. Thomas Klimkait, PhD, Co-Investigator, Department of Biomedicine, University of Basel|Beatrice Achieng, Study nurse & Clinical Officer, Butha-Buthe Hospital, Lesotho|Mamorena Sepeka, Study nurse, Butha-Buthe Hospital, Lesotho|Katleho Tlali, MLS, Laboratory Technician Laboratory Butha-Buthe Hospital, Lesotho|Lebohang Sao, MD, District Health Manager Butha-Buthe, Lesotho|Kyaw Thin, MD & MPH, Head of Research Coordination Unit, Ministry of Health Lesotho',\n",
       " 'Sentien Biotechnologies, Inc.',\n",
       " 'Karadeniz Technical University|Trabzon Kanuni Education and Research Hospital',\n",
       " 'National Cancer Center, Japan|Ono Pharmaceutical Co. Ltd|Clinical Study Support, Inc.|Fiverings Co., Ltd.',\n",
       " 'University of Illinois at Chicago|Society of Developmental and Behavioral Pediatrics',\n",
       " 'Milton S. Hershey Medical Center',\n",
       " 'The First Affiliated Hospital of Guangzhou Medical University',\n",
       " 'Economic Opportunity Planning Association dba Pathway, Inc.',\n",
       " 'University of Arkansas|Janssen, LP',\n",
       " 'Sue Yom|Merck Sharp & Dohme Corp.|University of California, San Francisco',\n",
       " 'Zhongshan Ophthalmic Center, Sun Yet-san University',\n",
       " 'Weill Medical College of Cornell University|National Development and Research Institutes, Inc.|National Institute on Drug Abuse (NIDA)',\n",
       " 'Pharmacosmos A/S',\n",
       " 'Universidade Federal do Rio Grande do Norte',\n",
       " 'Guangdong General Hospital',\n",
       " 'Universidad de Caldas|Universidad de Manizales',\n",
       " 'University of Southern California|National Institute on Drug Abuse (NIDA)',\n",
       " 'Georgetown University|Novartis|University of Texas Southwestern Medical Center|Cedars-Sinai Medical Center|Virginia Mason Hospital/Medical Center',\n",
       " 'Icahn School of Medicine at Mount Sinai|National Institute on Aging (NIA)',\n",
       " 'Institut Mutualiste Montsouris',\n",
       " 'Shengyun Lin|Zhejiang Provincial Hospital of TCM',\n",
       " 'Albert Einstein Healthcare Network|Ruhr University of Bochum',\n",
       " 'Philogen S.p.A.|Boehringer Ingelheim',\n",
       " 'Memorial Sloan Kettering Cancer Center|Genentech, Inc.',\n",
       " 'Northern Arizona University',\n",
       " 'OncoTherapy Science, Inc.',\n",
       " 'Universit\\xc3\\xa4tsklinikum Hamburg-Eppendorf|University of Giessen|University of Rostock',\n",
       " 'Cellectar Biosciences, Inc.',\n",
       " 'S\\xc3\\xa3o Paulo State University|Ricardo Nitrini|Sonia Brucki|Maira Okada de Oliveira|Edson Amaro Junior|Maria da Graca M Martin|Rodolfo dos Anjos|Camila Carneiro Pedroza|Ana Carolina Cruz|Aline Gisele Gon\\xc3\\xa7alves',\n",
       " 'Dental Innovation Foundation Under Royal Patronage|Mahidol University|Srinakharinwirot University|Ministry of Health, Thailand',\n",
       " 'Squarex, LLC',\n",
       " 'University of Oviedo',\n",
       " 'Meander Medical Center',\n",
       " 'GlycoMimetics Incorporated|Celerion',\n",
       " 'Melbourne Health',\n",
       " 'Centre for Addiction and Mental Health',\n",
       " 'Mark Evers|University of Kentucky',\n",
       " 'University of Hawaii|Society of Family Planning',\n",
       " 'Song Lin|Beijing Tiantan Hospital',\n",
       " 'Massachusetts General Hospital|Takeda',\n",
       " 'Daiichi Sankyo, Inc.|Chiltern International Inc.',\n",
       " 'Wills Eye|Mid Atlantic Retina',\n",
       " 'Allergan',\n",
       " 'University of Campinas, Brazil',\n",
       " 'Cliniques universitaires Saint-Luc- Universit\\xc3\\xa9 Catholique de Louvain',\n",
       " 'H. Lee Moffitt Cancer Center and Research Institute|National Comprehensive Cancer Network',\n",
       " 'Photozig, Inc.|National Institute on Deafness and Other Communication Disorders (NIDCD)',\n",
       " 'RedHill Biopharma Limited|Medical University of South Carolina|Apogee Biotechnology Corporation|National Cancer Institute (NCI)',\n",
       " 'Carmat SA',\n",
       " 'Oregon Research Institute|Michigan State University',\n",
       " 'The University of Texas Health Science Center, Houston',\n",
       " 'Qilu Pharmaceutical Co., Ltd.',\n",
       " 'Cambridge University Hospitals NHS Foundation Trust|University of Cambridge',\n",
       " 'National Taiwan University Hospital|National Taiwan University Hospital, Yun-Lin Branch',\n",
       " 'Institute of Medical Sciences and SUM Hospital',\n",
       " 'Joshua Brody|Merck Sharp & Dohme Corp.|Icahn School of Medicine at Mount Sinai',\n",
       " 'Baylor Research Institute|Takeda',\n",
       " 'Oslo University Hospital|University of Malawi College of Medicine',\n",
       " 'Taisho Pharmaceutical R&D Inc.',\n",
       " 'Cantonal Hospital, Frauenfeld',\n",
       " 'The University of Texas at Arlington',\n",
       " 'Washington University School of Medicine|National Center for Advancing Translational Science (NCATS)',\n",
       " 'SCARM Institute, Tabriz, Iran',\n",
       " 'Centre Leon Berard|Roche Pharma AG',\n",
       " 'Unilever R&D|University of Bristol',\n",
       " 'Pellficure Pharmaceuticals, Inc',\n",
       " 'Laureate Institute for Brain Research, Inc.|Brain & Behavior Research Foundation',\n",
       " 'Beijing Chao Yang Hospital',\n",
       " 'Medsenic|Fovea',\n",
       " 'Klinikum Berchtesgadener Land der Sch\\xc3\\xb6n-Kliniken|Linde AG',\n",
       " 'Qingdao University',\n",
       " 'Jeffrey Goldberger|National Heart, Lung, and Blood Institute (NHLBI)|University of Miami',\n",
       " 'Baylor College of Medicine|Avex LLC',\n",
       " 'Universit\\xc3\\xa4tsklinikum Hamburg-Eppendorf|Deutsche Multiple Sklerose Gesellschaft Hamburg',\n",
       " 'Nexstim Ltd',\n",
       " 'NeuroTronik Inc.',\n",
       " 'Cornell University|Africa Future Foundation',\n",
       " 'Medical University of South Carolina|National Institutes of Health (NIH)|National Institute on Alcohol Abuse and Alcoholism (NIAAA)',\n",
       " 'Assiut University',\n",
       " 'ISU Abxis Co., Ltd.|Catalyst Biosciences',\n",
       " 'F Care Systems NV',\n",
       " 'Shanghai Institute of Acupuncture, Moxibustion and Meridian',\n",
       " 'Newcastle University',\n",
       " 'University of California, San Diego|University of Toronto|University of California, Davis',\n",
       " 'High Risk Obstetrical Consultants',\n",
       " 'Pei-Yuan Lee, MD|Aeon Biotechnology Corporation|Show Chwan Memorial Hospital',\n",
       " 'Jiangsu Institute of Parasitic Diseases|World Health Organization',\n",
       " 'New York State Psychiatric Institute|University of California, San Francisco',\n",
       " 'Omeros Corporation',\n",
       " 'Swedish University of Agricultural Sciences',\n",
       " 'Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd|The First Affiliated Hospital of Soochow University',\n",
       " 'Prothena Therapeutics Ltd.',\n",
       " 'Zimmer Biomet|MedNet Solutions|Medical Metrics, Inc',\n",
       " 'Instituto Nacional de Psiquiatr\\xc3\\xada Dr. Ram\\xc3\\xb3n de la Fuente|National Council of Science and Technology, Mexico',\n",
       " 'Dr. Franco Molteni|Ecole Polytechnique F\\xc3\\xa9d\\xc3\\xa9rale de Lausanne|Ab.Acus, Milan, Italy|Control Systems Group, Technische Universit\\xc3\\xa4t Berlin, Germany|Ottobock Health Products GmbH, Wien, Austria|Hasomed GmbH, Magdeburg, Germany|Asklepios Neurologische Klinik Falkenstein, K\\xc3\\xb6nigstein, Germany|Technische Universit\\xc3\\xa4t Wien, Austria|Dept. of Electronics, Informatics, Bioengineering, Politecnico di Milano, Italy|Villa Beretta Rehabilitation Center',\n",
       " 'University of Zurich|St. Jude Medical',\n",
       " 'First Affiliated Hospital of Chengdu Medical College',\n",
       " 'Temple University|Fisher and Paykel Healthcare',\n",
       " 'xuhuijuan|Fujian Academy of Traditional Chinese Medicine',\n",
       " 'University of Washington|Michigan State University|University of Maryland',\n",
       " 'Sven O. Skouby|Rigshospitalet, Denmark|Hvidovre University Hospital|Holbaek Sygehus|Skane University Hospital|Region Capital Denmark|Copenhagen University Hospital, Denmark|Herlev Hospital',\n",
       " 'University of Essex',\n",
       " 'Vanda Pharmaceuticals',\n",
       " 'University Hospital, Rouen|ADIR Association',\n",
       " 'Albany Research Institute, Inc.',\n",
       " 'Srinvasan Beddhu|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|University of Utah',\n",
       " 'Shanghai GeneChem Co., Ltd.|Beijing 302 Hospital',\n",
       " 'Amgen|Onyx Therapeutics, Inc.',\n",
       " 'Belfast Health and Social Care Trust|Bristol Royal Infirmary|Golden Jubilee National Hospital|Royal Infirmary of Edinburgh',\n",
       " 'Peking University|Shanghai Junshi Biosciencee Co.,Ltd',\n",
       " 'University Hospital, Clermont-Ferrand|Rennes University Hospital|University Hospital, Montpellier',\n",
       " 'Shenzhen Geno-Immune Medical Institute',\n",
       " 'Youngstown State University',\n",
       " 'Sault Area Hospital',\n",
       " 'Dana-Farber Cancer Institute',\n",
       " 'National Jewish Health|Genentech, Inc.',\n",
       " 'Jeil Pharmaceutical Co., Ltd.',\n",
       " 'Uijeongbu St. Mary Hospital|Daewoong Pharmaceutical Co. LTD.',\n",
       " 'Admir Hadzic, M.D., Ph.D.|New York School of Regional Anesthesia',\n",
       " 'China Resources Zizhu Pharmaceutical Co., Ltd.',\n",
       " 'Vanderbilt University Medical Center',\n",
       " 'Matthew Wieduwilt, M.D., Ph.D.|Merck Sharp & Dohme Corp.|Amgen|University of California, San Diego',\n",
       " 'Ministry of Science and Technology, Taiwan',\n",
       " 'LifeBridge Health',\n",
       " 'Center of Integrative Addiction Research, Austria|Medical University of Graz',\n",
       " 'Valencia Technologies Corporation',\n",
       " 'Fred Hutchinson Cancer Research Center|National Cancer Institute (NCI)',\n",
       " 'Instituto Nacional de Cardiologia Ignacio Chavez',\n",
       " 'M.D. Anderson Cancer Center|Intrexon Corporation|Ziopharm',\n",
       " 'Jing Qiao|Peking University',\n",
       " \"Xiao-Lin Yin|303rd Hospital of the People's Liberation Army\",\n",
       " 'Faiq Gorial|University of Baghdad',\n",
       " 'Population Council',\n",
       " 'Jonsson Comprehensive Cancer Center|National Cancer Institute (NCI)|Bayer',\n",
       " \"Second Affiliated Hospital of Xi'an Jiaotong University\",\n",
       " 'University of Trier|German Research Foundation',\n",
       " 'Intron Biotechnology, Inc.',\n",
       " 'University of Alcala',\n",
       " 'Universit\\xc3\\xa4t Duisburg-Essen|Ministerium f\\xc3\\xbcr Schule und Weiterbildung, Land Nordrhein-Westfalen|Ministerium f\\xc3\\xbcr Gesundheit, Emanzipation, Pflege und Alter, Land Nordrhein-Westfalen',\n",
       " 'University of Michigan Cancer Center',\n",
       " 'Kite Pharma, Inc.|Genentech, Inc.',\n",
       " 'Ellume Pty Ltd',\n",
       " 'University of Texas Southwestern Medical Center|Defense Advanced Research Projects Agency|Nerves Incorporated, Inc.|Arizona State University|Advanced Arm Dynamics',\n",
       " 'University of Castilla-La Mancha',\n",
       " 'University of Copenhagen|Frederiksberg University Hospital|Hillerod Hospital, Denmark|Aarhus University Hospital',\n",
       " 'Takeda|Ovid Therapeutics',\n",
       " 'Jiangxi University of Traditional Chinese Medicine|The First Affiliated Hospital of Nanchang University|Second Affiliated Hospital of Nanchang University|Jiangxi Provincial Cancer Hospital',\n",
       " \"Jordan Joy|Compound Solutions LLC|Texas Woman's University\",\n",
       " 'Aarhus University Hospital Skejby',\n",
       " 'University Hospital, Bordeaux',\n",
       " 'Medical University of Graz|Krankenhaus der Barmherzigen Br\\xc3\\xbcder Graz|Krankenhaus der Elisabethinen Graz|Landeskrankenhaus Feldbach|LKH Hartberg|Krankenhaus der Barmherzigen Br\\xc3\\xbcder St. Veit/Glan',\n",
       " 'Merz Pharmaceuticals GmbH',\n",
       " 'Encube Ethicals Pvt. Ltd.|Novum Pharmaceutical Research Services',\n",
       " 'Inovio Pharmaceuticals|University of Pennsylvania|University of North Carolina|Thomas Jefferson University|University of Pittsburgh|Wayne State University|Mayo Clinic',\n",
       " 'University of Oklahoma',\n",
       " \"Bioforce AG|University Children's Hospital, Zurich\",\n",
       " 'Guangzhou University of Chinese Medicine',\n",
       " 'McMaster University|Canadian Institutes of Health Research (CIHR)',\n",
       " 'Da Nang Hospital|Kitano Hospital|Translational Research Informatics Center, Kobe, Hyogo, Japan',\n",
       " 'emad mamdouh|Assiut University',\n",
       " 'Dexa Medica Group|Binawaluya Cardiac Hospital, Jakarta',\n",
       " \"Huai'an No.1 People's Hospital|Regend Therapeutics\",\n",
       " 'Selecta Biosciences, Inc.',\n",
       " 'Spry Health',\n",
       " 'Erzurum Paland\\xc3\\xb6ken State Hospital',\n",
       " 'M.D. Anderson Cancer Center|Genentech, Inc.',\n",
       " 'Sorrento Therapeutics, Inc.|Scintilla Pharmaceuticals, Inc.',\n",
       " \"GeneScience Pharmaceuticals Co., Ltd.|Tongji Hospital|Beijing Children's Hospital|The First Affiliated Hospital with Nanjing Medical University|Shanghai Children's Hospital|The Children's Hospital of Zhejiang University School of Medicine\",\n",
       " 'University of the Incarnate Word',\n",
       " 'Biosense Webster, Inc.',\n",
       " 'University Hospital Muenster|Deutsche Krebshilfe e.V., Bonn (Germany)',\n",
       " 'Russian Academy of Medical Sciences',\n",
       " \"King's College London|University of Oxford|Newcastle University|Oxford Health NHS Foundation Trust|Northumberland, Tyne and Wear NHS Foundation Trust|South London and Maudsley NHS Foundation Trust\",\n",
       " 'Fondazione IRCCS Istituto Nazionale dei Tumori, Milano|AstraZeneca',\n",
       " 'University of Saskatchewan|Multiple Sclerosis Society of Canada',\n",
       " 'Memorial Sloan Kettering Cancer Center|Weill Medical College of Cornell University',\n",
       " 'Poznan University of Medical Sciences|Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke|Department of Hygiene and Human Nutrition, Poznan University of Life Sciences',\n",
       " 'Baylor College of Medicine|Genzyme, a Sanofi Company|Shriners Hospitals for Children|Hugo W. Moser Research Institute at Kennedy Krieger, Inc.|Hospital for Special Surgery, New York|University of California, Los Angeles|University of Nebraska|Oregon Health and Science University|University of South Florida',\n",
       " 'Centre Hospitalier Ren\\xc3\\xa9 Dubos',\n",
       " 'Erasmus Medical Center',\n",
       " 'Charite University, Berlin, Germany|NeuroCure Clinical Research Center, Charite, Berlin',\n",
       " 'Petr Kavan|McGill University Health Center',\n",
       " 'Autumn McRee, MD|Merck Sharp & Dohme Corp.|Hoosier Cancer Research Network',\n",
       " 'Syneron Medical',\n",
       " 'Bolton Medical|Bolton Medical Espana SLU',\n",
       " 'United Therapeutics',\n",
       " 'Centre Francois Baclesse',\n",
       " 'The National Center of Oncology, Azerbaijan',\n",
       " 'University of Copenhagen|Carlsberg Group',\n",
       " 'University of Wisconsin, Madison|National Cancer Institute (NCI)|National Institutes of Health (NIH)',\n",
       " 'Per-Ola Carlsson|Uppsala University Hospital',\n",
       " 'G\\xc3\\xa9raldine Martens|Centre Hospitalier Universitaire Dinant Godinne - UCL Namur|University Hospital of Liege',\n",
       " 'Our Lady of Maryknoll Hospital|Wong Tai Sin Hospital',\n",
       " 'International Piezosurgery Academy|University of Trieste',\n",
       " 'Aronora, Inc.',\n",
       " 'BIO-CAT Microbials, LLC|KGK Synergize Inc.',\n",
       " 'liuxingju|Ministry of Science and Technology of the People\\xc2\\xb4s Republic of China',\n",
       " 'Samuel Lunenfeld Research Institute, Mount Sinai Hospital',\n",
       " 'LKC Technologies, Inc.',\n",
       " 'Ruggeri, Mirella|Universita di Verona',\n",
       " \"St. Jude Children's Research Hospital|Bristol-Myers Squibb|Incyte Corporation|Shire\",\n",
       " 'Peptinnovate',\n",
       " 'Alpha Tau Medical LTD.',\n",
       " \"Woman's Health University Hospital, Egypt\",\n",
       " 'Kaohsiung Medical University Chung-Ho Memorial Hospital|Kaohsiung Medical University',\n",
       " 'Region Skane|University of California, San Francisco',\n",
       " 'Jena University Hospital',\n",
       " 'Vanderbilt University Medical Center|Washington University School of Medicine',\n",
       " 'Jordi Gol i Gurina Foundation|Instituto de Salud Carlos III|Department of Health, Generalitat de Catalunya|Parc Sanitari Sant Joan de D\\xc3\\xa9u|Sanidad de Castilla y Le\\xc3\\xb3n|Servei de Salut de les Illes Balears|Institut Catal\\xc3\\xa0 de la Salut|Servicio Aragon\\xc3\\xa9s de Salud|Osakidetza|Andaluz Health Service|Fundaci\\xc3\\xb3n P\\xc3\\xbablica Andaluza para la Investigaci\\xc3\\xb3n de M\\xc3\\xa1laga en Biomedicina y Salud|Servicio Galego de Sa\\xc3\\xbade (SERGAS)',\n",
       " \"Kingston University|St George's, University of London|King's College London\",\n",
       " 'Universidade Federal de Pernambuco|Real Hospital Portugu\\xc3\\xaas de Benefic\\xc3\\xaancia em Pernambuco',\n",
       " 'Wayne State University',\n",
       " 'University Hospital Inselspital, Berne|Cliniques universitaires Saint-Luc- Universit\\xc3\\xa9 Catholique de Louvain|Cork University Hospital|UMC Utrecht|University of Basel|Universit\\xc3\\xa9 Catholique de Louvain|Utrecht University|University of Bern|State Secretariat for Education Research and Innovation, Switzerland|European Commission',\n",
       " 'MinaPharm Pharmaceuticals',\n",
       " 'Fondazione IRCCS Istituto Nazionale dei Tumori, Milano|Associazione Italiana per la Ricerca sul Cancro',\n",
       " 'Puerta de Hierro University Hospital',\n",
       " 'The Aurum Institute NPC',\n",
       " 'Sidney Kimmel Cancer Center at Thomas Jefferson University|Bristol-Myers Squibb|Thomas Jefferson University',\n",
       " 'Taro Pharmaceuticals USA',\n",
       " 'Hospital da Luz, Portugal|Universidade Nova de Lisboa',\n",
       " 'Vissum, Instituto Oftalmol\\xc3\\xb3gico de Alicante|Reviva Pharmaceuticals|Hospital Universitario La Paz|LASER VISION CENTER IN LIBANON|OPTICA GENERAL IN LIBANON',\n",
       " 'Universita di Verona|IGEA',\n",
       " 'M.D. Anderson Cancer Center|Hackett Family Foundation Award',\n",
       " 'The Guthrie Clinic',\n",
       " 'Kevin Houston|Massachusetts Eye and Ear Infirmary',\n",
       " 'Albert Einstein College of Medicine, Inc.|New York State Department of Health|Montefiore Medical Center',\n",
       " 'Christian Torp-Pedersen|Aalborg Universitetshospital|Aarhus University Hospital|Odense University Hospital|Rigshospitalet, Denmark',\n",
       " 'Laboratoris Sanifit|Clinipace Worldwide',\n",
       " 'Santa Barbara Cottage Hospital',\n",
       " 'Institut Paoli-Calmettes|Janssen-Cilag Ltd.',\n",
       " 'University of Malaya',\n",
       " 'Ampio Pharmaceuticals. Inc.',\n",
       " 'Hospital for Special Surgery, New York',\n",
       " 'Stony Brook University|National Center for Neuromodulation for Rehabilitation',\n",
       " 'University Hospital, Lille',\n",
       " \"Dr. Reddy's Laboratories Limited\",\n",
       " 'MICE Trial Group',\n",
       " 'Intarcia Therapeutics',\n",
       " 'Sheffield Teaching Hospitals NHS Foundation Trust|National Institute for Health Research, United Kingdom',\n",
       " 'University of Melbourne|Melbourne Health|Victorian Comprehensive Cancer Centre Peter Macallum hospital)|The Royal Womens Hospital Melbourne|Northpark Private hospital (Healthscope)',\n",
       " 'LimFlow, Inc.',\n",
       " 'University of Los Andes, Columbia',\n",
       " 'Kami Maddocks|National Cancer Institute (NCI)|Ohio State University Comprehensive Cancer Center',\n",
       " 'TWi Biotechnology, Inc.',\n",
       " 'PaxVax, Inc.',\n",
       " 'University of Hawaii|Genentech, Inc.|Dendreon',\n",
       " 'Factor Therapeutics Ltd.|Parexel|ARANZ Medical|Almac Clinical Services LLC',\n",
       " 'H\\xc3\\xb4pital Necker-Enfants Malades',\n",
       " 'SignalRX Pharmaceuticals, Inc.|University of California, San Diego',\n",
       " 'University of Miami|Fort Drum|United States Department of Defense',\n",
       " 'Qatar University|Imperial College London|Hamad Medical Corporation|Supreme Council Of Health, Qatar|Aspetar|Leeds Beckett University',\n",
       " 'M.D. Anderson Cancer Center|Millennium: The Takeda Oncology Company',\n",
       " 'Oslo University Hospital|Norwegian Cancer Society',\n",
       " 'Imperial College Healthcare NHS Trust',\n",
       " 'Thammasat University|Krit Boontanapibul',\n",
       " 'Venus Concept',\n",
       " 'Samanta Winck Madruga|Federal University of Pelotas',\n",
       " 'Universit\\xc3\\xa9 de Sherbrooke',\n",
       " 'Aduro Biotech, Inc.|Merck Sharp & Dohme Corp.',\n",
       " 'Terumo Europe N.V.',\n",
       " 'Portsmouth Hospitals NHS Trust',\n",
       " 'Kyungpook National University',\n",
       " 'Southeast University, China',\n",
       " 'ShangHai Ji Ai Genetics & IVF Institute|The University of Hong Kong',\n",
       " 'University of Valencia|Hospital Cl\\xc3\\xadnico Universitario de Valencia',\n",
       " 'Evangelisches Krankenhaus D\\xc3\\xbcsseldorf|Olympus',\n",
       " 'Harvard Pilgrim Health Care|Hospital Corporation of America|University of California, Irvine|University of Massachusetts, Amherst|Rush University|Centers for Disease Control and Prevention',\n",
       " 'Attikon Hospital|National and Kapodistrian University of Athens',\n",
       " 'Arizona State University',\n",
       " 'Zephyr Sleep Technologies',\n",
       " 'University of Maryland|AstraZeneca',\n",
       " 'GlaxoSmithKline|CRF health|Bristol-Myers Squibb',\n",
       " 'MetroHealth Medical Center|The Cleveland Clinic|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)',\n",
       " 'Tampere University Hospital|Pirkanmaa Hospice',\n",
       " 'McGill University Health Center|Jewish General Hospital',\n",
       " 'HaEmek Medical Center, Israel|AbbVie',\n",
       " 'M.D. Anderson Cancer Center|Genentech, Inc.|Roche Pharma AG',\n",
       " 'Memorial Sloan Kettering Cancer Center|Novartis',\n",
       " 'Shandong Eye Hospital',\n",
       " 'AbbVie|Bristol-Myers Squibb',\n",
       " 'Oslo and Akershus University College of Applied Sciences',\n",
       " 'Ingrid Jazet|Leiden University Medical Center',\n",
       " 'Hospital Clinico Universitario de Santiago|Instituto de Salud Carlos III|Fondo Europeo de Desarrollo Regional',\n",
       " 'Five Eleven Pharma, Inc.',\n",
       " 'Willem Daniel Francois Venter|University of Witwatersrand, South Africa',\n",
       " 'CytomX Therapeutics',\n",
       " 'First Affiliated Hospital of Harbin Medical University|Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd',\n",
       " 'Mirna Abraham-Nordling|Karolinska Institutet',\n",
       " 'University of Luebeck|Deutsches Zentrum f\\xc3\\xbcr Herz-Kreislauf-Forschung (DZHK)',\n",
       " 'JHL Biotech, Inc.',\n",
       " 'Geisinger Clinic|Wilkes University',\n",
       " 'Reading Health System',\n",
       " 'Ilkos Therapeutic Inc.',\n",
       " 'Holland Bloorview Kids Rehabilitation Hospital|IWK Health Centre|Dalhousie University|University of Alberta|University of East London|University of London',\n",
       " 'Fundacion Para La Investigacion Hospital La Fe',\n",
       " 'Hospital for Special Surgery, New York|Mallinckrodt',\n",
       " 'University of Copenhagen|Johannes Gutenberg University Mainz|University of Leeds|Liverpool John Moores University|Radboud University',\n",
       " 'Norte Study Group|Merck Sharp & Dohme Corp.',\n",
       " 'St. Petersburg Bekhterev Research Psychoneurological Institute',\n",
       " 'University of Vermont',\n",
       " 'Yiling Pharmaceutical Inc.',\n",
       " 'Promius Pharma, LLC',\n",
       " 'The Hospital for Sick Children|University of Malawi',\n",
       " 'InQpharm Group|Analyze & Realize',\n",
       " 'ResMed',\n",
       " \"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico|European Society of Intensive Care Medicine|University of Milan|University of Milano Bicocca\",\n",
       " 'Hospital Universitario Infanta Leonor',\n",
       " 'Bozyaka Training and Research Hospital',\n",
       " 'The Netherlands Cancer Institute',\n",
       " 'Baodong Qin|Shanghai Changzheng Hospital',\n",
       " 'Rajiv Gandhi Cancer Institute & Research Center, India',\n",
       " 'Lakehead University',\n",
       " 'University of Michigan|AbbVie',\n",
       " 'Technische Universit\\xc3\\xa4t Dresden|Istanbul University',\n",
       " 'St. Louis University|Lucerno Dynamics Limited Liability Company (LLC)',\n",
       " 'Ruhr University of Bochum',\n",
       " \"Medico's Hirata Inc.\",\n",
       " 'Douglas Mental Health University Institute',\n",
       " 'Instituto Fernandes Figueira|CoLab|SMSDC/RJ|University of Campinas, Brazil|UPECLIN HC FM Botucatu Unesp|HGA|HOSPITAL MATERNIDADE LEONOR MENDES DE BARROS|Hospital de Clinicas de Porto Alegre',\n",
       " 'University of Texas Southwestern Medical Center|Novo Nordisk A/S',\n",
       " 'Lady Davis Institute|H\\xc3\\xb4pital Cochin',\n",
       " 'SPD Development Company Limited',\n",
       " 'Oncotherapeutics|Incyte Corporation',\n",
       " 'Norwegian University of Science and Technology|St. Olavs Hospital',\n",
       " 'Corvia Medical',\n",
       " 'Tianjin Medical University Cancer Institute and Hospital',\n",
       " 'Duke University|National Institute on Deafness and Other Communication Disorders (NIDCD)',\n",
       " 'Xuzhou Medical University',\n",
       " 'Tel-Aviv Sourasky Medical Center|Weizmann Institute of Science',\n",
       " 'Wenjun Wu|First Affiliated Hospital of Wenzhou Medical Univeristy',\n",
       " 'Shandong University|Jinan Central Hospital|The Second Hospital of Shandong University|Qianfoshan Hospital|Qingdao University|Yantai Yuhuangding Hospital',\n",
       " 'Ospedale San Donato',\n",
       " 'Charite University, Berlin, Germany|University of G\\xc3\\xb6ttingen',\n",
       " 'University of British Columbia|Canadian Cancer Society Research Institute (CCSRI)',\n",
       " 'Vastra Gotaland Region|Sahlgrenska University Hospital, Sweden|Karolinska University Hospital|Nordic MDS Group',\n",
       " 'Beijing Luhe Hospital',\n",
       " 'Rigshospitalet, Denmark|Biogen',\n",
       " 'Sylentis, S.A.',\n",
       " 'University of Pennsylvania|NHS Human Services',\n",
       " 'Viking Therapeutics, Inc.',\n",
       " 'University of Texas at Austin',\n",
       " 'Hospital Universitario Dr. Jose E. Gonzalez',\n",
       " 'Central Jutland Regional Hospital',\n",
       " 'Odense University Hospital|REHPA|Rigshospitalet, Denmark|Danish Cancer Society',\n",
       " 'Universidad de Murcia',\n",
       " 'Watkins Conti Products. Inc.|University of Oklahoma',\n",
       " \"Children's Hospital of Eastern Ontario\",\n",
       " 'Maastricht University',\n",
       " 'State University of New York at Buffalo',\n",
       " 'Florida State University',\n",
       " 'Nicolaus Copernicus University',\n",
       " 'M.D. Anderson Cancer Center|Sirtex Medical',\n",
       " 'Vietnam National University',\n",
       " \"Evelyne D.Trottier|St. Justine's Hospital\",\n",
       " 'Astellas Pharma Global Development, Inc.|Cytokinetics|Astellas Pharma Inc',\n",
       " 'University of Michigan|Mahidol University|John E. Fogarty International Center (FIC)',\n",
       " 'Washington Hospital Center',\n",
       " 'Memorial Sloan Kettering Cancer Center|Merck Sharp & Dohme Corp.|Astex Pharmaceuticals|Mirati Therapeutics Inc.',\n",
       " \"Children's Mercy Hospital Kansas City|Heartland Primary Care of Sunflower Medical Group|Washington University School of Medicine\",\n",
       " 'Inventiva Pharma',\n",
       " 'Haemostatix Ltd',\n",
       " 'Massachusetts General Hospital|Robert Wood Johnson Foundation',\n",
       " 'Amgen',\n",
       " 'Vedic Lifesciences Pvt. Ltd.|Leading Edge Marketing LTD.',\n",
       " 'Chinese Academy of Medical Sciences|Hebei Medical University Fourth Hospital|Tianjin Medical University Cancer Institute and Hospital|Anyang Tumor Hospital|The First Affiliated Hospital with Nanjing Medical University|Affiliated Hospital of Hebei University|Fujian Cancer Hospital',\n",
       " 'Syntimmune, Inc.',\n",
       " 'Fredrik Piehl|Karolinska Institutet',\n",
       " 'Bruyere Research Institute|Ottawa Hospital Research Institute|Shirati KMT Hospital',\n",
       " 'Vitaflo International, Ltd',\n",
       " 'Ashutosh Kumar Tewari|Oncovir, Inc.|Icahn School of Medicine at Mount Sinai',\n",
       " 'Peter Anderson|Case Comprehensive Cancer Center',\n",
       " 'University of California, Los Angeles|Gilead Sciences',\n",
       " 'Huons Co.,Ltd.',\n",
       " 'PepsiCo Global R&D',\n",
       " 'University of Missouri-Columbia|Merck Sharp & Dohme Corp.',\n",
       " 'Memorial Sloan Kettering Cancer Center|Novartis|Dana-Farber Cancer Institute|M.D. Anderson Cancer Center',\n",
       " 'Oregon Health and Science University',\n",
       " 'Pharmacyclics LLC.|Janssen Research & Development, LLC',\n",
       " 'Shirley Ryan AbilityLab',\n",
       " 'University of Khartoum|Awad, Mohamed Ibrahim, M.D.|Duria abdulwahab Elrrayes',\n",
       " 'Shaine Morris|Baylor College of Medicine',\n",
       " \"University of Washington|National Institute on Drug Abuse (NIDA) (DA038095)|Alliance for Child Welfare Excellence|Department of Social and Health Services, Children's Administration|Partners for our Children\",\n",
       " 'Memorial Sloan Kettering Cancer Center|Weizmann Institute of Science|Steba Biotech S.A.',\n",
       " 'Icadom|Philips Respironics',\n",
       " 'William Beaumont Hospitals',\n",
       " 'Lachlan Pharma Holdings',\n",
       " 'Hui ting Xu\\xef\\xbc\\x8cMD|Jiangsu HengRui Medicine Co., Ltd.|Hubei Cancer Hospital',\n",
       " 'St. Olavs Hospital|Norwegian National Advisory Unit for Ultrasound and Image-guided Therapy|SINTEF Health Research',\n",
       " 'Applied Genetic Technologies Corp',\n",
       " 'Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.|Beijing 302 Hospital',\n",
       " 'The University of Tennessee, Knoxville|United States Department of Agriculture (USDA)|University of Florida|West Virginia University|South Dakota State University|Auburn University|Syracuse University|University of Maine|Kansas State University',\n",
       " 'VA National Center for Rehabilitative Auditory Research|Desyncra, Inc.',\n",
       " 'St. Petersburg State Pavlov Medical University',\n",
       " 'Seoul National University Bundang Hospital|Hanlim Pharm. Co., Ltd.',\n",
       " 'Memorial Sloan Kettering Cancer Center|Millennium: The Takeda Oncology Company',\n",
       " 'University of Sheffield',\n",
       " 'Steve Yoelin M.D. Medical Associates, Inc.|Allergan',\n",
       " 'CHEN De-chang|RenJi Hospital|Shanghai Changzheng Hospital',\n",
       " 'Universidade Estadual Paulista J\\xc3\\xbalio de Mesquita Filho|Funda\\xc3\\xa7\\xc3\\xa3o de Amparo \\xc3\\xa0 Pesquisa do Estado de S\\xc3\\xa3o Paulo',\n",
       " 'Eastern Mediterranean University',\n",
       " 'National Cancer Center, Korea',\n",
       " 'Universit\\xc3\\xa9 de Sherbrooke|Canadian Institutes of Health Research (CIHR)',\n",
       " \"Rady Children's Hospital, San Diego|STACK Velocity San Diego\",\n",
       " 'Western University, Canada|Nutrigenomix Inc.|East Elgin Family Health Team|Canadian Transplant Association',\n",
       " \"It's My Community Initiative\",\n",
       " 'Tianjin Anding Hospital',\n",
       " 'Guangdong Women and Children Hospital',\n",
       " 'Canadian Cancer Trials Group',\n",
       " 'University of Windsor|Manitoba Gambling Research Program|Treatment Innovations|University of Manitoba',\n",
       " 'New York State Psychiatric Institute|National Institute on Drug Abuse (NIDA)',\n",
       " 'Institut Curie',\n",
       " \"Anne Comi, MD|Children's Hospital Medical Center, Cincinnati|Pfizer|National Institutes of Health (NIH)|Faneca 66 Foundation|National Institute of Neurological Disorders and Stroke (NINDS)|Hugo W. Moser Research Institute at Kennedy Krieger, Inc.\",\n",
       " 'University of Wisconsin, Madison|Novartis Pharmaceuticals',\n",
       " 'MD Stem Cells|The Healing Institute',\n",
       " 'Laboratoires Thea',\n",
       " 'Changhai Hospital',\n",
       " 'GlaxoSmithKline',\n",
       " 'Richmond University Medical Center',\n",
       " 'Lungpacer Medical Inc.|Syntactx',\n",
       " 'Odense University Hospital',\n",
       " 'Duke University',\n",
       " 'Korea University Anam Hospital|Biosense Webster, Inc.',\n",
       " 'Arbeitsgemeinschaft medikamentoese Tumortherapie|Takeda',\n",
       " 'Fox Chase Cancer Center|Genentech, Inc.',\n",
       " 'Johannes Gutenberg University Mainz|Boehringer Ingelheim',\n",
       " 'University of Prince Edward Island|Yale University',\n",
       " 'Universitair Ziekenhuis Brussel',\n",
       " 'Seoul National University Hospital|Ministry of Food and Drug Safety, Korea',\n",
       " 'Duke University|Otsuka America Pharmaceutical',\n",
       " 'The Catholic University of Korea',\n",
       " 'Washington State University',\n",
       " 'Imperial College London|Malaysia Palm Oil Board',\n",
       " 'Capital Medical University',\n",
       " 'Wolfson Medical Center',\n",
       " 'Chulalongkorn University',\n",
       " 'CORD, LLC',\n",
       " 'DMF Medical Incorporated',\n",
       " 'Pantec Biosolutions AG',\n",
       " 'AIO-Studien-gGmbH|Pfizer|Celerion',\n",
       " 'Institut de Recherche pour le Developpement|Institute of Tropical Medicine, Belgium|Institut National de Recherche Biom\\xc3\\xa9dicale|Ministry of Public Health, Democratic Republic of the Congo',\n",
       " 'University of Cambridge|European Commission|Medtronic|Cambridge University Hospitals NHS Foundation Trust|The Leeds Teaching Hospitals NHS Trust|University of Luxembourg|University of Leipzig|Medical University of Graz|Medical University Innsbruck|Medical University of Vienna|Jaeb Center for Health Research',\n",
       " 'Chang Gung Memorial Hospital',\n",
       " 'University of Texas Southwestern Medical Center|Texas Tech University Health Sciences Center|BerGenBio ASA',\n",
       " 'Voyager Therapeutics',\n",
       " 'Taris Biomedical LLC',\n",
       " 'Mersana Therapeutics',\n",
       " 'University Medicine Greifswald',\n",
       " 'West Cancer Center|University of Tennessee Health Science Center|Amgen',\n",
       " 'Gachon University Gil Medical Center|Seoul National University Hospital',\n",
       " 'Boston University',\n",
       " 'Hanan Jafar|University of Jordan',\n",
       " 'Centre Leon Berard|Transgene',\n",
       " 'Impulse Dynamics',\n",
       " 'Konkuk University Medical Center',\n",
       " 'University of Chicago|EarlySense Ltd.',\n",
       " 'Centre Hospitalier Sud Francilien|Centre National de Ressources de lutte contre la Douleur',\n",
       " 'City, University of London',\n",
       " 'Yale University|National Institute on Drug Abuse (NIDA)',\n",
       " 'Lipogems International spa',\n",
       " 'charbel salamon|Atlantic Health System',\n",
       " 'Hybrigenics Corporation',\n",
       " 'Vanderbilt University|University of California, San Diego',\n",
       " 'The Pur Clinic|PercuVision',\n",
       " 'University Hospital, Gentofte, Copenhagen|University of Copenhagen',\n",
       " 'Macfarlane Burnet Institute for Medical Research and Public Health Ltd|Gilead Sciences',\n",
       " 'Yale University|American Cancer Society, Inc.',\n",
       " 'University of Maryland',\n",
       " 'Dr Cipto Mangunkusumo General Hospital|Indonesia University',\n",
       " 'University of Alberta|Alberta Innovates Health Solutions|Orpyx Medical Technologies Inc.',\n",
       " 'Gage Development Company, LLC|Health Decisions',\n",
       " 'University Hospital, Lille|R\\xc3\\xa9gion Hauts de France, France|Ministry of Health, France',\n",
       " 'Turku University Hospital|UKK Institute',\n",
       " 'Sichuan University',\n",
       " 'Colorado State University|United States Department of Agriculture (USDA)',\n",
       " 'CLJI Worldwide|Applied Clinical Services BV|UMC Utrecht|University of Rotterdam, The Netherlands|University of Washington|EB FlevoResearch BV|PreCare Trial & Recruitment B.V.',\n",
       " 'Peking University First Hospital|Beijing Cancer Hospital',\n",
       " 'McMaster University|Prostate Cancer Canada',\n",
       " 'University of Massachusetts, Worcester|The Cleveland Clinic|University of Texas Southwestern Medical Center|University of Louisville',\n",
       " ...}"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "set(df['Sponsor/Collaborators'].values)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "---\n",
    "We can similarly get the idea of what values are contained in various atributes. \n",
    "For further analysis to find out questions to reduce serach space we can ignore some of the attributes, since many of them have either single value or intutively not relevant to assignment problem. For example. it is not obvious that people will know Acronym, URL or Title of trial. We want to look for those attributes which are relevant to patient and for these attributes patient knows the values.  "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(10000, 26)"
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Creating a Copy of original dataframe, so that any changes hereafter wont affect original df\n",
    "df1 = df.copy()\n",
    "df1.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "to_drop = ['Rank','Title', 'Recruitment', 'Study Results', 'Funded Bys', 'Study Types',\n",
    "       'Other IDs', 'First Received', 'Start Date', 'Sponsor/Collaborators',\n",
    "       'Last Updated', 'Last Verified',\n",
    "       'Results First Received', 'Acronym', 'Primary Completion Date',\n",
    "       'Outcome Measures', 'URL']\n",
    "df1.drop(to_drop, axis=1, inplace=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(10000, 9)\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style>\n",
       "    .dataframe thead tr:only-child th {\n",
       "        text-align: right;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: left;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Gender</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Study Designs</th>\n",
       "      <th>Completion Date</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT03269526</td>\n",
       "      <td>Locally Advanced Pancreatic Adenocarcinoma|Met...</td>\n",
       "      <td>Drug: EGFR BATs after standard of care chemo</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>Phase 1|Phase 2</td>\n",
       "      <td>22</td>\n",
       "      <td>Intervention Model: Single Group Assignment|Ma...</td>\n",
       "      <td>June 1, 2022</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT03269422</td>\n",
       "      <td>Prostate Cancer</td>\n",
       "      <td>Radiation: MR-based image-guided, intensity-mo...</td>\n",
       "      <td>Male</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>30</td>\n",
       "      <td>Intervention Model: Single Group Assignment|Ma...</td>\n",
       "      <td>August 28, 2019</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT03269344</td>\n",
       "      <td>Oropharynx Cancer</td>\n",
       "      <td>Drug: Gabapentin|Drug: Placebo Oral Capsule</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>60</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>March 2019</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT03269279</td>\n",
       "      <td>Medical; Abortion, Fetus</td>\n",
       "      <td>Drug: Mifepristone|Drug: Misoprostol</td>\n",
       "      <td>Female</td>\n",
       "      <td>Child, Adult, Senior</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>100</td>\n",
       "      <td>Intervention Model: Single Group Assignment|Ma...</td>\n",
       "      <td>May 19, 2018</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT03269227</td>\n",
       "      <td>Malignant Pleural Mesothelioma</td>\n",
       "      <td>Radiation: Accelerated hypofractionation with ...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 85 Years   (Adult, Senior)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>30</td>\n",
       "      <td>Intervention Model: Single Group Assignment|Ma...</td>\n",
       "      <td>July 2020</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                         Conditions  \\\n",
       "0  NCT03269526  Locally Advanced Pancreatic Adenocarcinoma|Met...   \n",
       "1  NCT03269422                                    Prostate Cancer   \n",
       "2  NCT03269344                                  Oropharynx Cancer   \n",
       "3  NCT03269279                           Medical; Abortion, Fetus   \n",
       "4  NCT03269227                     Malignant Pleural Mesothelioma   \n",
       "\n",
       "                                       Interventions  Gender  \\\n",
       "0       Drug: EGFR BATs after standard of care chemo     All   \n",
       "1  Radiation: MR-based image-guided, intensity-mo...    Male   \n",
       "2        Drug: Gabapentin|Drug: Placebo Oral Capsule     All   \n",
       "3               Drug: Mifepristone|Drug: Misoprostol  Female   \n",
       "4  Radiation: Accelerated hypofractionation with ...     All   \n",
       "\n",
       "                                      Age           Phases Enrollment  \\\n",
       "0    18 Years and older   (Adult, Senior)  Phase 1|Phase 2         22   \n",
       "1    18 Years and older   (Adult, Senior)          Phase 1         30   \n",
       "2    18 Years and older   (Adult, Senior)          Phase 3         60   \n",
       "3                    Child, Adult, Senior          Phase 3        100   \n",
       "4  18 Years to 85 Years   (Adult, Senior)              NaN         30   \n",
       "\n",
       "                                       Study Designs  Completion Date  \n",
       "0  Intervention Model: Single Group Assignment|Ma...     June 1, 2022  \n",
       "1  Intervention Model: Single Group Assignment|Ma...  August 28, 2019  \n",
       "2  Allocation: Randomized|Intervention Model: Par...       March 2019  \n",
       "3  Intervention Model: Single Group Assignment|Ma...     May 19, 2018  \n",
       "4  Intervention Model: Single Group Assignment|Ma...        July 2020  "
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "print df1.shape\n",
    "df1.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style>\n",
       "    .dataframe thead tr:only-child th {\n",
       "        text-align: right;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: left;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr>\n",
       "      <th></th>\n",
       "      <th colspan=\"4\" halign=\"left\">Age</th>\n",
       "      <th colspan=\"4\" halign=\"left\">Completion Date</th>\n",
       "      <th colspan=\"2\" halign=\"left\">Conditions</th>\n",
       "      <th>...</th>\n",
       "      <th colspan=\"2\" halign=\"left\">NCT Number</th>\n",
       "      <th colspan=\"4\" halign=\"left\">Phases</th>\n",
       "      <th colspan=\"4\" halign=\"left\">Study Designs</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th></th>\n",
       "      <th>count</th>\n",
       "      <th>unique</th>\n",
       "      <th>top</th>\n",
       "      <th>freq</th>\n",
       "      <th>count</th>\n",
       "      <th>unique</th>\n",
       "      <th>top</th>\n",
       "      <th>freq</th>\n",
       "      <th>count</th>\n",
       "      <th>unique</th>\n",
       "      <th>...</th>\n",
       "      <th>top</th>\n",
       "      <th>freq</th>\n",
       "      <th>count</th>\n",
       "      <th>unique</th>\n",
       "      <th>top</th>\n",
       "      <th>freq</th>\n",
       "      <th>count</th>\n",
       "      <th>unique</th>\n",
       "      <th>top</th>\n",
       "      <th>freq</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Gender</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>All</th>\n",
       "      <td>8494</td>\n",
       "      <td>797</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>2892</td>\n",
       "      <td>8494</td>\n",
       "      <td>1102</td>\n",
       "      <td>December 2017</td>\n",
       "      <td>392</td>\n",
       "      <td>8494</td>\n",
       "      <td>5693</td>\n",
       "      <td>...</td>\n",
       "      <td>NCT03179995</td>\n",
       "      <td>1</td>\n",
       "      <td>4133</td>\n",
       "      <td>7</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>1258</td>\n",
       "      <td>8491</td>\n",
       "      <td>444</td>\n",
       "      <td>Intervention Model: Single Group Assignment|Ma...</td>\n",
       "      <td>1498</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Female</th>\n",
       "      <td>1023</td>\n",
       "      <td>203</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>281</td>\n",
       "      <td>1023</td>\n",
       "      <td>305</td>\n",
       "      <td>December 2017</td>\n",
       "      <td>62</td>\n",
       "      <td>1023</td>\n",
       "      <td>756</td>\n",
       "      <td>...</td>\n",
       "      <td>NCT03015129</td>\n",
       "      <td>1</td>\n",
       "      <td>448</td>\n",
       "      <td>7</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>125</td>\n",
       "      <td>1022</td>\n",
       "      <td>152</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>153</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Male</th>\n",
       "      <td>483</td>\n",
       "      <td>122</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>124</td>\n",
       "      <td>483</td>\n",
       "      <td>231</td>\n",
       "      <td>December 2017</td>\n",
       "      <td>28</td>\n",
       "      <td>483</td>\n",
       "      <td>327</td>\n",
       "      <td>...</td>\n",
       "      <td>NCT02940080</td>\n",
       "      <td>1</td>\n",
       "      <td>273</td>\n",
       "      <td>7</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>114</td>\n",
       "      <td>483</td>\n",
       "      <td>132</td>\n",
       "      <td>Intervention Model: Single Group Assignment|Ma...</td>\n",
       "      <td>86</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>3 rows × 32 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "         Age                                                     \\\n",
       "       count unique                                   top  freq   \n",
       "Gender                                                            \n",
       "All     8494    797  18 Years and older   (Adult, Senior)  2892   \n",
       "Female  1023    203  18 Years and older   (Adult, Senior)   281   \n",
       "Male     483    122  18 Years and older   (Adult, Senior)   124   \n",
       "\n",
       "       Completion Date                            Conditions         ...   \\\n",
       "                 count unique            top freq      count unique  ...    \n",
       "Gender                                                               ...    \n",
       "All               8494   1102  December 2017  392       8494   5693  ...    \n",
       "Female            1023    305  December 2017   62       1023    756  ...    \n",
       "Male               483    231  December 2017   28        483    327  ...    \n",
       "\n",
       "         NCT Number      Phases                       Study Designs         \\\n",
       "                top freq  count unique      top  freq         count unique   \n",
       "Gender                                                                       \n",
       "All     NCT03179995    1   4133      7  Phase 2  1258          8491    444   \n",
       "Female  NCT03015129    1    448      7  Phase 2   125          1022    152   \n",
       "Male    NCT02940080    1    273      7  Phase 1   114           483    132   \n",
       "\n",
       "                                                                 \n",
       "                                                      top  freq  \n",
       "Gender                                                           \n",
       "All     Intervention Model: Single Group Assignment|Ma...  1498  \n",
       "Female  Allocation: Randomized|Intervention Model: Par...   153  \n",
       "Male    Intervention Model: Single Group Assignment|Ma...    86  \n",
       "\n",
       "[3 rows x 32 columns]"
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "gender_grouped = df1.groupby(['Gender']) # Number of Gender specific trials\n",
    "gender_grouped.describe()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Mine some features from Interventions attribute"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "def h1(x):\n",
    "    '''\n",
    "    Helper function to mine Intervention types broadly \n",
    "    '''\n",
    "    T = []\n",
    "    #print x\n",
    "    fl = 1\n",
    "    try :\n",
    "        x = '|' + x\n",
    "    except TypeError:\n",
    "        T.append('nan')\n",
    "        fl = 0\n",
    "    while fl and len(x) >0 :\n",
    "        try :\n",
    "            id1 = x.index('|')\n",
    "            id2 = x.index(':')\n",
    "        except ValueError:\n",
    "            break\n",
    "        if not x[id1+1:id2] in T:\n",
    "            to_append = x[id1+1:id2]\n",
    "            to_append = to_append.replace(' ','_')\n",
    "            T.append(to_append)\n",
    "        x = x[id2+2:] \n",
    "    return ' '.join(T)\n",
    "    #return T\n",
    "\n",
    "df1['Intervention_types'] = df1['Interventions'].apply(lambda x: h1(x) )\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['Drug', 'Radiation', 'Dietary_Supplement', 'Diagnostic_Test', 'Device', 'Other', 'Behavioral', 'Biological', 'Procedure', 'Combination_Product', 'Genetic']\n"
     ]
    }
   ],
   "source": [
    "# Get list of unique Intervention types\n",
    "type_interven = []\n",
    "idx = 0\n",
    "for tag_str in df1.Intervention_types.values:\n",
    "    types = tag_str.split(' ')\n",
    "    for t in types:\n",
    "        if t not in type_interven:\n",
    "            if not t=='':\n",
    "                #print idx            \n",
    "                type_interven.append(t)\n",
    "    idx += 1\n",
    "print type_interven"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "NCT Number                                                   NCT03269526\n",
       "Conditions             Locally Advanced Pancreatic Adenocarcinoma|Met...\n",
       "Interventions               Drug: EGFR BATs after standard of care chemo\n",
       "Gender                                                               All\n",
       "Age                                 18 Years and older   (Adult, Senior)\n",
       "Phases                                                   Phase 1|Phase 2\n",
       "Enrollment                                                            22\n",
       "Study Designs          Intervention Model: Single Group Assignment|Ma...\n",
       "Completion Date                                             June 1, 2022\n",
       "Intervention_types                                                  Drug\n",
       "Drug                                                                   1\n",
       "Radiation                                                              0\n",
       "Dietary_Supplement                                                     0\n",
       "Diagnostic_Test                                                        0\n",
       "Device                                                                 0\n",
       "Other                                                                  0\n",
       "Behavioral                                                             0\n",
       "Biological                                                             0\n",
       "Procedure                                                              0\n",
       "Combination_Product                                                    0\n",
       "Genetic                                                                0\n",
       "Name: 0, dtype: object"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Add onehot features for Intervention_type\n",
    "for t in type_interven:\n",
    "    df1[t] = df1['Intervention_types'].apply(lambda x: 1 if t in x.split(' ') else 0)\n",
    "df1.iloc[0]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "---\n",
    "Know what Study Designs types are, the subtypes are categorical in this case"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "# Study designs types, ['Intervention_Model', 'Masking', 'Primary_Purpose', 'Allocation', 'nan']\n",
    "df1['S_types'] = df1['Study Designs'].apply(lambda x: h1(x) )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['Intervention_Model', 'Masking', 'Primary_Purpose', 'Allocation', 'nan']\n"
     ]
    }
   ],
   "source": [
    "# Get list of unique Study design types\n",
    "# For some trials no Study design type (nan) is indicated\n",
    "type_study = []\n",
    "idx = 0\n",
    "for tag_str in df1.S_types.values:\n",
    "    types = tag_str.split(' ')\n",
    "    for t in types:\n",
    "        if t not in type_study:\n",
    "            if not t=='':\n",
    "                #print idx            \n",
    "                type_study.append(t)\n",
    "    idx += 1\n",
    "print type_study"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "def h2(x):\n",
    "    '''\n",
    "    Helper function to mine a dict {Study_Design_types : Subtype } \n",
    "    '''\n",
    "    T = {}\n",
    "    #print x\n",
    "    fl = 1\n",
    "    \n",
    "    try :\n",
    "        x = x.split('|')\n",
    "        for ele in x:\n",
    "            ele = ele.split(': ')\n",
    "            T[ele[0]] = ele[1]\n",
    "    except (AttributeError,TypeError):\n",
    "        pass\n",
    "    return T\n",
    "\n",
    "df1['S_type3'] = df1['Study Designs'].apply(lambda x: h2(x) );"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "40000"
      ]
     },
     "execution_count": 26,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Creating Dataframe listing study design sub_types \n",
    "SD_subtype = pd.DataFrame.from_dict({}, orient='index')\n",
    "for i in range(len(df1)):\n",
    "    s = df1.iloc[i]['S_type3']\n",
    "    if s != {}:\n",
    "        D = pd.DataFrame.from_dict(s, orient='index').T\n",
    "    else:\n",
    "        D = {'Intervention Model': 'NaN', 'Masking':'NaN', 'Primary Purpose':'NaN', 'Allocation': 'NaN'}\n",
    "        D = pd.DataFrame.from_dict(D,orient='index').T\n",
    "    SD_subtype = pd.concat([SD_subtype, D], ignore_index=True)\n",
    "SD_subtype.size\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "# Appending into original dataframe\n",
    "#pd.merge(SD_subtype, df1, on=['Intervention Model', 'Masking', 'Primary Purpose', 'Allocation'])\n",
    "df1 = pd.concat([df1, SD_subtype], axis=1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style>\n",
       "    .dataframe thead tr:only-child th {\n",
       "        text-align: right;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: left;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Gender</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Study Designs</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>Intervention_types</th>\n",
       "      <th>...</th>\n",
       "      <th>Other</th>\n",
       "      <th>Behavioral</th>\n",
       "      <th>Biological</th>\n",
       "      <th>Procedure</th>\n",
       "      <th>Combination_Product</th>\n",
       "      <th>Genetic</th>\n",
       "      <th>Allocation</th>\n",
       "      <th>Intervention Model</th>\n",
       "      <th>Masking</th>\n",
       "      <th>Primary Purpose</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT03269526</td>\n",
       "      <td>Locally Advanced Pancreatic Adenocarcinoma|Met...</td>\n",
       "      <td>Drug: EGFR BATs after standard of care chemo</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>Phase 1|Phase 2</td>\n",
       "      <td>22</td>\n",
       "      <td>Intervention Model: Single Group Assignment|Ma...</td>\n",
       "      <td>June 1, 2022</td>\n",
       "      <td>Drug</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT03269422</td>\n",
       "      <td>Prostate Cancer</td>\n",
       "      <td>Radiation: MR-based image-guided, intensity-mo...</td>\n",
       "      <td>Male</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>30</td>\n",
       "      <td>Intervention Model: Single Group Assignment|Ma...</td>\n",
       "      <td>August 28, 2019</td>\n",
       "      <td>Radiation</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT03269344</td>\n",
       "      <td>Oropharynx Cancer</td>\n",
       "      <td>Drug: Gabapentin|Drug: Placebo Oral Capsule</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>60</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>March 2019</td>\n",
       "      <td>Drug</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>Quadruple (Participant, Care Provider, Investi...</td>\n",
       "      <td>Supportive Care</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT03269279</td>\n",
       "      <td>Medical; Abortion, Fetus</td>\n",
       "      <td>Drug: Mifepristone|Drug: Misoprostol</td>\n",
       "      <td>Female</td>\n",
       "      <td>Child, Adult, Senior</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>100</td>\n",
       "      <td>Intervention Model: Single Group Assignment|Ma...</td>\n",
       "      <td>May 19, 2018</td>\n",
       "      <td>Drug</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT03269227</td>\n",
       "      <td>Malignant Pleural Mesothelioma</td>\n",
       "      <td>Radiation: Accelerated hypofractionation with ...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 85 Years   (Adult, Senior)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>30</td>\n",
       "      <td>Intervention Model: Single Group Assignment|Ma...</td>\n",
       "      <td>July 2020</td>\n",
       "      <td>Radiation</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows × 25 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number                                         Conditions  \\\n",
       "0  NCT03269526  Locally Advanced Pancreatic Adenocarcinoma|Met...   \n",
       "1  NCT03269422                                    Prostate Cancer   \n",
       "2  NCT03269344                                  Oropharynx Cancer   \n",
       "3  NCT03269279                           Medical; Abortion, Fetus   \n",
       "4  NCT03269227                     Malignant Pleural Mesothelioma   \n",
       "\n",
       "                                       Interventions  Gender  \\\n",
       "0       Drug: EGFR BATs after standard of care chemo     All   \n",
       "1  Radiation: MR-based image-guided, intensity-mo...    Male   \n",
       "2        Drug: Gabapentin|Drug: Placebo Oral Capsule     All   \n",
       "3               Drug: Mifepristone|Drug: Misoprostol  Female   \n",
       "4  Radiation: Accelerated hypofractionation with ...     All   \n",
       "\n",
       "                                      Age           Phases Enrollment  \\\n",
       "0    18 Years and older   (Adult, Senior)  Phase 1|Phase 2         22   \n",
       "1    18 Years and older   (Adult, Senior)          Phase 1         30   \n",
       "2    18 Years and older   (Adult, Senior)          Phase 3         60   \n",
       "3                    Child, Adult, Senior          Phase 3        100   \n",
       "4  18 Years to 85 Years   (Adult, Senior)              NaN         30   \n",
       "\n",
       "                                       Study Designs  Completion Date  \\\n",
       "0  Intervention Model: Single Group Assignment|Ma...     June 1, 2022   \n",
       "1  Intervention Model: Single Group Assignment|Ma...  August 28, 2019   \n",
       "2  Allocation: Randomized|Intervention Model: Par...       March 2019   \n",
       "3  Intervention Model: Single Group Assignment|Ma...     May 19, 2018   \n",
       "4  Intervention Model: Single Group Assignment|Ma...        July 2020   \n",
       "\n",
       "  Intervention_types       ...         Other  Behavioral  Biological  \\\n",
       "0               Drug       ...             0           0           0   \n",
       "1          Radiation       ...             0           0           0   \n",
       "2               Drug       ...             0           0           0   \n",
       "3               Drug       ...             0           0           0   \n",
       "4          Radiation       ...             0           0           0   \n",
       "\n",
       "   Procedure  Combination_Product  Genetic  Allocation  \\\n",
       "0          0                    0        0         NaN   \n",
       "1          0                    0        0         NaN   \n",
       "2          0                    0        0  Randomized   \n",
       "3          0                    0        0         NaN   \n",
       "4          0                    0        0         NaN   \n",
       "\n",
       "        Intervention Model                                            Masking  \\\n",
       "0  Single Group Assignment                                  None (Open Label)   \n",
       "1  Single Group Assignment                                  None (Open Label)   \n",
       "2      Parallel Assignment  Quadruple (Participant, Care Provider, Investi...   \n",
       "3  Single Group Assignment                                  None (Open Label)   \n",
       "4  Single Group Assignment                                  None (Open Label)   \n",
       "\n",
       "   Primary Purpose  \n",
       "0        Treatment  \n",
       "1        Treatment  \n",
       "2  Supportive Care  \n",
       "3        Treatment  \n",
       "4        Treatment  \n",
       "\n",
       "[5 rows x 25 columns]"
      ]
     },
     "execution_count": 28,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df1 = df1.drop(['S_types', 'S_type3'], axis=1)\n",
    "df1.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Intervention Model\n",
       "Crossover Assignment        677\n",
       "Factorial Assignment        139\n",
       "NaN                           4\n",
       "Parallel Assignment        6125\n",
       "Sequential Assignment       207\n",
       "Single Group Assignment    2840\n",
       "dtype: int64"
      ]
     },
     "execution_count": 29,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df1.groupby('Intervention Model').size()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Masking\n",
       "Double                                                                        5\n",
       "Double (Care Provider, Investigator)                                         15\n",
       "Double (Care Provider, Outcomes Assessor)                                    24\n",
       "Double (Investigator, Outcomes Assessor)                                    148\n",
       "Double (Participant, Care Provider)                                          87\n",
       "Double (Participant, Investigator)                                          609\n",
       "Double (Participant, Outcomes Assessor)                                     298\n",
       "NaN                                                                           4\n",
       "None (Open Label)                                                          5741\n",
       "Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)     924\n",
       "Single                                                                        2\n",
       "Single (Care Provider)                                                       37\n",
       "Single (Investigator)                                                       145\n",
       "Single (Outcomes Assessor)                                                  656\n",
       "Single (Participant)                                                        570\n",
       "Triple (Care Provider, Investigator, Outcomes Assessor)                      21\n",
       "Triple (Participant, Care Provider, Investigator)                           289\n",
       "Triple (Participant, Care Provider, Outcomes Assessor)                      100\n",
       "Triple (Participant, Investigator, Outcomes Assessor)                       305\n",
       "dtype: int64"
      ]
     },
     "execution_count": 30,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df1.groupby('Masking').size()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Primary Purpose\n",
       "Basic Science                551\n",
       "Device Feasibility           106\n",
       "Diagnostic                   527\n",
       "Health Services Research     255\n",
       "NaN                            4\n",
       "Other                        571\n",
       "Prevention                  1005\n",
       "Screening                     87\n",
       "Supportive Care              517\n",
       "Treatment                   6292\n",
       "dtype: int64"
      ]
     },
     "execution_count": 31,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df1.groupby(['Primary Purpose']).size()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Allocation\n",
       "NaN                  4\n",
       "Non-Randomized     976\n",
       "Randomized        6339\n",
       "dtype: int64"
      ]
     },
     "execution_count": 32,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df1.groupby(['Allocation']).size()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "def similar(a,b):\n",
    "    ''' Returns a score based on matching strings'''\n",
    "    return SequenceMatcher(None, a, b).ratio()\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style>\n",
       "    .dataframe thead tr:only-child th {\n",
       "        text-align: right;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: left;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Gender</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Study Designs</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>Intervention_types</th>\n",
       "      <th>...</th>\n",
       "      <th>Other</th>\n",
       "      <th>Behavioral</th>\n",
       "      <th>Biological</th>\n",
       "      <th>Procedure</th>\n",
       "      <th>Combination_Product</th>\n",
       "      <th>Genetic</th>\n",
       "      <th>Allocation</th>\n",
       "      <th>Intervention Model</th>\n",
       "      <th>Masking</th>\n",
       "      <th>Primary Purpose</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT03269422</td>\n",
       "      <td>Prostate Cancer</td>\n",
       "      <td>Radiation: MR-based image-guided, intensity-mo...</td>\n",
       "      <td>Male</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>30</td>\n",
       "      <td>Intervention Model: Single Group Assignment|Ma...</td>\n",
       "      <td>August 28, 2019</td>\n",
       "      <td>Radiation</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT03269344</td>\n",
       "      <td>Oropharynx Cancer</td>\n",
       "      <td>Drug: Gabapentin|Drug: Placebo Oral Capsule</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>60</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>March 2019</td>\n",
       "      <td>Drug</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>Quadruple (Participant, Care Provider, Investi...</td>\n",
       "      <td>Supportive Care</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>NCT03268993</td>\n",
       "      <td>Head and Neck Cancer|Head and Neck Squamous Ce...</td>\n",
       "      <td>Dietary Supplement: Avmacol</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>36</td>\n",
       "      <td>Intervention Model: Single Group Assignment|Ma...</td>\n",
       "      <td>June 2020</td>\n",
       "      <td>Dietary_Supplement</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Basic Science</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>NCT03268785</td>\n",
       "      <td>Thyroid Cancer|Parathyroid; Absent|Hypocalcemi...</td>\n",
       "      <td>Diagnostic Test: Intraoperative identification...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 60 Years   (Adult)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>200</td>\n",
       "      <td>Allocation: Non-Randomized|Intervention Model:...</td>\n",
       "      <td>August 1, 2020</td>\n",
       "      <td>Diagnostic_Test</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>Non-Randomized</td>\n",
       "      <td>Sequential Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Diagnostic</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>NCT03268382</td>\n",
       "      <td>High-grade Serous Ovarian Cancer</td>\n",
       "      <td>Drug: APR-246|Drug: Pegylated Liposomal Doxoru...</td>\n",
       "      <td>Female</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>25</td>\n",
       "      <td>Intervention Model: Single Group Assignment|Ma...</td>\n",
       "      <td>November 2018</td>\n",
       "      <td>Drug</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>NCT03267914</td>\n",
       "      <td>Dental Caries|Oral Cavity Cancer|Oral Complica...</td>\n",
       "      <td>Other: Tray|Other: Brush</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 100 Years   (Adult, Senior)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>45</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>May 31, 2019</td>\n",
       "      <td>Other</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Prevention</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45</th>\n",
       "      <td>NCT03267173</td>\n",
       "      <td>Pancreatic Cancer|CAR</td>\n",
       "      <td>Drug: Chimeric antigen receptor T cell</td>\n",
       "      <td>Male</td>\n",
       "      <td>18 Years to 65 Years   (Adult)</td>\n",
       "      <td>Early Phase 1</td>\n",
       "      <td>10</td>\n",
       "      <td>Intervention Model: Single Group Assignment|Ma...</td>\n",
       "      <td>June 2019</td>\n",
       "      <td>Drug</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>81</th>\n",
       "      <td>NCT03264807</td>\n",
       "      <td>Gastric Cancer</td>\n",
       "      <td>Procedure: D2 lymphadenectomy|Procedure: D2 an...</td>\n",
       "      <td>All</td>\n",
       "      <td>19 Years and older   (Adult, Senior)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>518</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>December 31, 2021</td>\n",
       "      <td>Procedure</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>110</th>\n",
       "      <td>NCT03263520</td>\n",
       "      <td>Cachexia; Cancer</td>\n",
       "      <td>Drug: Nandrolone Decanoate|Drug: Dexamethasone</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>60</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>October 31, 2017</td>\n",
       "      <td>Drug</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>Double (Investigator, Outcomes Assessor)</td>\n",
       "      <td>Supportive Care</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>112</th>\n",
       "      <td>NCT03263429</td>\n",
       "      <td>Colorectal Cancer|Metastatic Colorectal Cancer...</td>\n",
       "      <td>Drug: Glutaminase Inhibitor CB-839|Biological:...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>Phase 1|Phase 2</td>\n",
       "      <td>40</td>\n",
       "      <td>Intervention Model: Single Group Assignment|Ma...</td>\n",
       "      <td>August 2021</td>\n",
       "      <td>Drug Biological Other Device</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>135</th>\n",
       "      <td>NCT03262103</td>\n",
       "      <td>Prostate Cancer</td>\n",
       "      <td>Biological: Intratumoral (IT) Poly ICLC 0.5 mg...</td>\n",
       "      <td>Male</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>24</td>\n",
       "      <td>Allocation: Non-Randomized|Intervention Model:...</td>\n",
       "      <td>May 1, 2020</td>\n",
       "      <td>Biological Procedure</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>Non-Randomized</td>\n",
       "      <td>Sequential Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>153</th>\n",
       "      <td>NCT03261336</td>\n",
       "      <td>Castration-resistant Prostate Cancer</td>\n",
       "      <td>Drug: Calcitriol, Ketoconazole, Hydrocortisone</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>15</td>\n",
       "      <td>Intervention Model: Single Group Assignment|Ma...</td>\n",
       "      <td>June 30, 2018</td>\n",
       "      <td>Drug</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>156</th>\n",
       "      <td>NCT03261271</td>\n",
       "      <td>Obesity|Prostate Cancer</td>\n",
       "      <td>Behavioral: Weight Loss Program|Behavioral: St...</td>\n",
       "      <td>Male</td>\n",
       "      <td>50 Years and older   (Adult, Senior)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>40</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>September 2021</td>\n",
       "      <td>Behavioral</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Basic Science</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>180</th>\n",
       "      <td>NCT03259438</td>\n",
       "      <td>Fatigue|Cancer Survivorship</td>\n",
       "      <td>Behavioral: Qigong|Behavioral: Healthy Living ...</td>\n",
       "      <td>Female</td>\n",
       "      <td>18 Years to 70 Years   (Adult, Senior)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>75</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>January 30, 2018</td>\n",
       "      <td>Behavioral</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>Double (Investigator, Outcomes Assessor)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>194</th>\n",
       "      <td>NCT03258541</td>\n",
       "      <td>Rectal Tumors|Rectal Cancer|Advanced Cancer</td>\n",
       "      <td>Device: TraceIT®|Radiation: Volumetric Arc The...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 85 Years   (Adult, Senior)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>10</td>\n",
       "      <td>Intervention Model: Single Group Assignment|Ma...</td>\n",
       "      <td>January 2019</td>\n",
       "      <td>Device Radiation Procedure</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>199</th>\n",
       "      <td>NCT03258320</td>\n",
       "      <td>Prostate Cancer Patients</td>\n",
       "      <td>Drug: Cabazitaxel, Docetaxel, Mitoxantrone or ...</td>\n",
       "      <td>Male</td>\n",
       "      <td>40 Years to 75 Years   (Adult, Senior)</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>50</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>December 2020</td>\n",
       "      <td>Drug</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>Double (Participant, Care Provider)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>200</th>\n",
       "      <td>NCT03258307</td>\n",
       "      <td>Gynecologic Cancer</td>\n",
       "      <td>Other: Preoperative level</td>\n",
       "      <td>Female</td>\n",
       "      <td>18 Years to 90 Years   (Adult, Senior)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>25</td>\n",
       "      <td>Allocation: Non-Randomized|Intervention Model:...</td>\n",
       "      <td>December 31, 2018</td>\n",
       "      <td>Other</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>Non-Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>Double (Participant, Investigator)</td>\n",
       "      <td>Health Services Research</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>221</th>\n",
       "      <td>NCT03257124</td>\n",
       "      <td>Non-Small Cell Lung Cancer With EGFR T790M Mut...</td>\n",
       "      <td>Drug: AZD9291</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>80</td>\n",
       "      <td>Intervention Model: Single Group Assignment|Ma...</td>\n",
       "      <td>December 31, 2019</td>\n",
       "      <td>Drug</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>225</th>\n",
       "      <td>NCT03257007</td>\n",
       "      <td>Mindfulness|Meditation|Metastatic Cancer|Quali...</td>\n",
       "      <td>Behavioral: Mindfulness</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>60</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>December 22, 2017</td>\n",
       "      <td>Behavioral</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Supportive Care</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>235</th>\n",
       "      <td>NCT03256721</td>\n",
       "      <td>Nonsmall Cell Lung Cancer</td>\n",
       "      <td>Drug: Apatinib/docetaxel/pemetrexed|Drug: doce...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 75 Years   (Adult, Senior)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>135</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>May 26, 2019</td>\n",
       "      <td>Drug</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>Double (Participant, Investigator)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>247</th>\n",
       "      <td>NCT03256201</td>\n",
       "      <td>Pancreatic Cancer</td>\n",
       "      <td>Behavioral: Nutritional Counseling|Behavioral:...</td>\n",
       "      <td>All</td>\n",
       "      <td>30 Years and older   (Adult, Senior)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>60</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>September 30, 2019</td>\n",
       "      <td>Behavioral</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>Single (Outcomes Assessor)</td>\n",
       "      <td>Supportive Care</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>250</th>\n",
       "      <td>NCT03256084</td>\n",
       "      <td>Colorectal Cancer</td>\n",
       "      <td>Procedure: Blood and tumor samples</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>160</td>\n",
       "      <td>Intervention Model: Single Group Assignment|Ma...</td>\n",
       "      <td>July 17, 2022</td>\n",
       "      <td>Procedure</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Basic Science</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>260</th>\n",
       "      <td>NCT03255577</td>\n",
       "      <td>Breast Cancer|Locally Advanced Breast Cancer</td>\n",
       "      <td>Procedure: Sentinel Lymph Node Biopsy (SLNB)</td>\n",
       "      <td>Female</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>100</td>\n",
       "      <td>Intervention Model: Single Group Assignment|Ma...</td>\n",
       "      <td>August 2020</td>\n",
       "      <td>Procedure</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>264</th>\n",
       "      <td>NCT03255434</td>\n",
       "      <td>Stage III Colon Cancer</td>\n",
       "      <td>Drug: Oxaliplatin|Drug: Oxaliplatin LBM</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 75 Years   (Adult, Senior)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>308</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>April 2022</td>\n",
       "      <td>Drug</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>280</th>\n",
       "      <td>NCT03254875</td>\n",
       "      <td>Breast Cancer</td>\n",
       "      <td>Behavioral: Individually tailored nurse naviga...</td>\n",
       "      <td>Female</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>324</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>May 31, 2021</td>\n",
       "      <td>Behavioral</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>Single (Outcomes Assessor)</td>\n",
       "      <td>Supportive Care</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>285</th>\n",
       "      <td>NCT03254732</td>\n",
       "      <td>Advanced Solid Cancers</td>\n",
       "      <td>Drug: ADI PEG20|Drug: Pembrolizumab</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>47</td>\n",
       "      <td>Intervention Model: Single Group Assignment|Ma...</td>\n",
       "      <td>January 2019</td>\n",
       "      <td>Drug</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>286</th>\n",
       "      <td>NCT03254654</td>\n",
       "      <td>Advanced Triple-Negative Breast Cancer</td>\n",
       "      <td>Drug: Vinorelbine|Drug: Apatinib</td>\n",
       "      <td>Female</td>\n",
       "      <td>18 Years to 70 Years   (Adult, Senior)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>66</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>August 2020</td>\n",
       "      <td>Drug</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>289</th>\n",
       "      <td>NCT03254420</td>\n",
       "      <td>Prostate Cancer</td>\n",
       "      <td>Device: Calypso beacon implant|Radiation: Radi...</td>\n",
       "      <td>Male</td>\n",
       "      <td>18 Years to 80 Years   (Adult, Senior)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>166</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>February 2023</td>\n",
       "      <td>Device Radiation</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>290</th>\n",
       "      <td>NCT03254394</td>\n",
       "      <td>Neuropathy, Painful|Chemotherapy-induced Perip...</td>\n",
       "      <td>Drug: Lidocaine Hydrochloride|Drug: Placebo|Dr...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>Phase 1|Phase 2</td>\n",
       "      <td>38</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>June 1, 2019</td>\n",
       "      <td>Drug</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>Quadruple (Participant, Care Provider, Investi...</td>\n",
       "      <td>Prevention</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>297</th>\n",
       "      <td>NCT03253978</td>\n",
       "      <td>Prostate Cancer</td>\n",
       "      <td>Radiation: Stereotatic Radiotherapy</td>\n",
       "      <td>Male</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>30</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Sin...</td>\n",
       "      <td>December 31, 2028</td>\n",
       "      <td>Radiation</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9632</th>\n",
       "      <td>NCT02934685</td>\n",
       "      <td>Prostate Cancer</td>\n",
       "      <td>Radiation: hypofraction|Radiation: convention</td>\n",
       "      <td>Male</td>\n",
       "      <td>50 Years to 79 Years   (Adult, Senior)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>60</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>May 2021</td>\n",
       "      <td>Radiation</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9635</th>\n",
       "      <td>NCT02934568</td>\n",
       "      <td>Continued Access to Study Treatment(s), Cancer...</td>\n",
       "      <td>Drug: LEE011</td>\n",
       "      <td>All</td>\n",
       "      <td>Child, Adult, Senior</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>40</td>\n",
       "      <td>Intervention Model: Single Group Assignment|Ma...</td>\n",
       "      <td>April 27, 2022</td>\n",
       "      <td>Drug</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9638</th>\n",
       "      <td>NCT02934529</td>\n",
       "      <td>Metastatic Colorectal Cancer</td>\n",
       "      <td>Drug: Irinotecan|Drug: Folinic Acid|Drug: 5-FU...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>550</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>March 2022</td>\n",
       "      <td>Drug</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9646</th>\n",
       "      <td>NCT02934230</td>\n",
       "      <td>Cancer</td>\n",
       "      <td>Behavioral: Prehabilitation Program</td>\n",
       "      <td>All</td>\n",
       "      <td>65 Years and older   (Adult, Senior)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>200</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>October 2018</td>\n",
       "      <td>Behavioral</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>Single (Outcomes Assessor)</td>\n",
       "      <td>Prevention</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9656</th>\n",
       "      <td>NCT02933944</td>\n",
       "      <td>Rectal Cancer</td>\n",
       "      <td>Biological: TG02-treatment|Drug: Pembrolizumab</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>20</td>\n",
       "      <td>Intervention Model: Single Group Assignment|Ma...</td>\n",
       "      <td>null</td>\n",
       "      <td>Biological Drug</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9660</th>\n",
       "      <td>NCT02933801</td>\n",
       "      <td>Prostate Cancer Metastatic|Prostate Cancer</td>\n",
       "      <td>Drug: ODM-201|Other: Placebo</td>\n",
       "      <td>Male</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>88</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>December 2024</td>\n",
       "      <td>Drug Other</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>Quadruple (Participant, Care Provider, Investi...</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9674</th>\n",
       "      <td>NCT02933255</td>\n",
       "      <td>Prostate Cancer</td>\n",
       "      <td>Biological: PROSTVAC-V/F|Drug: Nivolumab|Drug:...</td>\n",
       "      <td>Male</td>\n",
       "      <td>18 Years to 100 Years   (Adult, Senior)</td>\n",
       "      <td>Phase 1|Phase 2</td>\n",
       "      <td>65</td>\n",
       "      <td>Allocation: Non-Randomized|Intervention Model:...</td>\n",
       "      <td>August 1, 2021</td>\n",
       "      <td>Biological Drug</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>Non-Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9679</th>\n",
       "      <td>NCT02933073</td>\n",
       "      <td>Ovarian Cancer</td>\n",
       "      <td>Biological: OncoImmunome</td>\n",
       "      <td>Female</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>15</td>\n",
       "      <td>Intervention Model: Single Group Assignment|Ma...</td>\n",
       "      <td>October 2026</td>\n",
       "      <td>Biological</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9702</th>\n",
       "      <td>NCT02932332</td>\n",
       "      <td>Cancer</td>\n",
       "      <td>Other: High-flow Oxygen|Other: Low-flow Oxygen...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>36</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Cro...</td>\n",
       "      <td>October 2018</td>\n",
       "      <td>Other</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Crossover Assignment</td>\n",
       "      <td>Double (Participant, Investigator)</td>\n",
       "      <td>Supportive Care</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9746</th>\n",
       "      <td>NCT02930902</td>\n",
       "      <td>Pancreatic Cancer</td>\n",
       "      <td>Drug: Pembrolizumab|Drug: Paricalcitol|Drug: G...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>30</td>\n",
       "      <td>Allocation: Non-Randomized|Intervention Model:...</td>\n",
       "      <td>February 2020</td>\n",
       "      <td>Drug Procedure</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>Non-Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9770</th>\n",
       "      <td>NCT02929862</td>\n",
       "      <td>Cancer</td>\n",
       "      <td>Drug: LYC-55716</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>Phase 1|Phase 2</td>\n",
       "      <td>90</td>\n",
       "      <td>Intervention Model: Single Group Assignment|Ma...</td>\n",
       "      <td>June 2018</td>\n",
       "      <td>Drug</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9804</th>\n",
       "      <td>NCT02928692</td>\n",
       "      <td>Prostate Cancer|Carcinoma of the Rectum|Colon ...</td>\n",
       "      <td>Drug: Minocycline|Drug: Placebo</td>\n",
       "      <td>All</td>\n",
       "      <td>65 Years and older   (Adult, Senior)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>750</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>June 2017</td>\n",
       "      <td>Drug</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>Quadruple (Participant, Care Provider, Investi...</td>\n",
       "      <td>Prevention</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9807</th>\n",
       "      <td>NCT02928640</td>\n",
       "      <td>Cellular Diagnosis, Prostate Cancer</td>\n",
       "      <td>Device: ClariCore System</td>\n",
       "      <td>Male</td>\n",
       "      <td>22 Years and older   (Adult, Senior)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>200</td>\n",
       "      <td>Intervention Model: Single Group Assignment|Ma...</td>\n",
       "      <td>December 2017</td>\n",
       "      <td>Device</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Diagnostic</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9815</th>\n",
       "      <td>NCT02928406</td>\n",
       "      <td>Urinary Tract Cancer</td>\n",
       "      <td>Drug: Atezolizumab</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>1000</td>\n",
       "      <td>Intervention Model: Single Group Assignment|Ma...</td>\n",
       "      <td>May 31, 2022</td>\n",
       "      <td>Drug</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9822</th>\n",
       "      <td>NCT02928224</td>\n",
       "      <td>BRAF V600E-mutant Metastatic Colorectal Cancer</td>\n",
       "      <td>Drug: Encorafenib|Drug: Binimetinib|Drug: Cetu...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>645</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>July 2019</td>\n",
       "      <td>Drug</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9832</th>\n",
       "      <td>NCT02927912</td>\n",
       "      <td>Stage IA Breast Cancer|Stage IB Breast Cancer|...</td>\n",
       "      <td>Radiation: Electron Beam Therapy|Procedure: Lu...</td>\n",
       "      <td>Female</td>\n",
       "      <td>18 Years to 59 Years   (Adult)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>176</td>\n",
       "      <td>Intervention Model: Single Group Assignment|Ma...</td>\n",
       "      <td>November 1, 2022</td>\n",
       "      <td>Radiation Procedure Other</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9846</th>\n",
       "      <td>NCT02927340</td>\n",
       "      <td>Non-Small Cell Lung Cancer (NSCLC)</td>\n",
       "      <td>Drug: Lorlatinib</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>30</td>\n",
       "      <td>Intervention Model: Single Group Assignment|Ma...</td>\n",
       "      <td>March 2023</td>\n",
       "      <td>Drug</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9848</th>\n",
       "      <td>NCT02927301</td>\n",
       "      <td>Non-Small Cell Lung Cancer</td>\n",
       "      <td>Drug: Atezolizumab (MPDL3280A), an engineered ...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>180</td>\n",
       "      <td>Intervention Model: Single Group Assignment|Ma...</td>\n",
       "      <td>July 31, 2023</td>\n",
       "      <td>Drug</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9850</th>\n",
       "      <td>NCT02927249</td>\n",
       "      <td>Node Positive HER2 Negative Breast Cancer</td>\n",
       "      <td>Other: Placebo|Drug: Aspirin</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 69 Years   (Adult, Senior)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>2936</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>null</td>\n",
       "      <td>Other Drug</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>Double (Participant, Investigator)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9870</th>\n",
       "      <td>NCT02926690</td>\n",
       "      <td>Relapsed/Refractory Locally Advanced or Metast...</td>\n",
       "      <td>Drug: OTS167PO</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>70</td>\n",
       "      <td>Intervention Model: Single Group Assignment|Ma...</td>\n",
       "      <td>April 2020</td>\n",
       "      <td>Drug</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9873</th>\n",
       "      <td>NCT02926573</td>\n",
       "      <td>Head and Neck Cancer|Acute Pain|Postoperative ...</td>\n",
       "      <td>Drug: Gabapentin|Drug: Placebo</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>120</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>July 2017</td>\n",
       "      <td>Drug</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>Double (Participant, Investigator)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9882</th>\n",
       "      <td>NCT02926209</td>\n",
       "      <td>Cancer</td>\n",
       "      <td>Device: Aer-O-Scope (Colonoscopy)|Procedure: C...</td>\n",
       "      <td>All</td>\n",
       "      <td>45 Years to 75 Years   (Adult, Senior)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>300</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>March 20, 2018</td>\n",
       "      <td>Device Procedure</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Screening</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9909</th>\n",
       "      <td>NCT02925234</td>\n",
       "      <td>Cancer|Tumors|Neoplasm|Neoplasia</td>\n",
       "      <td>Drug: Panitumumab|Drug: Olaparib|Drug: Dabrafe...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>400</td>\n",
       "      <td>Allocation: Non-Randomized|Intervention Model:...</td>\n",
       "      <td>December 2019</td>\n",
       "      <td>Drug</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>Non-Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9916</th>\n",
       "      <td>NCT02925000</td>\n",
       "      <td>Cancer</td>\n",
       "      <td>Drug: TLC178</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>Phase 1|Phase 2</td>\n",
       "      <td>51</td>\n",
       "      <td>Intervention Model: Single Group Assignment|Ma...</td>\n",
       "      <td>September 2019</td>\n",
       "      <td>Drug</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9921</th>\n",
       "      <td>NCT02924883</td>\n",
       "      <td>Metastatic Breast Cancer</td>\n",
       "      <td>Drug: Atezolizumab|Drug: Trastuzumab emtansine...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>200</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>August 29, 2019</td>\n",
       "      <td>Drug Other</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>Double (Participant, Investigator)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9933</th>\n",
       "      <td>NCT02924480</td>\n",
       "      <td>Invasive Bladder Cancer</td>\n",
       "      <td>Procedure: Cystectomy|Drug: Lidocaine|Drug: Sa...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>50</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>August 2018</td>\n",
       "      <td>Procedure Drug</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>Double (Participant, Investigator)</td>\n",
       "      <td>Supportive Care</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9953</th>\n",
       "      <td>NCT02923921</td>\n",
       "      <td>Pancreatic Cancer</td>\n",
       "      <td>Biological: AM0010|Drug: FOLFOX</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>566</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>January 2020</td>\n",
       "      <td>Biological Drug</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9964</th>\n",
       "      <td>NCT02923570</td>\n",
       "      <td>Head and Neck Cancer</td>\n",
       "      <td>Radiation: Photon intensity modulated radiatio...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>132</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>October 2021</td>\n",
       "      <td>Radiation</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>Randomized</td>\n",
       "      <td>Parallel Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9974</th>\n",
       "      <td>NCT02923349</td>\n",
       "      <td>Advanced Cancer|Metastatic Cancer</td>\n",
       "      <td>Drug: INCAGN01949</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>Phase 1|Phase 2</td>\n",
       "      <td>157</td>\n",
       "      <td>Intervention Model: Single Group Assignment|Ma...</td>\n",
       "      <td>February 2019</td>\n",
       "      <td>Drug</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9982</th>\n",
       "      <td>NCT02923180</td>\n",
       "      <td>Prostate Cancer</td>\n",
       "      <td>Drug: Enoblituzumab</td>\n",
       "      <td>Male</td>\n",
       "      <td>18 Years and older   (Adult, Senior)</td>\n",
       "      <td>Early Phase 1</td>\n",
       "      <td>16</td>\n",
       "      <td>Intervention Model: Single Group Assignment|Ma...</td>\n",
       "      <td>October 2019</td>\n",
       "      <td>Drug</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Single Group Assignment</td>\n",
       "      <td>None (Open Label)</td>\n",
       "      <td>Treatment</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>1062 rows × 25 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "       NCT Number                                         Conditions  \\\n",
       "1     NCT03269422                                    Prostate Cancer   \n",
       "2     NCT03269344                                  Oropharynx Cancer   \n",
       "5     NCT03268993  Head and Neck Cancer|Head and Neck Squamous Ce...   \n",
       "10    NCT03268785  Thyroid Cancer|Parathyroid; Absent|Hypocalcemi...   \n",
       "21    NCT03268382                   High-grade Serous Ovarian Cancer   \n",
       "30    NCT03267914  Dental Caries|Oral Cavity Cancer|Oral Complica...   \n",
       "45    NCT03267173                              Pancreatic Cancer|CAR   \n",
       "81    NCT03264807                                     Gastric Cancer   \n",
       "110   NCT03263520                                   Cachexia; Cancer   \n",
       "112   NCT03263429  Colorectal Cancer|Metastatic Colorectal Cancer...   \n",
       "135   NCT03262103                                    Prostate Cancer   \n",
       "153   NCT03261336               Castration-resistant Prostate Cancer   \n",
       "156   NCT03261271                            Obesity|Prostate Cancer   \n",
       "180   NCT03259438                        Fatigue|Cancer Survivorship   \n",
       "194   NCT03258541        Rectal Tumors|Rectal Cancer|Advanced Cancer   \n",
       "199   NCT03258320                           Prostate Cancer Patients   \n",
       "200   NCT03258307                                 Gynecologic Cancer   \n",
       "221   NCT03257124  Non-Small Cell Lung Cancer With EGFR T790M Mut...   \n",
       "225   NCT03257007  Mindfulness|Meditation|Metastatic Cancer|Quali...   \n",
       "235   NCT03256721                          Nonsmall Cell Lung Cancer   \n",
       "247   NCT03256201                                  Pancreatic Cancer   \n",
       "250   NCT03256084                                  Colorectal Cancer   \n",
       "260   NCT03255577       Breast Cancer|Locally Advanced Breast Cancer   \n",
       "264   NCT03255434                             Stage III Colon Cancer   \n",
       "280   NCT03254875                                      Breast Cancer   \n",
       "285   NCT03254732                             Advanced Solid Cancers   \n",
       "286   NCT03254654             Advanced Triple-Negative Breast Cancer   \n",
       "289   NCT03254420                                    Prostate Cancer   \n",
       "290   NCT03254394  Neuropathy, Painful|Chemotherapy-induced Perip...   \n",
       "297   NCT03253978                                    Prostate Cancer   \n",
       "...           ...                                                ...   \n",
       "9632  NCT02934685                                    Prostate Cancer   \n",
       "9635  NCT02934568  Continued Access to Study Treatment(s), Cancer...   \n",
       "9638  NCT02934529                       Metastatic Colorectal Cancer   \n",
       "9646  NCT02934230                                             Cancer   \n",
       "9656  NCT02933944                                      Rectal Cancer   \n",
       "9660  NCT02933801         Prostate Cancer Metastatic|Prostate Cancer   \n",
       "9674  NCT02933255                                    Prostate Cancer   \n",
       "9679  NCT02933073                                     Ovarian Cancer   \n",
       "9702  NCT02932332                                             Cancer   \n",
       "9746  NCT02930902                                  Pancreatic Cancer   \n",
       "9770  NCT02929862                                             Cancer   \n",
       "9804  NCT02928692  Prostate Cancer|Carcinoma of the Rectum|Colon ...   \n",
       "9807  NCT02928640                Cellular Diagnosis, Prostate Cancer   \n",
       "9815  NCT02928406                               Urinary Tract Cancer   \n",
       "9822  NCT02928224     BRAF V600E-mutant Metastatic Colorectal Cancer   \n",
       "9832  NCT02927912  Stage IA Breast Cancer|Stage IB Breast Cancer|...   \n",
       "9846  NCT02927340                 Non-Small Cell Lung Cancer (NSCLC)   \n",
       "9848  NCT02927301                         Non-Small Cell Lung Cancer   \n",
       "9850  NCT02927249          Node Positive HER2 Negative Breast Cancer   \n",
       "9870  NCT02926690  Relapsed/Refractory Locally Advanced or Metast...   \n",
       "9873  NCT02926573  Head and Neck Cancer|Acute Pain|Postoperative ...   \n",
       "9882  NCT02926209                                             Cancer   \n",
       "9909  NCT02925234                   Cancer|Tumors|Neoplasm|Neoplasia   \n",
       "9916  NCT02925000                                             Cancer   \n",
       "9921  NCT02924883                           Metastatic Breast Cancer   \n",
       "9933  NCT02924480                            Invasive Bladder Cancer   \n",
       "9953  NCT02923921                                  Pancreatic Cancer   \n",
       "9964  NCT02923570                               Head and Neck Cancer   \n",
       "9974  NCT02923349                  Advanced Cancer|Metastatic Cancer   \n",
       "9982  NCT02923180                                    Prostate Cancer   \n",
       "\n",
       "                                          Interventions  Gender  \\\n",
       "1     Radiation: MR-based image-guided, intensity-mo...    Male   \n",
       "2           Drug: Gabapentin|Drug: Placebo Oral Capsule     All   \n",
       "5                           Dietary Supplement: Avmacol     All   \n",
       "10    Diagnostic Test: Intraoperative identification...     All   \n",
       "21    Drug: APR-246|Drug: Pegylated Liposomal Doxoru...  Female   \n",
       "30                             Other: Tray|Other: Brush     All   \n",
       "45               Drug: Chimeric antigen receptor T cell    Male   \n",
       "81    Procedure: D2 lymphadenectomy|Procedure: D2 an...     All   \n",
       "110      Drug: Nandrolone Decanoate|Drug: Dexamethasone     All   \n",
       "112   Drug: Glutaminase Inhibitor CB-839|Biological:...     All   \n",
       "135   Biological: Intratumoral (IT) Poly ICLC 0.5 mg...    Male   \n",
       "153      Drug: Calcitriol, Ketoconazole, Hydrocortisone     All   \n",
       "156   Behavioral: Weight Loss Program|Behavioral: St...    Male   \n",
       "180   Behavioral: Qigong|Behavioral: Healthy Living ...  Female   \n",
       "194   Device: TraceIT®|Radiation: Volumetric Arc The...     All   \n",
       "199   Drug: Cabazitaxel, Docetaxel, Mitoxantrone or ...    Male   \n",
       "200                           Other: Preoperative level  Female   \n",
       "221                                       Drug: AZD9291     All   \n",
       "225                             Behavioral: Mindfulness     All   \n",
       "235   Drug: Apatinib/docetaxel/pemetrexed|Drug: doce...     All   \n",
       "247   Behavioral: Nutritional Counseling|Behavioral:...     All   \n",
       "250                  Procedure: Blood and tumor samples     All   \n",
       "260        Procedure: Sentinel Lymph Node Biopsy (SLNB)  Female   \n",
       "264             Drug: Oxaliplatin|Drug: Oxaliplatin LBM     All   \n",
       "280   Behavioral: Individually tailored nurse naviga...  Female   \n",
       "285                 Drug: ADI PEG20|Drug: Pembrolizumab     All   \n",
       "286                    Drug: Vinorelbine|Drug: Apatinib  Female   \n",
       "289   Device: Calypso beacon implant|Radiation: Radi...    Male   \n",
       "290   Drug: Lidocaine Hydrochloride|Drug: Placebo|Dr...     All   \n",
       "297                 Radiation: Stereotatic Radiotherapy    Male   \n",
       "...                                                 ...     ...   \n",
       "9632      Radiation: hypofraction|Radiation: convention    Male   \n",
       "9635                                       Drug: LEE011     All   \n",
       "9638  Drug: Irinotecan|Drug: Folinic Acid|Drug: 5-FU...     All   \n",
       "9646                Behavioral: Prehabilitation Program     All   \n",
       "9656     Biological: TG02-treatment|Drug: Pembrolizumab     All   \n",
       "9660                       Drug: ODM-201|Other: Placebo    Male   \n",
       "9674  Biological: PROSTVAC-V/F|Drug: Nivolumab|Drug:...    Male   \n",
       "9679                           Biological: OncoImmunome  Female   \n",
       "9702  Other: High-flow Oxygen|Other: Low-flow Oxygen...     All   \n",
       "9746  Drug: Pembrolizumab|Drug: Paricalcitol|Drug: G...     All   \n",
       "9770                                    Drug: LYC-55716     All   \n",
       "9804                    Drug: Minocycline|Drug: Placebo     All   \n",
       "9807                           Device: ClariCore System    Male   \n",
       "9815                                 Drug: Atezolizumab     All   \n",
       "9822  Drug: Encorafenib|Drug: Binimetinib|Drug: Cetu...     All   \n",
       "9832  Radiation: Electron Beam Therapy|Procedure: Lu...  Female   \n",
       "9846                                   Drug: Lorlatinib     All   \n",
       "9848  Drug: Atezolizumab (MPDL3280A), an engineered ...     All   \n",
       "9850                       Other: Placebo|Drug: Aspirin     All   \n",
       "9870                                     Drug: OTS167PO     All   \n",
       "9873                     Drug: Gabapentin|Drug: Placebo     All   \n",
       "9882  Device: Aer-O-Scope (Colonoscopy)|Procedure: C...     All   \n",
       "9909  Drug: Panitumumab|Drug: Olaparib|Drug: Dabrafe...     All   \n",
       "9916                                       Drug: TLC178     All   \n",
       "9921  Drug: Atezolizumab|Drug: Trastuzumab emtansine...     All   \n",
       "9933  Procedure: Cystectomy|Drug: Lidocaine|Drug: Sa...     All   \n",
       "9953                    Biological: AM0010|Drug: FOLFOX     All   \n",
       "9964  Radiation: Photon intensity modulated radiatio...     All   \n",
       "9974                                  Drug: INCAGN01949     All   \n",
       "9982                                Drug: Enoblituzumab    Male   \n",
       "\n",
       "                                          Age           Phases Enrollment  \\\n",
       "1        18 Years and older   (Adult, Senior)          Phase 1         30   \n",
       "2        18 Years and older   (Adult, Senior)          Phase 3         60   \n",
       "5        18 Years and older   (Adult, Senior)              NaN         36   \n",
       "10             18 Years to 60 Years   (Adult)              NaN        200   \n",
       "21       18 Years and older   (Adult, Senior)          Phase 2         25   \n",
       "30    18 Years to 100 Years   (Adult, Senior)              NaN         45   \n",
       "45             18 Years to 65 Years   (Adult)    Early Phase 1         10   \n",
       "81       19 Years and older   (Adult, Senior)          Phase 3        518   \n",
       "110      18 Years and older   (Adult, Senior)              NaN         60   \n",
       "112      18 Years and older   (Adult, Senior)  Phase 1|Phase 2         40   \n",
       "135      18 Years and older   (Adult, Senior)          Phase 1         24   \n",
       "153      18 Years and older   (Adult, Senior)          Phase 2         15   \n",
       "156      50 Years and older   (Adult, Senior)              NaN         40   \n",
       "180    18 Years to 70 Years   (Adult, Senior)              NaN         75   \n",
       "194    18 Years to 85 Years   (Adult, Senior)              NaN         10   \n",
       "199    40 Years to 75 Years   (Adult, Senior)          Phase 1         50   \n",
       "200    18 Years to 90 Years   (Adult, Senior)              NaN         25   \n",
       "221      18 Years and older   (Adult, Senior)          Phase 2         80   \n",
       "225      18 Years and older   (Adult, Senior)              NaN         60   \n",
       "235    18 Years to 75 Years   (Adult, Senior)          Phase 2        135   \n",
       "247      30 Years and older   (Adult, Senior)              NaN         60   \n",
       "250      18 Years and older   (Adult, Senior)              NaN        160   \n",
       "260      18 Years and older   (Adult, Senior)              NaN        100   \n",
       "264    18 Years to 75 Years   (Adult, Senior)          Phase 2        308   \n",
       "280      18 Years and older   (Adult, Senior)              NaN        324   \n",
       "285      18 Years and older   (Adult, Senior)          Phase 1         47   \n",
       "286    18 Years to 70 Years   (Adult, Senior)          Phase 2         66   \n",
       "289    18 Years to 80 Years   (Adult, Senior)          Phase 2        166   \n",
       "290      18 Years and older   (Adult, Senior)  Phase 1|Phase 2         38   \n",
       "297      18 Years and older   (Adult, Senior)              NaN         30   \n",
       "...                                       ...              ...        ...   \n",
       "9632   50 Years to 79 Years   (Adult, Senior)          Phase 3         60   \n",
       "9635                     Child, Adult, Senior          Phase 2         40   \n",
       "9638     18 Years and older   (Adult, Senior)          Phase 3        550   \n",
       "9646     65 Years and older   (Adult, Senior)              NaN        200   \n",
       "9656     18 Years and older   (Adult, Senior)          Phase 1         20   \n",
       "9660     18 Years and older   (Adult, Senior)          Phase 2         88   \n",
       "9674  18 Years to 100 Years   (Adult, Senior)  Phase 1|Phase 2         65   \n",
       "9679     18 Years and older   (Adult, Senior)          Phase 1         15   \n",
       "9702     18 Years and older   (Adult, Senior)          Phase 2         36   \n",
       "9746     18 Years and older   (Adult, Senior)          Phase 1         30   \n",
       "9770     18 Years and older   (Adult, Senior)  Phase 1|Phase 2         90   \n",
       "9804     65 Years and older   (Adult, Senior)          Phase 3        750   \n",
       "9807     22 Years and older   (Adult, Senior)              NaN        200   \n",
       "9815     18 Years and older   (Adult, Senior)          Phase 3       1000   \n",
       "9822     18 Years and older   (Adult, Senior)          Phase 3        645   \n",
       "9832           18 Years to 59 Years   (Adult)          Phase 2        176   \n",
       "9846     18 Years and older   (Adult, Senior)          Phase 2         30   \n",
       "9848     18 Years and older   (Adult, Senior)          Phase 2        180   \n",
       "9850   18 Years to 69 Years   (Adult, Senior)          Phase 3       2936   \n",
       "9870     18 Years and older   (Adult, Senior)          Phase 1         70   \n",
       "9873     18 Years and older   (Adult, Senior)          Phase 4        120   \n",
       "9882   45 Years to 75 Years   (Adult, Senior)              NaN        300   \n",
       "9909     18 Years and older   (Adult, Senior)          Phase 2        400   \n",
       "9916     18 Years and older   (Adult, Senior)  Phase 1|Phase 2         51   \n",
       "9921     18 Years and older   (Adult, Senior)          Phase 2        200   \n",
       "9933     18 Years and older   (Adult, Senior)              NaN         50   \n",
       "9953     18 Years and older   (Adult, Senior)          Phase 3        566   \n",
       "9964     18 Years and older   (Adult, Senior)          Phase 2        132   \n",
       "9974     18 Years and older   (Adult, Senior)  Phase 1|Phase 2        157   \n",
       "9982     18 Years and older   (Adult, Senior)    Early Phase 1         16   \n",
       "\n",
       "                                          Study Designs     Completion Date  \\\n",
       "1     Intervention Model: Single Group Assignment|Ma...     August 28, 2019   \n",
       "2     Allocation: Randomized|Intervention Model: Par...          March 2019   \n",
       "5     Intervention Model: Single Group Assignment|Ma...           June 2020   \n",
       "10    Allocation: Non-Randomized|Intervention Model:...      August 1, 2020   \n",
       "21    Intervention Model: Single Group Assignment|Ma...       November 2018   \n",
       "30    Allocation: Randomized|Intervention Model: Par...        May 31, 2019   \n",
       "45    Intervention Model: Single Group Assignment|Ma...           June 2019   \n",
       "81    Allocation: Randomized|Intervention Model: Par...   December 31, 2021   \n",
       "110   Allocation: Randomized|Intervention Model: Par...    October 31, 2017   \n",
       "112   Intervention Model: Single Group Assignment|Ma...         August 2021   \n",
       "135   Allocation: Non-Randomized|Intervention Model:...         May 1, 2020   \n",
       "153   Intervention Model: Single Group Assignment|Ma...       June 30, 2018   \n",
       "156   Allocation: Randomized|Intervention Model: Par...      September 2021   \n",
       "180   Allocation: Randomized|Intervention Model: Par...    January 30, 2018   \n",
       "194   Intervention Model: Single Group Assignment|Ma...        January 2019   \n",
       "199   Allocation: Randomized|Intervention Model: Par...       December 2020   \n",
       "200   Allocation: Non-Randomized|Intervention Model:...   December 31, 2018   \n",
       "221   Intervention Model: Single Group Assignment|Ma...   December 31, 2019   \n",
       "225   Allocation: Randomized|Intervention Model: Par...   December 22, 2017   \n",
       "235   Allocation: Randomized|Intervention Model: Par...        May 26, 2019   \n",
       "247   Allocation: Randomized|Intervention Model: Par...  September 30, 2019   \n",
       "250   Intervention Model: Single Group Assignment|Ma...       July 17, 2022   \n",
       "260   Intervention Model: Single Group Assignment|Ma...         August 2020   \n",
       "264   Allocation: Randomized|Intervention Model: Par...          April 2022   \n",
       "280   Allocation: Randomized|Intervention Model: Par...        May 31, 2021   \n",
       "285   Intervention Model: Single Group Assignment|Ma...        January 2019   \n",
       "286   Allocation: Randomized|Intervention Model: Par...         August 2020   \n",
       "289   Allocation: Randomized|Intervention Model: Par...       February 2023   \n",
       "290   Allocation: Randomized|Intervention Model: Par...        June 1, 2019   \n",
       "297   Allocation: Randomized|Intervention Model: Sin...   December 31, 2028   \n",
       "...                                                 ...                 ...   \n",
       "9632  Allocation: Randomized|Intervention Model: Par...            May 2021   \n",
       "9635  Intervention Model: Single Group Assignment|Ma...      April 27, 2022   \n",
       "9638  Allocation: Randomized|Intervention Model: Par...          March 2022   \n",
       "9646  Allocation: Randomized|Intervention Model: Par...        October 2018   \n",
       "9656  Intervention Model: Single Group Assignment|Ma...                null   \n",
       "9660  Allocation: Randomized|Intervention Model: Par...       December 2024   \n",
       "9674  Allocation: Non-Randomized|Intervention Model:...      August 1, 2021   \n",
       "9679  Intervention Model: Single Group Assignment|Ma...        October 2026   \n",
       "9702  Allocation: Randomized|Intervention Model: Cro...        October 2018   \n",
       "9746  Allocation: Non-Randomized|Intervention Model:...       February 2020   \n",
       "9770  Intervention Model: Single Group Assignment|Ma...           June 2018   \n",
       "9804  Allocation: Randomized|Intervention Model: Par...           June 2017   \n",
       "9807  Intervention Model: Single Group Assignment|Ma...       December 2017   \n",
       "9815  Intervention Model: Single Group Assignment|Ma...        May 31, 2022   \n",
       "9822  Allocation: Randomized|Intervention Model: Par...           July 2019   \n",
       "9832  Intervention Model: Single Group Assignment|Ma...    November 1, 2022   \n",
       "9846  Intervention Model: Single Group Assignment|Ma...          March 2023   \n",
       "9848  Intervention Model: Single Group Assignment|Ma...       July 31, 2023   \n",
       "9850  Allocation: Randomized|Intervention Model: Par...                null   \n",
       "9870  Intervention Model: Single Group Assignment|Ma...          April 2020   \n",
       "9873  Allocation: Randomized|Intervention Model: Par...           July 2017   \n",
       "9882  Allocation: Randomized|Intervention Model: Par...      March 20, 2018   \n",
       "9909  Allocation: Non-Randomized|Intervention Model:...       December 2019   \n",
       "9916  Intervention Model: Single Group Assignment|Ma...      September 2019   \n",
       "9921  Allocation: Randomized|Intervention Model: Par...     August 29, 2019   \n",
       "9933  Allocation: Randomized|Intervention Model: Par...         August 2018   \n",
       "9953  Allocation: Randomized|Intervention Model: Par...        January 2020   \n",
       "9964  Allocation: Randomized|Intervention Model: Par...        October 2021   \n",
       "9974  Intervention Model: Single Group Assignment|Ma...       February 2019   \n",
       "9982  Intervention Model: Single Group Assignment|Ma...        October 2019   \n",
       "\n",
       "                Intervention_types            ...             Other  \\\n",
       "1                        Radiation            ...                 0   \n",
       "2                             Drug            ...                 0   \n",
       "5               Dietary_Supplement            ...                 0   \n",
       "10                 Diagnostic_Test            ...                 0   \n",
       "21                            Drug            ...                 0   \n",
       "30                           Other            ...                 1   \n",
       "45                            Drug            ...                 0   \n",
       "81                       Procedure            ...                 0   \n",
       "110                           Drug            ...                 0   \n",
       "112   Drug Biological Other Device            ...                 1   \n",
       "135           Biological Procedure            ...                 0   \n",
       "153                           Drug            ...                 0   \n",
       "156                     Behavioral            ...                 0   \n",
       "180                     Behavioral            ...                 0   \n",
       "194     Device Radiation Procedure            ...                 0   \n",
       "199                           Drug            ...                 0   \n",
       "200                          Other            ...                 1   \n",
       "221                           Drug            ...                 0   \n",
       "225                     Behavioral            ...                 0   \n",
       "235                           Drug            ...                 0   \n",
       "247                     Behavioral            ...                 0   \n",
       "250                      Procedure            ...                 0   \n",
       "260                      Procedure            ...                 0   \n",
       "264                           Drug            ...                 0   \n",
       "280                     Behavioral            ...                 0   \n",
       "285                           Drug            ...                 0   \n",
       "286                           Drug            ...                 0   \n",
       "289               Device Radiation            ...                 0   \n",
       "290                           Drug            ...                 0   \n",
       "297                      Radiation            ...                 0   \n",
       "...                            ...            ...               ...   \n",
       "9632                     Radiation            ...                 0   \n",
       "9635                          Drug            ...                 0   \n",
       "9638                          Drug            ...                 0   \n",
       "9646                    Behavioral            ...                 0   \n",
       "9656               Biological Drug            ...                 0   \n",
       "9660                    Drug Other            ...                 1   \n",
       "9674               Biological Drug            ...                 0   \n",
       "9679                    Biological            ...                 0   \n",
       "9702                         Other            ...                 1   \n",
       "9746                Drug Procedure            ...                 0   \n",
       "9770                          Drug            ...                 0   \n",
       "9804                          Drug            ...                 0   \n",
       "9807                        Device            ...                 0   \n",
       "9815                          Drug            ...                 0   \n",
       "9822                          Drug            ...                 0   \n",
       "9832     Radiation Procedure Other            ...                 1   \n",
       "9846                          Drug            ...                 0   \n",
       "9848                          Drug            ...                 0   \n",
       "9850                    Other Drug            ...                 1   \n",
       "9870                          Drug            ...                 0   \n",
       "9873                          Drug            ...                 0   \n",
       "9882              Device Procedure            ...                 0   \n",
       "9909                          Drug            ...                 0   \n",
       "9916                          Drug            ...                 0   \n",
       "9921                    Drug Other            ...                 1   \n",
       "9933                Procedure Drug            ...                 0   \n",
       "9953               Biological Drug            ...                 0   \n",
       "9964                     Radiation            ...                 0   \n",
       "9974                          Drug            ...                 0   \n",
       "9982                          Drug            ...                 0   \n",
       "\n",
       "      Behavioral  Biological  Procedure  Combination_Product  Genetic  \\\n",
       "1              0           0          0                    0        0   \n",
       "2              0           0          0                    0        0   \n",
       "5              0           0          0                    0        0   \n",
       "10             0           0          0                    0        0   \n",
       "21             0           0          0                    0        0   \n",
       "30             0           0          0                    0        0   \n",
       "45             0           0          0                    0        0   \n",
       "81             0           0          1                    0        0   \n",
       "110            0           0          0                    0        0   \n",
       "112            0           1          0                    0        0   \n",
       "135            0           1          1                    0        0   \n",
       "153            0           0          0                    0        0   \n",
       "156            1           0          0                    0        0   \n",
       "180            1           0          0                    0        0   \n",
       "194            0           0          1                    0        0   \n",
       "199            0           0          0                    0        0   \n",
       "200            0           0          0                    0        0   \n",
       "221            0           0          0                    0        0   \n",
       "225            1           0          0                    0        0   \n",
       "235            0           0          0                    0        0   \n",
       "247            1           0          0                    0        0   \n",
       "250            0           0          1                    0        0   \n",
       "260            0           0          1                    0        0   \n",
       "264            0           0          0                    0        0   \n",
       "280            1           0          0                    0        0   \n",
       "285            0           0          0                    0        0   \n",
       "286            0           0          0                    0        0   \n",
       "289            0           0          0                    0        0   \n",
       "290            0           0          0                    0        0   \n",
       "297            0           0          0                    0        0   \n",
       "...          ...         ...        ...                  ...      ...   \n",
       "9632           0           0          0                    0        0   \n",
       "9635           0           0          0                    0        0   \n",
       "9638           0           0          0                    0        0   \n",
       "9646           1           0          0                    0        0   \n",
       "9656           0           1          0                    0        0   \n",
       "9660           0           0          0                    0        0   \n",
       "9674           0           1          0                    0        0   \n",
       "9679           0           1          0                    0        0   \n",
       "9702           0           0          0                    0        0   \n",
       "9746           0           0          1                    0        0   \n",
       "9770           0           0          0                    0        0   \n",
       "9804           0           0          0                    0        0   \n",
       "9807           0           0          0                    0        0   \n",
       "9815           0           0          0                    0        0   \n",
       "9822           0           0          0                    0        0   \n",
       "9832           0           0          1                    0        0   \n",
       "9846           0           0          0                    0        0   \n",
       "9848           0           0          0                    0        0   \n",
       "9850           0           0          0                    0        0   \n",
       "9870           0           0          0                    0        0   \n",
       "9873           0           0          0                    0        0   \n",
       "9882           0           0          1                    0        0   \n",
       "9909           0           0          0                    0        0   \n",
       "9916           0           0          0                    0        0   \n",
       "9921           0           0          0                    0        0   \n",
       "9933           0           0          1                    0        0   \n",
       "9953           0           1          0                    0        0   \n",
       "9964           0           0          0                    0        0   \n",
       "9974           0           0          0                    0        0   \n",
       "9982           0           0          0                    0        0   \n",
       "\n",
       "          Allocation       Intervention Model  \\\n",
       "1                NaN  Single Group Assignment   \n",
       "2         Randomized      Parallel Assignment   \n",
       "5                NaN  Single Group Assignment   \n",
       "10    Non-Randomized    Sequential Assignment   \n",
       "21               NaN  Single Group Assignment   \n",
       "30        Randomized      Parallel Assignment   \n",
       "45               NaN  Single Group Assignment   \n",
       "81        Randomized      Parallel Assignment   \n",
       "110       Randomized      Parallel Assignment   \n",
       "112              NaN  Single Group Assignment   \n",
       "135   Non-Randomized    Sequential Assignment   \n",
       "153              NaN  Single Group Assignment   \n",
       "156       Randomized      Parallel Assignment   \n",
       "180       Randomized      Parallel Assignment   \n",
       "194              NaN  Single Group Assignment   \n",
       "199       Randomized      Parallel Assignment   \n",
       "200   Non-Randomized      Parallel Assignment   \n",
       "221              NaN  Single Group Assignment   \n",
       "225       Randomized      Parallel Assignment   \n",
       "235       Randomized      Parallel Assignment   \n",
       "247       Randomized      Parallel Assignment   \n",
       "250              NaN  Single Group Assignment   \n",
       "260              NaN  Single Group Assignment   \n",
       "264       Randomized      Parallel Assignment   \n",
       "280       Randomized      Parallel Assignment   \n",
       "285              NaN  Single Group Assignment   \n",
       "286       Randomized      Parallel Assignment   \n",
       "289       Randomized      Parallel Assignment   \n",
       "290       Randomized      Parallel Assignment   \n",
       "297       Randomized  Single Group Assignment   \n",
       "...              ...                      ...   \n",
       "9632      Randomized      Parallel Assignment   \n",
       "9635             NaN  Single Group Assignment   \n",
       "9638      Randomized      Parallel Assignment   \n",
       "9646      Randomized      Parallel Assignment   \n",
       "9656             NaN  Single Group Assignment   \n",
       "9660      Randomized      Parallel Assignment   \n",
       "9674  Non-Randomized      Parallel Assignment   \n",
       "9679             NaN  Single Group Assignment   \n",
       "9702      Randomized     Crossover Assignment   \n",
       "9746  Non-Randomized      Parallel Assignment   \n",
       "9770             NaN  Single Group Assignment   \n",
       "9804      Randomized      Parallel Assignment   \n",
       "9807             NaN  Single Group Assignment   \n",
       "9815             NaN  Single Group Assignment   \n",
       "9822      Randomized      Parallel Assignment   \n",
       "9832             NaN  Single Group Assignment   \n",
       "9846             NaN  Single Group Assignment   \n",
       "9848             NaN  Single Group Assignment   \n",
       "9850      Randomized      Parallel Assignment   \n",
       "9870             NaN  Single Group Assignment   \n",
       "9873      Randomized      Parallel Assignment   \n",
       "9882      Randomized      Parallel Assignment   \n",
       "9909  Non-Randomized      Parallel Assignment   \n",
       "9916             NaN  Single Group Assignment   \n",
       "9921      Randomized      Parallel Assignment   \n",
       "9933      Randomized      Parallel Assignment   \n",
       "9953      Randomized      Parallel Assignment   \n",
       "9964      Randomized      Parallel Assignment   \n",
       "9974             NaN  Single Group Assignment   \n",
       "9982             NaN  Single Group Assignment   \n",
       "\n",
       "                                                Masking  \\\n",
       "1                                     None (Open Label)   \n",
       "2     Quadruple (Participant, Care Provider, Investi...   \n",
       "5                                     None (Open Label)   \n",
       "10                                    None (Open Label)   \n",
       "21                                    None (Open Label)   \n",
       "30                                    None (Open Label)   \n",
       "45                                    None (Open Label)   \n",
       "81                                    None (Open Label)   \n",
       "110            Double (Investigator, Outcomes Assessor)   \n",
       "112                                   None (Open Label)   \n",
       "135                                   None (Open Label)   \n",
       "153                                   None (Open Label)   \n",
       "156                                   None (Open Label)   \n",
       "180            Double (Investigator, Outcomes Assessor)   \n",
       "194                                   None (Open Label)   \n",
       "199                 Double (Participant, Care Provider)   \n",
       "200                  Double (Participant, Investigator)   \n",
       "221                                   None (Open Label)   \n",
       "225                                   None (Open Label)   \n",
       "235                  Double (Participant, Investigator)   \n",
       "247                          Single (Outcomes Assessor)   \n",
       "250                                   None (Open Label)   \n",
       "260                                   None (Open Label)   \n",
       "264                                   None (Open Label)   \n",
       "280                          Single (Outcomes Assessor)   \n",
       "285                                   None (Open Label)   \n",
       "286                                   None (Open Label)   \n",
       "289                                   None (Open Label)   \n",
       "290   Quadruple (Participant, Care Provider, Investi...   \n",
       "297                                   None (Open Label)   \n",
       "...                                                 ...   \n",
       "9632                                  None (Open Label)   \n",
       "9635                                  None (Open Label)   \n",
       "9638                                  None (Open Label)   \n",
       "9646                         Single (Outcomes Assessor)   \n",
       "9656                                  None (Open Label)   \n",
       "9660  Quadruple (Participant, Care Provider, Investi...   \n",
       "9674                                  None (Open Label)   \n",
       "9679                                  None (Open Label)   \n",
       "9702                 Double (Participant, Investigator)   \n",
       "9746                                  None (Open Label)   \n",
       "9770                                  None (Open Label)   \n",
       "9804  Quadruple (Participant, Care Provider, Investi...   \n",
       "9807                                  None (Open Label)   \n",
       "9815                                  None (Open Label)   \n",
       "9822                                  None (Open Label)   \n",
       "9832                                  None (Open Label)   \n",
       "9846                                  None (Open Label)   \n",
       "9848                                  None (Open Label)   \n",
       "9850                 Double (Participant, Investigator)   \n",
       "9870                                  None (Open Label)   \n",
       "9873                 Double (Participant, Investigator)   \n",
       "9882                                  None (Open Label)   \n",
       "9909                                  None (Open Label)   \n",
       "9916                                  None (Open Label)   \n",
       "9921                 Double (Participant, Investigator)   \n",
       "9933                 Double (Participant, Investigator)   \n",
       "9953                                  None (Open Label)   \n",
       "9964                                  None (Open Label)   \n",
       "9974                                  None (Open Label)   \n",
       "9982                                  None (Open Label)   \n",
       "\n",
       "               Primary Purpose  \n",
       "1                    Treatment  \n",
       "2              Supportive Care  \n",
       "5                Basic Science  \n",
       "10                  Diagnostic  \n",
       "21                   Treatment  \n",
       "30                  Prevention  \n",
       "45                   Treatment  \n",
       "81                   Treatment  \n",
       "110            Supportive Care  \n",
       "112                  Treatment  \n",
       "135                  Treatment  \n",
       "153                  Treatment  \n",
       "156              Basic Science  \n",
       "180                  Treatment  \n",
       "194                  Treatment  \n",
       "199                  Treatment  \n",
       "200   Health Services Research  \n",
       "221                  Treatment  \n",
       "225            Supportive Care  \n",
       "235                  Treatment  \n",
       "247            Supportive Care  \n",
       "250              Basic Science  \n",
       "260                  Treatment  \n",
       "264                  Treatment  \n",
       "280            Supportive Care  \n",
       "285                  Treatment  \n",
       "286                  Treatment  \n",
       "289                  Treatment  \n",
       "290                 Prevention  \n",
       "297                  Treatment  \n",
       "...                        ...  \n",
       "9632                 Treatment  \n",
       "9635                 Treatment  \n",
       "9638                 Treatment  \n",
       "9646                Prevention  \n",
       "9656                 Treatment  \n",
       "9660                 Treatment  \n",
       "9674                 Treatment  \n",
       "9679                 Treatment  \n",
       "9702           Supportive Care  \n",
       "9746                 Treatment  \n",
       "9770                 Treatment  \n",
       "9804                Prevention  \n",
       "9807                Diagnostic  \n",
       "9815                 Treatment  \n",
       "9822                 Treatment  \n",
       "9832                 Treatment  \n",
       "9846                 Treatment  \n",
       "9848                 Treatment  \n",
       "9850                 Treatment  \n",
       "9870                 Treatment  \n",
       "9873                 Treatment  \n",
       "9882                 Screening  \n",
       "9909                 Treatment  \n",
       "9916                 Treatment  \n",
       "9921                 Treatment  \n",
       "9933           Supportive Care  \n",
       "9953                 Treatment  \n",
       "9964                 Treatment  \n",
       "9974                 Treatment  \n",
       "9982                 Treatment  \n",
       "\n",
       "[1062 rows x 25 columns]"
      ]
     },
     "execution_count": 34,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "medical_cond = 'cancer'\n",
    "# Searching for a given medical condition\n",
    "LowerCase_df1 = df1.apply(lambda x: x.astype(str).str.lower())\n",
    "df1[LowerCase_df1['Conditions'].str.contains(medical_cond) ==True]\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(227, 25)"
      ]
     },
     "execution_count": 35,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Filtering out using multiple conditions\n",
    "mask = (LowerCase_df1['Conditions'].str.contains('cancer') == True) & (LowerCase_df1['Age'].str.contains('18') == True)\n",
    "mask = mask & (LowerCase_df1['Phases'].str.contains('1') == True)\n",
    "df1[mask].shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {},
   "outputs": [],
   "source": [
    "def get_categories(atr):\n",
    "    '''\n",
    "    Calculate partition size for a categorical variable or simply the categories (Excluding NaN)\n",
    "    '''\n",
    "    s = (set(df1.groupby(atr).size().keys())).difference({'NaN'})\n",
    "    return len(s)\n",
    "\n",
    "#s = (set(df1.groupby(['Allocation']).size().keys())).difference({'NaN'})\n",
    "#len(s)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "#k = df1.keys()\n",
    "atr_cat ={}\n",
    "for atr in list(df1.keys()):\n",
    "    atr_cat[atr] = get_categories(atr)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.axes._subplots.AxesSubplot at 0x7f56a3d91e10>"
      ]
     },
     "execution_count": 38,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAXQAAAFdCAYAAAATwJatAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\nCIKgJYRAD4IgaAkh0IMgCFrC/w8/EpaO22lt5QAAAABJRU5ErkJggg==\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7f56ad8c3dd0>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.ylim(0,40)\n",
    "s = pd.Series(atr_cat).sort_values(ascending=False)\n",
    "s.plot.bar()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Int64Index([   0,  194,  260,  510,  589,  612,  862,  899, 1039, 1175, 1297,\n",
       "            1339, 1667, 1807, 1814, 1925, 1933, 1951, 2230, 2408, 2435, 2469,\n",
       "            2571, 2870, 2927, 2993, 3001, 3155, 3210, 3441, 3483, 3580, 3644,\n",
       "            3715, 3736, 3812, 3872, 3924, 4270, 4812, 4861, 4997, 5018, 5099,\n",
       "            5235, 5315, 5336, 5377, 5412, 5677, 5806, 5993, 6016, 6190, 6217,\n",
       "            6480, 6595, 6618, 6644, 6856, 6999, 7274, 7292, 7297, 7305, 7410,\n",
       "            7752, 7874, 7972, 8022, 8129, 8167, 8172, 8337, 8447, 8462, 8475,\n",
       "            8558, 8578, 8622, 8637, 8712, 8971, 8996, 9229, 9416, 9493, 9638,\n",
       "            9822, 9921, 9974],\n",
       "           dtype='int64')"
      ]
     },
     "execution_count": 46,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#for val in df1['Conditions'].values:\n",
    "#    v = val.split('|')\n",
    "#    for s in v:\n",
    "#        df1['Conditions'].apply(lambda x:similar(x,s)) > 0.5\n",
    "#df1[df1['Conditions'].apply(lambda x:similar(x,s)) > 0.5].index"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "---\n",
    "We can see from above graph features such as primary purpose, phases, Masking has higher number of categories.\n",
    "Although we should reorder the above ordering after grouping similar categories, as explained in the case of Conditions since the grouping is done based on string matching, so we should group some categories with similar string content. (We can define a measure of similarity with sequence matching and presence of particular string)\n",
    "Feature such as NCT Number is unqiue hence if patient know them we can narrow down our search to the exact clinical trial. But, In most cases patient won't be knowing it.\n",
    "Large number of categories are shown by Age atribute, again we've to look for ways to club similar categories into one.\n",
    "Once we get the proper grouping done, we can use the above approach to know what questions we should ask to narrow our search space."
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 2",
   "language": "python",
   "name": "python2"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 2
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython2",
   "version": "2.7.13"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
